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1. Food toxicology 
 
Nutrition is a primary necessity, safe nutrition is therefore of pivotal importance to human 
health and wellbeing. Humans have always been practicing food toxicology. In pre-historic 
times, humans were hunter-gatherers; berries picked could be poisonous and hunted meat 
could become spoiled. Consuming, and thus testing, gathered and hunted food could lead to 
illness and even death. In later times, food toxicology would be practiced by food tasters that 
were employed by monarchs. Evidence of the existence of food tasters goes back to ancient 
Rome and are even still employed in the modern world. Famous state heads employing food 
tasters are for instance the Russian president Vladimir Putin and most, if not all, US presidents 
[1]. Not all food contaminants make you ill instantly. Most food-induced illnesses occur 
slowly and are more due to an unhealthy diet than to bacterial contamination and poison. 
The current Western diet generally considered an unhealthy diet. It includes high levels of 
sugars and fats and is usually highly processed. This all contributes to the development of the 
metabolic syndrome that is associated with a higher risk of cardiovascular diseases and many 
other diseases [2].
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2. The Maillard reaction 
2.1 The reaction 
During food processing, new compounds are introduced to food and process contaminants 
are being formed. Additionally, food products are often enriched with sugars and fats; 
proteins are often added to obtain foods that may help build muscle. All of these can 
potentially impact human health. The processes that food products undergo often include 
industrial heat treatments, such as sterilization, but also cooking and baking at home. During 
thermal treatment of foods that contain proteins and carbohydrates, the Maillard reaction 
(MR) can occur. This is a chemical reaction between reducing sugars and amino acids, which 
is responsible for the browning of food. The MR is an intricate reaction with multiple parallel 
and sequential steps, as presented in figure 1. In the first initial stage, a carbonyl (from 
reducing sugars, oxidized lipids, vitamin C or quinones) condensates with an amine moiety in 
amino acids and proteins, and leads to the formation of a Schiff base adduct. Following this 
stage, the Schiff base adduct is rearranged into an Amadori product in the intermediate stage. 
Amadori products are unstable and prone to polymerization due to being highly unsaturated. 
In the final stage, both sequential and parallel reactions lead to different molecules. These 
reactions include oxidation, dehydration, enolization, cyclization, and fragmentation [3]. 
During the MR many different classes of compounds are formed. These compounds are also 
known as MR products (MRPs), which include Amadori products, early glycation products, 
advanced glycation endproducts (AGEs) and melanoidins. 
Especially the subgroup AGEs which are formed during one of the last stages of the MR 
have received attention lately.  The term AGEs implies a whole group of different molecules. 
Some well-known AGEs are: Nε-carboxymethyl-lysine (CML), Nε-carboxyethyl-lysine (CEL), 
methylglyoxal-derived hydroimidazolone-1 (MG-H1), pentosidine, and pyrraline. Within the 
large group of different AGEs it is possible to make a distinction between low molecular 
weight (LMW) and high molecular weight (HMW) AGEs. LMW AGEs consist of up to four 
Figure 1. Simplified overview on AGE formation via the Maillard reaction. As an example, the molecular structure 
of four different AGEs are shown. 
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linked rings weighing up to 1 kDa [4]. HMW AGEs are assumed to be water-soluble and 
coloured, weighing up to 150 kDa [4]. Additionally, AGEs exist in both a protein-bound form 
and a free form and their visible colour is brown. The formation of AGEs has been nicely 
explained by Poulsen et al. (2013) [3]. AGEs do not only form during the MR, other reactions 
may lead to the formation of AGEs as well. Intermediate compounds that can form AGEs are 
1,2-dicarbonyl derivatives such as glyoxal (GO), methylglyoxal (MG), and 3-deoxyglucosone 
(3-DG), which can interact with monoacids to form AGEs. MG and GO can be formed during 
caramelization, while through the radical Namiki pathway (lipid oxidation) 1,2-dicarbonyls 
can also be formed [5]. Fructose metabolites such as fructose-3-phosphate are formed in 
the polyol pathway which are then converted into α-oxaldehydes. α-Oxaldehydes can form 
AGEs by interacting with monoacids [6, 7]. The formation of MRPs can be monitored by the 
formation of brown colours, as Hofmann et al. (1998) stated that the browning intensity 
seemed to be parallel with cross-linking of casein [8].
2.2 Factors influencing the MR 
The MR and other pathways through which AGEs form, can be influenced by different 
factors. AGEs formed in food products are named dietary AGEs (dAGEs). An important factor 
influencing the rate of dAGE formation is the macronutrient composition of the food products. 
The presence of sugar leads to both initiation of the MR and caramelization. Proteins are 
made up from amino acids, so their presence increases the rate of the MR as well. Lipids 
can be oxidized, leading to the formation of 1,2-dicarbonyls via the Namiki pathway [3]. One 
factor relating to this is the reactivity of the amino groups themselves. Primary amines are 
more reactive than secondary amines, whereas tertiary amines are inactive [9].  The primary 
amino group present in the side-chains of lysine is the most reactive precursor amine in 
proteins. Next to this, the guanidino group of arginine, the indole group of tryptophan, and 
the imidazole group of histidine are reactive sites, but to a lesser extent. Practically any 
N-terminal amino group and free amino group is reactive [10]. The sugars that react in the MR 
are reducing sugars. These are sugars with a free aldehyde or ketone group such as glucose, 
galactose and fructose [11]. Besides these groups, other chemical characteristics of sugars, 
carbohydrates, and amino acids also determine their reactivity in the MR. In a very early 
study by Ashoor et al. (1984), the browning of common amino acids in combination with 
different sugars was assessed and the different amino acids were categorized by high, middle, 
and low reactivity [12]. The high reactivity group included Lys, Gly, Trp, and Tyr. The middle 
group included Pro, Leu, Ile, Ala, Hypro, Phe, Met, Val, Gln, Ser, and Asn. The amino acids 
with the lowest reactivity in their study were His, Thr, Asp, Arg, Glu, and Cys [12]. Although 
the high reactivity of lysine is shown in several studies, the level of reactivity of the other 
amino acids is under dispute [10, 13-15].  Kwak et al. (2004) analysed the browning of all 
possible combinations between 12 different amino acids with five different sugars (glucose, 
fructose, maltose, xylose, and arabinose), which is an indication of MRP formation. Lysine 
showed the highest formation of MRPs with all five sugars. The order of reactivity of the other 
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amino acids depended on the type of sugar: pentoses were for instance more reactive than 
hexoses [14]. Most commonly analysed and used dAGEs are therefore formed from lysine 
and arginine. In the case of glucose, arginine was indeed the second most reactive amino 
acid. However, the reaction between glucose and arginine did not lead to a brown colour, 
despite the fact that glucose was depleted quickly. By using a peptide library (SPOT library) 
to assess the reactivity of different amino acid residues to glucose, fructose and AGE-BSA, 
Münch et al. (1999) also found that the binding reactivity of amino acids depended on the 
type of sugar or dAGE provided [10]. In the case of glucose and fructose, amino acids with 
nucleophilic side chains (lysine, cysteine, and histidine) were prone to bind these sugars, 
whereas AGE-BSA preferentially bound to arginine and tryptophan and to a lesser extent to 
lysine. This difference in binding reactivity between dAGEs and reducing sugars could be an 
explanation why both lysine and arginine based protein-bound dAGEs are largely present in 
food products. 
To identify the products formed during the MR, Hemmler et al. (2018) recently used a non-
targeted analysis with Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR-
MS) to derive the molecular formulae of compounds formed after 10 h of heating at 100°C 
for different sugar-amino acid combinations [15]. The reaction rate order that was found 
for amino acids was: lysine > cysteine > isoleucine ≈ glycine. Interestingly, when assessing 
the browning of the different combinations, the order of reactivity was lysine > isoleucine 
> glycine > cysteine. Showing that cysteine produces many non-brown MRPs. The order 
of reaction rates for the sugars was: ribose > arabinose > fructose ≈ xylose > galactose > 
glucose. Joubran et al. (2017) confirmed the higher galactose reactivity compared to glucose 
in combination with α-lactalbumine. Which can be explained by the equatorial orientation of 
the hydroxyl groups in glucose and glucose’ stable closed-ring structure. The open chain-form 
of sugars react more quickly than the closed ring [16]. Important in the sugar reactivity is also 
the proportion of free carbonyls and the length of the carbon backbone. As seen earlier in the 
study of Kwak et al. (2004), pentoses have a faster reaction rate than hexoses. Next to this, 
the monosaccharides have a higher reactivity than disaccharides, with disaccharide being 
more reactive than oligosaccharides [16, 17]. 
Next to the composition of the raw materials, baking conditions influence the formation of 
dAGEs to a large extent [18]. An increase in temperature leads to an increased formation of 
dAGEs. The compounds formed during the different pathways are very reactive, but for the 
reaction to continue the molecules must react with each other. Therefore, diluting these 
molecules in aqueous solutions slows down the formation of dAGEs. Also, H+ ions are capable 
of binding to the intermediate reactants, making them less reactive and slowing down the 
formation of dAGEs. These effects have nicely been reviewed by Lund et al. (2017) [17]. The 
MR is an ongoing reaction and therefore does not only occur during the processing of food 
products, but also during the storage of food. Storage conditions apparently influence the 
rate of the MR, like temperature and moisture/humidity level [19]. Since 1,2-dicarbonyls can 
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be formed via the Namiki pathway from the oxidation of fat, the presence of oxygen in the 
packaging can accelerate the MR, while addition of antioxidants may hamper the rate of the 
MR due to trapping of oxidation products. A practical example of the importance of starting 
product in the MR is the difference between goat’s milk infant formula and cow’s milk infant 
formula. Infant formulas from goat’s milk have a lower CML content than from cow’s milk, 
consequently also heat processing leads to lower levels of CML in goat’s milk compared to 
cow’s milk [20]. 
As mentioned earlier, Amadori products, early glycation products, AGEs and melanoidins all 
fall under the umbrella term ‘MRPs’. Hence, all these compounds are being formed during 
thermal processing of food rich in carbohydrates and proteins. Therefore, a problem that 
arises with studies into the effect of dAGEs when using food matrices, is the simultaneous 
formation of this broad and varying subset of molecules and the unclear border between 
these different subsets. dAGEs have defined molecular structures such as CML, CEL, MG-
H1, pentosidine, and pyrraline. A second subset of molecules formed in the end-stage of 
the MR are melanoidins, which have a higher molecular weight than dAGEs. The dAGEs are 
considered to be the reactive intermediates, whose condensation forms melanoidins [21, 
22]. The use of the terms ‘AGEs’ and ‘melanoidins’ in existing literature is not always fully 
clear. dAGEs contribute to the brown colour of thermally treated food and some of them have 
fluorescent properties. Remarkably, melanoidins are also defined as brown, high molecular 
weight heterogeneous polymers, and are usually analysed in food products by measuring 
the intensity of the browning and fluorescence [21]. It is therefore almost impossible to out 
rule the presence of dAGEs in those studies measuring melanoidin levels only. The presence 
and ratio of the different subsets in food products is dependent on the food matrix and the 
above discussed processing conditions. The difficult distinction within the end-stage of the 
MR makes it difficult to attribute the effects of heated foods to specific compounds. In this 
chapter we will try to distinguish between the different subsets and focus on the effects of 
dAGEs as a subset but will include the effects of MRPs in general since all of these compounds 
are present in food, but attempt to make a distinction in the terminology where possible. 
When discussing literature, it will be specifically stated which subset of compounds were 
investigated. 
2.3 Assessment of dietary AGEs in food products 
In order to define the characteristics of dAGE-rich food products, it is important to know 
in what kind of food products they are present. This brings us to an important problem in 
current literature. Since dAGEs are a heterogeneous group of compounds, it makes it difficult 
to analyse them very specifically. Different methods are being used throughout literature 
to determine the amount of dAGEs present in different food products. Several AGEs have 
fluorescent properties and the fluorescence spectrum of vesperlysine (λex = 370 nm/λem 
= 440 nm) is considered as an AGE-wide specific fluorescence in multiple studies [23-25]. A 
major drawback of this method is that not all AGEs have fluorescent properties. For instance 
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CML, which is regarded in current literature as the most important dAGE in food, does not 
have any fluorescent properties [26]. A different technique used in multiple studies to detect 
dAGE presence is competitive ELISA [27]. Both ELISA and fluorescence assays are easy to 
perform but have a low accuracy in measuring dAGEs. As stated before, dAGEs are a group 
of different compounds and for ELISA you need specific antibodies for specific molecules. 
Goldberg et al. (2004) made a database of food products measured with an AGE ELISA using 
anti-CML antibodies [27]. It is however questionable what specific molecules are recognized 
by the anti-AGE antibodies. The values obtained in these studies are expressed as AGE-kU, 
for which the definition of AGE-kU remains unclear. It is therefore only possible to compare 
trends between food products within the same study. More specific analytical techniques 
are based on chromatography and mass spectrometry. UPLC-MS/MS can more specifically 
measure specific molecules and quantify them. Other, less often used, techniques are nuclear 
magnetic resonance (NMR) spectroscopy [28] and size exclusion chromatography combined 
with fluorescence [29]. All methods used in the analysis of MRPs have been recently reviewed 
by Troise [30]. Interestingly, the use of different techniques leads to different results. Figure 2 
depicts the average CML content of different food groups per average portion size, comparing 
the results of the ELISA database of Goldberg et al. (2004) and the mass spectrometry 
database of Hull et al. (2012) [27, 31]. As can be seen, the trend between the two methods is 
completely different. This was also seen by Niquet-Léridon et al. (2015), who showed lower 
CML levels and other CML patterns when comparing food groups, especially in the fat and 
carbohydrate food groups, when measured by ELISA compared to the LC-MS/MS 
measurement [32].   
Figure 2. Difference in AGE content of food products using different quantification methods. (A) Data from Hull et 
al. (2012) [31]. (B) Data from analyses using CML antibodies from Goldberg et al. (2004) [27].
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Several databases exist on the amount of dAGEs in food products measured by mass 
spectrometry. Scheijen et al. (2016) assessed CML, CEL, and MG-H1 levels in the Dutch food 
products [33], Delatour et al. (2009) assessed CML in dairy products [34], and Hull et al. 
(2012) assessed a vast range of food products from the Western diet on CML levels [31]. The 
precursors 3-DG, 3-deoxygalactosone, MG, and 5-hydroxymethylfurfural (HMF) have been 
assessed by Degen et al. (2012) [35]. Table 1 shows a selection of food products relatively 
high in dAGE content, based on the database published by Scheijen et al. (2016). 
Additionally, although the databases published give good indications on the levels of specific 
dAGEs in food products, they do not make a distinction between free and protein-bound 
dAGEs. Protein-bound dAGEs are in general much more abundant in food products than free 
dAGEs, as was recently reviewed by Zhao et al. (2019) [36]. The ratios in which dAGEs are 
present in either free or protein-bound form seems to depend on the type of food product, 
as was shown in the study by Hegele et al. (2008) who compared levels of free and protein-
bound dAGEs in raw and processed milk products [37]. In samples of pasteurized milk, 
especially the early glycation product Nɛ-fructoselysine was found to be up to 800-fold higher 
present in protein-bound form compared to free form, protein bound CML was found in levels 
30-fold higher than its free form. Levels of dAGEs in pasteurized and ultra-high temperature 
(UHT) treated milk did not differ significantly from levels found in raw milk. Increasing the 
processing however led to much higher levels of dAGEs as in the case of condensed milk. 
Processed food proteins generally have 2% of their lysine modified. However, in samples like 
heated milk and bread crust this can be up to 10-20% [38]. 
Table 1. Average CML, CEL, and MG-H1 content of several food products as published by Scheijen et al. (2016) [33].
Food product CML (mg)/100g CEL (mg)/100g MG-H1 (mg)/100g
Blood sausages 4.8 7.7 63.0
Peanut butter 3.1 6.7 44.5
Cereals 2.0 1.6 41.6
Ginger biscuit 2.5 2.0 28.3
Salted peanuts 1.7 3.4 25.7
Rusk 2.0 1.4 23.1
Red cooked beef 2.0 5.6 13.5
Chocolate sprinkles 
“Hagelslag” 5.1 2.0 9.3
Canned salmon 1.2 2.8 11.0
Fried tofu 0.9 1.2 10.9
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3. Endogenous AGEs
As stated before, the specific MRP subset AGEs has gained a lot of attention in recent 
years due to their potential negative effect on human health. Existing literature on AGEs 
mostly focuses on endogenously formed AGEs, which form when endogenous sugars 
react with endogenous proteins at 37°C. The health effects of endogenous AGEs, including 
inflammation, tissue damage, stiffening of collagen, and enhancement of oxidative stress, 
have been studied thoroughly [5]. AGEs can bind to different receptors, of which the receptor 
for advanced glycation endproducts (RAGE) is the most well known receptor. Under normal 
physiological conditions, RAGE is expressed at low levels in all organs, except in lung tissue, 
which has a high baseline expression of RAGE [39]. Under pathophysiological conditions, 
such as diabetes, inflammatory diseases, and neurodegenerative disorders, RAGE is strongly 
upregulated in different tissues, such as vasculature, central nervous system and gastro-
intestinal tract [39-41]. RAGE is a 35 kDa transmembrane receptor and member of the 
immunoglobulin superfamily, a large protein superfamily that shares structural features with 
antibodies [42]. Different variants of RAGE exist, of which full length RAGE is the only variant 
that is both capable of ligand binding and signal transduction. Full length RAGE consists of the 
extracellular site of a V-type domain for ligand binding and two C-type domains of which the 
exact function is unknown. RAGE is integrated in the cell membrane with a transmembrane 
spanning helix, and intracellularly consists of a C-terminal cytosolic domain for signal 
transduction [40, 43, 44]. RAGE is proposed to be a pattern recognition receptor and has many 
different ligands next to AGEs, among which are proteins with high inflammatory potentials 
such as high mobility group box 1 (HMGB1), lipopolysaccharides (LPS), the signalling molecule 
lysophosphatic acid, damage-associated molecular patterns, and advanced oxidation protein 
products [39, 40, 43, 45, 46]. RAGE signalling and outcome has been discussed in several 
reviews [40, 47]. RAGE signalling leads to several different (patho)physiological outcomes 
including, but not limited to, inflammation, oxidative stress, apoptosis, proliferation, and 
autophagy [40]. Upon extracellular ligand binding and activation, a small intracellular protein, 
mDia1, binds to the cytosolic C-domain of RAGE, activating nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-κB) through phosphoinositide 3-kinase (PI3K), eventually 
leading to the release of an array of pro-inflammatory cytokines such as interleukin (IL)-1β, 
IL-6, tumour necrosis factor (TNF)-α, and chemokine ligand 2 (CCL2). This was confirmed 
by blockage of RAGE, which resulted in delaying the inflammatory response [40, 48]. In 
macrophages, ligand binding to RAGE induces a pro-inflammatory phenotype, resembling 
the pattern of M1 polarized macrophages, and stimulated the migration of monocytes and 
leukocytes through the endothelium [49]. RAGE signalling furthermore results in a positive-
feedback loop through activation of NF-κB, which in turn upregulates RAGE expression [6, 
39]. In addition to RAGE, AGEs bind to a variety of different other receptors, which are mainly 
implicated in regulating endocytosis and degradation of AGEs. These receptors include 
macrophage scavenger receptors, 80 K-H phosphoprotein (AGE-R2), galectin-3 (AGE-R3), 
lectin-like oxidized low density lipoprotein receptor-1 (Lox-1), fasciclin EGF-like, laminin-
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type EGF-like, link domain-containing scavenger receptor-1/2 (FEEL1/2), and CD36 [40]. 
Furthermore, AGEs bind to AGER1, also known as oligosaccharyl transferase-48 (OST48). This 
receptor is involved in cellular uptake and degradation of AGEs and has been found to inhibit 
RAGE activated NF-κB activation and to mitigate the generation of reactive oxygen species 
(ROS) by RAGE, as well as the downstream effects [50-52]. In case of inflammatory diseases, 
the AGER1 to RAGE ratio seems to be decreased [53].
Apart from an inflammatory response, AGEs induce oxidative stress. After ligand binding, 
RAGE activates nicotinamide adenine dinucleotide phosphate (NADPH)-oxidases, eventually 
leading to the formation of ROS [51]. Activation of RAGE also eventually leads to an increased 
intracellular nitric oxide synthase (iNOS) expression [54, 55]. Next to RAGE-induced ROS, 
AGEs themselves are formed under oxidative conditions making them very pro-oxidant 
molecules [56-58]. Due to their pro-oxidative nature, AGEs react with proteins, resulting in 
cross-linking or other irreversible modifications, leading to loss of protein function [3]. It has 
been suggested that AGEs increase stiffness in muscle tissue, probably via cross-linking to 
collagen and elastin, leading to alterations in muscle function [59]. Other consequences are 
glycation of the blood-brain barrier, modification of low-density lipoprotein (LDL), impaired 
wound healing and non-enzymatic glycation of DNA [60, 61]. 
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4. Dietary AGEs
As stated before, AGEs specifically formed during food processing are considered as dAGEs. 
Differences in the health effects between endogenous AGEs and dAGEs may be expected 
due to the different manner of formation between both: endogenous AGEs are formed at 
37°C with endogenous carbohydrates and endogenous proteins over a longer period of time, 
while dAGEs are formed with exogenous proteins and carbohydrates in a shorter period of 
time and under more extreme conditions, e.g. higher temperatures. Consequently, different 
subsets of molecules are expected to be formed. This was also shown in a recent review by 
Liang et al. (2019), who summarized the occurrence of different AGEs in food and in the 
body [62]. The systemic effects caused by endogenous AGEs can therefore not be directly 
extrapolated to the potential effect of dAGEs. 
4.1 Absorption
In order to be able to assess the systemic and local effects of dAGEs, it is important to 
know whether dAGEs are absorbed. When dAGEs are not absorbed, they will remain in the 
gastrointestinal (GI) tract, travel further and potentially affect the colon. A few reviews have 
already included an assessment of the absorption of specific dAGEs: Delgado et al. (2015) 
concluded that CML is taken up to some extent. More specifically, free CML was most likely 
absorbed by simple diffusion, and CML bound to dipeptides by peptide transporters (PEPT1) 
[63]. Faist et al. (2001) and Somoza et al. (2005) both concluded that MRPs are most likely 
taken up, but that more research on the uptake and mechanisms is needed to confirm this. 
In general, HMW dAGEs may be absorbed to a much lesser extent than LMW dAGEs [64, 
65]. Besides these reviews, several in vitro studies on the absorption mechanism of specific 
AGEs have been published and their results are summarized in table 2. Most free dAGEs are 
capable of entering the GI cells by diffusion, but seem to be retained inside the cell, whereas 
peptide-bound dAGEs are transported inside the cell by peptide transporters. The absorption 
of dAGEs has also been investigated in several in vivo animal studies. It should be noted 
that the physiological relevance of such animal studies regarding the uptake in humans is 
debatable, due to large differences in GI physiology between the animal species and humans. 
Taking the available animal studies into account, differences between free compounds and 
protein bound compounds exist in their ability to be absorbed. When assessing the different 
animal studies, free compounds seem to be taken up more easily [3], although this seems 
not to be the case for free CML [66]. HMW dAGEs are less absorbed due to insufficient 
degradation by GI enzymes. Intragastric administration of 18F- CML in mice showed a 48% 
accumulation of CML in the intestines, 29% in bladder, and 18% in stomach, 120 min after 
administration [67]. Several human studies saw correlations between dAGE intake and serum 
AGE levels [68-70]. An intervention study with a low-AGE diet showed that changes in serum 
CML and the AGE precursor MG significantly correlated with changes in dAGE levels in the 
diet [71]. This is also seen in infants fed with formulas (IF), which contain more CML than 
human breast milk. Infants solely fed with IF had higher levels of CML in their blood and urine 
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than breast-fed infants [72]. Additionally, urinary excretion of pyrraline, fructoselysine (both 
90%) and pentosidine (40%) decreased in adults while consuming a diet low in dAGEs. No 
difference was seen for peptide-bound Amadori products [70]. A different study by Davis et 
al. (2015) exposed overweight and obese adults to a crossover exposure of one day to high-
fat, high-AGE and another day to low-fat, high-AGE diet. These acute exposures showed no 
important influence of dietary CML on CML serum levels, but rather an effect of high-fat diet 
compared to low-fat diet on CML serum levels [73]. A recent study by Scheijen et al. (2018) 
assessed total (no distinction between free and protein bound) dietary CML, CEL and MG-
H1 of 450 people with an elevated risk for T2DM and cardiovascular disease. A correlation 
between the intake of all three dAGEs and their free form levels in plasma was found. This 
correlation was however not found for the protein-bound plasma levels of the different 
dAGEs [74]. Based on this, it can be concluded that free dAGEs are indeed taken up in the 
systemic circulation. Overall, it must be noted that these studies gave no clear conclusion on 
the amounts or percentages of uptake. Hence, more research is needed to the extent and the 
exact mechanism of uptake.  
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Table 2. Summary of the uptake of individual AGEs in different in vitro studies. 
Compound Evidence Notes Reference(s)
CML Strongly retained 
inside Caco-2 cells.
Diffused into gastrointestinal 
epithelial (Caco-2) cells, but was 
not able to cross the basolateral 
membrane. Accumulation 
in instestinal cells. Not likely 
transported by amino acid 
and peptide carriers and the 
transepithelial flux measured 
for the compounds occurs most 
probably by simple diffusion.
[66, 67]
CEL Strongly retained 
inside Caco-2 cells.
- [66]
MG-H1 Strongly retained 
inside Caco-2 cells.
- [66]
Maltosine Absorbed as dipeptide 
into Caco-2 cells by 
PEPT1 and strongly 
retained in cells. Not 
absorbed in free form. 
Free maltosine permeates the 
basolateral cell membrane 
by simple diffusion down 
its concentration gradient 
and possibly by the action 
of basolateral amino acid 
transporters.
[66, 68]
Glycated 
dipeptides
Absorbed into Caco-2 
cells by PEPT1.
Intracellularly hydrolyzed by 
peptidases to the free modified 
amino acids and alanine.
[66]
Pyrraline Not free pyrraline, but 
the dipeptide with 
alanine is absorbed 
by PEPT1 in HeLa cells 
(cervical cancer cells).
After intracellular hydrolyzation 
free pyrraline diffused through 
the basolateral membrane.
[66, 69]
Fructoselysine Simple diffusion to a 
small extent in Caco-2 
cells.
Not likely transported by amino 
acid and peptide carriers and the 
transepithelial flux measured 
for the compounds occurs most 
probably by simple diffusion.
[67]
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5. The gastrointestinal tract
5.1 Physiology
Based on the evidence regarding absorption of dAGEs, we suggest that the potential local 
effect of dAGEs in the GI tract may be of larger importance than that of dAGEs ending up 
systemically. The human digestive system consists of multiple parts, which are responsible 
for the mechanical and chemical digestion of food [75, 76]. Mechanical digestion starts in 
the mouth with the chewing (mastication) of food products to small boluses, which are then 
swallowed and enter the stomach through the oesophagus. From there until the rectum, 
mechanic digestion occurs through the peristaltic movements of the GI tract. Transport of the 
digested food product is also aided by the mucus layer covering the complete GI tract, which 
provides a barrier between the epithelial layer and the contents of the lumen. Chemical 
digestion occurs through different mechanisms. In the mouth, saliva contains salivary 
amylase, which starts the digestion of starch. Through the oesophagus, the food product 
then enters the stomach, in which it is mixed with stomach juice containing hydrochloric acid 
and has a pH of 2. This low pH causes protein denaturation ensuring better access of pepsin 
(also secreted in the gastric juice) to the proteins. Pepsin hydrolyses proteins into peptides. 
After about one hour, the food product, now reduced to chyme, starts to pass the pyloric 
sphincter and travels further into the small intestine, which consists of the duodenum, 
jejunum, and ileum. The gradual transfer of chyme from the stomach to the duodenum can 
take up to two hours. In the duodenum, pancreatic juice containing pancreatic enzymes and 
sodium bicarbonate are added to the chyme. The sodium bicarbonate neutralizes the acidic 
chyme, while pancreatic enzymes hydrolyse carbohydrates, lipids, and proteins.  Bile from the 
liver is also added to the chyme in the duodenum and acts as an emulsifier to bring fats into 
suspension, to ensure that pancreatic lipase can digest the lipids. In the jejunum and ileum, 
this digestion process continues and is aided by peristalsis. After the small intestine, the food 
products enter the large intestine: the colon. In the colon, water and electrolytes are absorbed 
from the chyme and colonic bacteria in the gut flora further degrade and ferment the macro- 
and micronutrients [75, 76]. The intestinal microbiota includes over 800 species of bacteria 
and additionally contains fungi, protozoa, and archaea [77]. This collective genome is called 
the gut microbiome. Some important functions of the microbiota include the breakdown of 
undigested fiber (polysaccharides) into short-chain fatty acids (SCFA) and the production of 
vitamin K and biotin. Dysbiosis of the normal intestinal microbiota is associated with different 
diseases such as inflammatory bowel diseases (IBD), obesity, autoimmune diseases and 
diabetes [78]. Diet has a large influence on the intestinal microbiota composition and may 
therefore aid in the treatment of these diseases.  
5.2 Digestion of dAGEs
To what extent dAGEs are digested in the GI tract is currently unclear. Studies into the 
effect of gastric digestion on dAGEs are scarce and most studies are conducted using static 
in vitro models. In these models food products are most commonly exposed for two hours 
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to synthetic gastric juice and pepsin and is set to a pH value of 2-2.5. However, as explained 
before, human gastric digestion is not a static environment; it is dynamic and includes 
peristaltic mixing and alternating pH levels [79]. The physiological pH levels in the stomach 
differ between 1-1.5 for basal levels and 5-7 immediately after ingestion. After approximately 
three hours after ingestion, the pH returns to basal levels [80]. Additionally, digestive fluids 
and meal components are removed from the GI tract by both passive and active absorption 
[79]. Unfortunately, the static in vitro models do not take such physiological parameters into 
account. In one of the existing studies on dAGE digestion, Hellwig et al. (2013) exposed casein 
modified with Nε-fructoselysine, CML, and lysinoalanine to synthetic gastric juice and pepsin 
with a pH value of 2 at 37°C for two hours. In this study, modifying casein led to a reduction 
of digestibility of casein in the intestines [81]. Although most of the physical parameters 
were taken into account, all dAGEs were exposed to the gastric juices for the complete two 
hours. This is not the case in the human body where constantly a small portion of the meal 
is transported to the duodenum and the gastric emptying time is depending on the type of 
food [82, 83].
5.3 Colonic degradation
More research into the digestion of protein-bound dAGEs is therefore necessary. In case they 
are not degraded in the GI tract, dAGEs may be further transported into the colon where 
they come into contact with the human colonic microbiota. Based on the available literature, 
the human colonic microbiota seems to be capable of only fermenting LMW dAGEs, and 
not the more complex HMW structures, including dAGEs and melanoidins. Xu et al. (2019) 
subjected glyoxal-glycated casein to static in vitro digestion and assessed the capability of 
human colonic microbiota to ferment these digested compounds [84]. Their results showed 
that human colonic microbiota was indeed able to ferment the LMW structures to a better 
extent than HMW structures. Although in a different study bifidobacteria have been shown 
to be capable of using bread melanoidins as carbon source, indicating prebiotic potential of 
bread melanoidins. However, the melanoidins were not digested in a digestion model prior 
to microbial exposure [85]. For the LMW weight structures, additional evidence can be found 
on the utilization of Amadori products, or early glycation products, by colonic microbiota. 
Human intestinal microbiota contain deglycating enzyme systems for Amadori products. For 
instance, E. coli has genes encoding for fructosamine kinase, which catalyses the production 
of the stable intermediate fructosamine-6-phosphate, and fructosamine-6-phosphate 
deglycase that in turn cleaves fructosamine-6-phosphate to glucose 6-phosphate and the 
corresponding amines [86]. Additionally, E. coli has been shown to utilize fructoselysine 
and a human gut commensal (Intestinimonas AF211) can produce butyrate from lysine and 
fructoselysine [87, 88]. Amadori products can furthermore be degraded to 1,2-dicarbonyl 
compounds by colonic bacteria, which are highly reactive with lysine ε-amino groups and 
arginine guanidine groups to form AGEs within the colon [89].
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5.4 Inflammation in the gastrointestinal tract
Inflammatory bowel diseases (IBD) is the most commonly used term for a group of chronic 
inflammatory conditions of the GI tract, of which ulcerative colitis (UC) and Crohn’s disease 
(CD) are the two main types. As the name indicates, these diseases present themselves 
through inflammation in the GI tract. In CD this inflammation may affect any segment of 
the GI tract from the mouth to the anus, while inflammatory patches in UC are limited to 
the colon [90]. Over the past years, these inflammatory diseases have emerged as a public 
health challenge. Prevalence of IBD has been increasing substantially over the last decades. 
In 2017, approximately 6-8 million people suffered from IBD [91]. Although the aetiology of 
IBD has been extensively investigated, the exact pathogenesis is still not fully known. Multiple 
factors are involved in the pathogenesis of IBD, such as environmental factors, immunological 
factors, genetic susceptibility, and diet [92]. Not only in the Western world, but also in newly 
industrialised parts of the world such as Brazil and Taiwan, the incidence of IBD is increasing 
[93]. This suggests the important role of the environment in the development of the disease. 
More specifically, the introduction of the Western diet in those areas has been suggested as 
a potential explanation of increased IBD incidence [91, 94].  Treatment options of IBD include 
the use of glucocorticoids, which are very effective anti-inflammatory drugs. However, some 
people are resistant to glucocorticoids. This specific glucocorticoid resistance occurs in 
approximately 20% of people with IBD [95, 96]. IBD patients often report the influence of 
nutrition on their symptoms, either worsening of relieving them, which indicates a possible 
role for nutrition in either the onset or treatment of the diseases [94]. 
Several studies exist that investigated the association between dAGE consumption and IBD. 
Elevated levels of the dAGE pentosidine were found in several cell types within the bowel 
of IBD patients [97]. It was suggested that the level of pentosidine reflects the extent of 
tissue damage, since it correlated with the expression of 8-OHdG, a marker for oxidative 
DNA damage. However, the pentosidine levels were correlated with age in CD, but not UC, 
indicating an association between pentosidine levels and tissue damage in UC and not in CD. 
Additionally the pentosidine levels were measured using an ELISA technique, which is not 
the most reliable technique for measuring AGEs. Andrassy et al. (2006) showed presence 
of carboxymethylated (glycated) endogenous S100 proteins in the inflamed tissue of IBD 
patients compared to non-inflamed tissue of the same patients [98]. Additionally, other clinical 
studies show evidence of a role of RAGE in IBD inflammation: in CD, protein levels of RAGE are 
upregulated in inflamed areas and thereby appear to play a role in the mechanisms involved 
in chronic inflammation. Similarly, in inflamed areas of the ileum and colon in UC, RAGE may 
play a role in sustaining and worsening the inflammation [99-101]. The gut endothelium in 
IBD patients furthermore shows a strong increase in both RAGE and NF-κB expression [20]. 
sRAGE, the soluble version of RAGE, is able to bind RAGE and thereby blocking the receptor. 
In CD patients, but not in UC patients, serum levels of sRAGE were found to be inversely 
correlated with C-reactive protein (CRP) levels and clinical activity index [102]. Moreover, 
different polymorphisms of RAGE were found to be associated with IBD occurrence in 
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different patient groups, of which at least one polymorphism significantly increased RAGE 
transcriptional activation [103, 104]. These results indicate a potential involvement of AGEs, 
via RAGE, in the inflammatory processes underlying IBD. 
In addition to the aforementioned human studies, several animal studies also found interplays 
between IBD, dAGEs, and RAGE. By exposing C57BL/6 wild-type (WT) and RAGE -/- mice to 
CML-modified-proteins from human inflamed intestinal tissue in the colon, Andrassy et al. 
(2006) showed a higher IL-6 expression in WT mice compared to RAGE -/- mice, indicating an 
essential role of RAGE in the intestinal inflammation [98]. Rodent studies into IBD usually involve 
indomethacin-induced enteritis and dextran sulfate sodium (DSS)- and 2,4,6-trinitrobenzene 
sulfonic acid (TNBS)-induced colitis to mimic IBD disease status. A recent study by Body-
Malapel et al. (2019) showed that RAGE -/- mice were protected from indomethacin-induced 
enteritis and DSS- and TNBS-induced colitis, as iNOS expression was decreased in RAGE 
-/- mice compared to WT. This study concluded that reducing dAGEs may be a promising 
therapeutic target for IBD [101].Some animal studies have been conducted into IBD and an 
interplay with dAGEs, irrespective of investigating the role of RAGE. When giving healthy rats 
a heated diet that consisted of nine-fold higher dAGE levels than the normal diet, an increase 
in colonic oxidative stress and inflammation was seen [105]. Comparing a ‘bread crust diet’ to 
a normal diet, Yuan et al. (2018) found accumulation of dietary CML in intestinal tissue in rats, 
with the highest accumulation in the ileum [106]. The authors attributed this accumulation 
to the trapping of CML in the intestinal cell, as was seen earlier in the absorption studies by 
Hellwig et al. (2011) and Grunwald et al. (2006) [89, 107]. Additionally, a significant decrease 
in the activities of several antioxidant enzymes: superoxide dismutase (SOD) and glutathione 
peroxidase (GSH-Px), and a significant increase in TNF-α and IL-8 secretion were found in 
the duodenum compared to control group [106]. In a different study by Qu et al. (2017), 
rats were exposed to a regular (low-AGE) laboratory standard diet or heated (high-AGE) AIN-
93G diet for 6, 12, and 18 weeks. Histological examination of the colon showed distorted 
crypts, crypt loss, goblet cell depletion, increased dysplasia, loose cellular arrangements, 
and thickening of the mucosa with oedema in rats exposed to the high-AGE diet. However, 
no increased inflammatory infiltration was present. The 18-week exposure group showed 
significantly decreased expression levels of the tight junction proteins Occludin and zonula 
occludens-1. All these results indicate an increased colon permeability due to increased 
dAGE intake [108]. NF-κB is known to have a high activity in the GI tract of IBD patients 
[109]. Interestingly, transgenic mice expressing firefly luciferase under the control of an NF-κB 
responsive promoter showed NF-κB activation in particularly the gut after ingestion of dAGEs 
[110]. Remarkably, in an induced UC mice model, highly heated pellets reduced inflammation 
in the gut [111]. It has to be noted that this study focussed on melanoidins rather than dAGEs. 
In this study, Anton et al. (2012) exposed mice to standard, mildly heated, or highly heated 
pellets, after which a reduction in histopathological damage scores in mice fed highly heated 
pellets compared to mildly heated and standard pellets were found. However, the differences 
in CML content of the mildly heated and highly heated pellets were marginal, whereas the 
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melanoidin content was almost 3 times higher for the highly heated pellets. The protective 
effect of the diets was therefore probably due to the melanoidin content and not the dAGE 
content [111]. A follow-up study showed less mast cell infiltration in DSS treated mice when 
administered a highly heated diet. However, in this study the diet was not analysed on MRP 
content and the treatment of the chow was different than in the aforementioned study. It 
is likely the effects were again caused by the melanoidin content, but it is not possible to 
attribute the effects to a specific subset of the MR [112]. Additionally, ALJahdali et al. (2017) 
administered CML to mice for 3 weeks and then induced colitis in two different subgroups 
with either DSS or TNBS [113]. They found no inflammation caused by only CML, which can 
be explained by the fact that CML was administered in a non-protein bound form. They also 
stated that CML failed to prevent an inflammatory response, but the article did not include 
clear reasoning on why an anti-inflammatory effect was expected. It is unclear whether CML 
administration continued during colitis induction. CML did limit DSS-induced weight loss, but 
not TNBS-induced weight loss. They also saw a pattern towards the control state in the gut 
microbiota in CML-DSS exposed mice compared to only DSS exposed mice.
From the results of the studies investigating the interplay between IBD, RAGE, and dAGEs it 
can be concluded that RAGE is involved in the symptoms and possibly in the disease course 
of IBD. Making the food-derived natural ligands (dAGEs) an interesting therapeutic target. 
Next to IBD, another gastrointestinal disease which symptoms seems to be largely influenced 
by nutrition is irritable bowel syndrome (IBS). IBS comprises of a group of symptoms that 
include abdominal pain and changes in the patterns of bowel movements. Symptoms often 
also include diarrhoea and constipation. Approximately 45% of the global population is 
affected by IBS. The cause and disease mechanism of IBS is unknown and there is no known 
cure. Therefore, treatment is focussed on symptom reduction. These treatments include 
medication to stimulate bowel movements and often dietary changes such as increasing 
soluble fibre intake [114]. 
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Aims and outline of the thesis
In contrast to the multitude of studies into the effects of endogenous AGEs, dAGEs have 
been less well studied and several questions about these dAGEs remain. It is for instance still 
disputed to what extent and in what form dAGEs are absorbed. Independent of absorption, 
dAGEs enter the human GI tract after ingestion and it is also not clear what the local effects 
of dAGEs in the GI tract are. To obtain better insights into the possible effects of dAGEs in 
the GI tract, we performed several studies on the different effects that might occur after 
the ingestion of dAGEs. The overall aim of this thesis was to get an insight on the possible 
pro-inflammatory aspects of dAGEs in the GI tract. To have a first indication on the pro-
inflammatory potential of dAGEs, and to stay as close to the properties of food products 
as possible, we created a glycated casein model based on milk powder in chapter 2. This 
mixture is then assessed for its potential induction of TNF-α secretion in human macrophage-
like cells. Prior to entering the GI tract, dAGEs are ingested and digested by the human 
digestive system. To assess the effect of digestion on the dAGE-protein binding, in chapter 
3 we use the sophisticated TNO gastroIntestinal Model (TIM-1) to analyse the breakdown of 
the dAGE-protein binding in both our glycated casein model and different food products. To 
what extent the digestion influences the pro-inflammatory characteristics of dAGEs on both 
macrophages and gastrointestinal epithelial cells is analysed in chapter 4. Glucocorticoids are 
among the most used anti-inflammatory drugs, the potential of these drugs to reduce dAGE-
induced inflammation is researched and described in chapter 5. We show that dAGE-induced 
inflammation can cause glucocorticoid resistance in human macrophage-like cells, treating 
the cells with the antioxidant quercetin restores glucocorticoid sensitivity. Finally, all results, 
as well as its implications and limitations, are discussed in chapter 6.
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Abstract 
Advanced glycation endproducts (AGEs) can be found in protein- and sugar-rich food products 
processed at high temperatures, which make up a vast amount of the Western diet. The effect 
of AGE-rich food products on human health is not yet clear and controversy still exists due to 
possible contamination of samples with endotoxin and the use of endogenous formed AGEs. 
AGEs occur in food products, both as protein-bound and individual molecules. Which form 
exactly induces a pro-inflammatory effect is also unknown. In this study, we exposed human 
macrophage-like cells to dietary AGEs, both in a protein matrix and individual AGEs. It was 
ensured that all samples did not contain endotoxin concentrations > 0.06 EU/mL. The dietary 
AGEs induced TNF-α secretion of human macrophage-like cells. This effect was decreased 
by the addition of Nε-carboxymethyllysine (CML)-antibodies or a receptor for advanced 
glycation endproducts (RAGE) antagonist. None of the individual AGEs induce any TNF-α, 
indicating that AGEs should be bound to proteins to exert an inflammatory reaction. These 
findings show that dietary AGEs directly stimulate the inflammatory response of human 
innate immune cells and help us define the risk of regular consumption of AGE-rich food 
products on human health.
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1. Introduction 
During heating of food products containing protein and carbohydrates, dietary advanced 
glycation endproducts (AGEs) are formed via the Maillard reaction [1]. AGEs are greatly 
responsible for the flavor and taste of food, and increase palatability. In the Maillard reaction, 
the carbonyl group of a reducing sugar (sugars with a free anomeric carbon [2]) reacts with 
an amino moiety of an amino acid leading to reactive intermediates, the so-called Amadori 
products. These Amadori products then form different AGEs [3]. AGEs comprise a large body 
of different molecules [3]. Examples of well-studied AGEs are: Nε-carboxymethyllysine (CML), 
carboxyethyllysine (CEL), methylglyoxal-derived hydroimidazolone (MG-H1), pentosidine, 
and acrylamide. Although the quantification of AGEs in food products is frequently done 
by antibody-based techniques [4,5], liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) is the preferred technique to accurately identify and quantify individual 
AGEs [1,6–8]. Physiological consequences of exposure to dietary AGEs are not yet fully 
understood. Endogenously formed AGEs in diabetic patients, however, have been shown 
to induce an inflammatory reaction and contribute to the onset of cardiovascular diseases, 
such as atherosclerosis and diabetic cardiomyopathy [9]. The inflammatory effect seen in 
these situations is proposed to be caused by the binding of AGEs to the specific receptor 
for advanced glycation endproducts (RAGE). RAGE activates many enzymes and protein 
complexes, one of which is nuclear factor kappa-light-chain-enhancer of activated B cells 
(NF-κB) [10]. Even though inflammation caused by endogenous AGEs has been thoroughly 
studied, information on the generation of inflammation by dietary AGEs is scarce. As said, 
many of the studies on the effects of AGEs are conducted with endogenously formed AGEs, 
by heating bovine serum albumin or human serum albumin with different sugars at 37°C 
for several hours, mimicking the endogenous situation. This difference with a home cooking 
situation, in which dietary proteins and sugars are heated to higher temperatures, can lead to 
a different array of molecules, resulting in different immunological outcomes. In addition to 
endogenous AGEs, some individual AGEs have been researched. Acrylamide is a well-studied 
compound, but only with regards to its genotoxic and carcinogenic effects [11,12]. To our 
knowledge, no study has been published on the inflammatory effect of acrylamide. A clear 
cause-effect relationship between AGEs and inflammation has also not be established yet 
and the available results have been questioned as being caused by endotoxins rather than 
AGEs [13,14]. To our knowledge, we are the first to investigate the inflammatory effect of 
dietary AGEs in a home-cooking environment and the first to investigate the inflammatory 
effect of acrylamide. The present study aimed at investigating the effects of dietary AGEs on 
the inflammatory response of human cells of the innate immune system. To mimic a home 
cooking situation, only dietary protein and sugars were used and heated to a temperature 
of 100°C. The formation of dietary AGEs over time was quantified by LC-MS/MS and the 
presence of endotoxin was excluded. We also examined the effect of individual AGEs and 
whether the observed inflammatory effect was induced by activation of RAGE.
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2. Materials and Methods  
2.1 Chemicals and Reagents 
Casein from bovine milk, α-lactose monohydrate, NaOH, sodium-phospate, 
2-mercaptoethanol, and thiazolyl blue tetrazolium bromide (MTT) were obtained from Sigma-
Aldrich (Saint Louis, MO USA). D-glucose, glutamate, fetal bovine serum (FBS), Dulbeccco’s 
Phospate-Buffered Saline (DPBS) were obtained from Gibco (Thermo Scientific, Waltham, 
MA, USA). Analytical standards of CML (>99%), CEL (>95%), MG-H1 (>93%), and pentosidine 
(>99%), as well as the deuterium labelled internal standards CML-d2, CEL-d4, and MG-H1-d3, 
were obtained from Polypeptide (Strasbourg, France). Boric acid (99.5%), chloroform (99.5%), 
nonafluoropentanoic acid (NFPA; 99%), sodium hydroxide (98%), sodium borohydride (96%), 
trifluoroacetic acid (TFA; 99%), and phorbol 12-myristate 13-acetate (PMA) were obtained 
from Sigma (Zwijndrecht, Netherlands). HPLC-grade acetonitrile and methanol were obtained 
from Actu-all Chemicals (Oss, Netherlands). 
2.2 Preparation of Glycated Casein 
Casein, glucose, and lactose, in the proportions of milk powder (11 mM glucose, 0.2 M 
lactose, 10 g/L casein from bovine milk), were diluted in 50 mM phosphate buffer, pH 7.4 in 
and heated in an Erlenmeyer on a heating plate at 100°C up to 120 min. At time points 0, 15, 
30, 60, 90 and 120 min. samples were taken and immediately cooled in ice water. Samples 
were aliquoted and stored at −80 °C.
2.3 Determination of Endotoxin in Glycated Casein 
The presence of endotoxin in the glycated casein samples from all time points was assessed 
by the commercially available PYROGENT Gel Clot LAL Assay 0.06 EU/mL sensitivity (Lonza, 
Basel, Switzerland). The assay was performed in accordance with the manufacturer’s protocol 
using endotoxin-free dilutions and reagent tubes (Lonza, Basel, Switzerland).
2.4 Assessment of AGE-Formation by Fluorescence Spectroscopy 
AGE-formation was monitored by fluorometry measuring AGE-specific fluorescence. 100μL of 
each sample was added in duplicate in a clear bottom black polystyrene microplate (Corning, 
Corning, NY, USA) and read in a microplate reader (Spectramax M2 Multi-Mode, Molecular 
Devices, San Jose, CA, USA) at an excitation wavelength of λex = 370 nm and an emission 
wavelength of λem = 440 nm [14].
2.5 Quantification of AGEs in Glycated Casein by UPLC-Tandem MS/MS 
Sample preparation is based on published methods [6,15]. Briefly, sodium borate (0.33 M; 
pH 9) and sodium borohydride (2 M) were added to an aliquot of the samples (equivalent 
to ~1 mg protein) to obtain a sodium borohydride concentration of 0.2 M in the samples. 
These sample solutions were incubated for 4 h at room temperature. Subsequently, 1 mL of a 
chloroform/methanol (2/1 (v/v)) mix was added, and the samples were centrifuged for 10 min 
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at 12,000 rpm. The chloroform phase was discarded and the remaining solution containing 
proteins was hydrolyzed in 6 M HCl at 110°C for 18 h. The solutions were evaporated until 
dryness at 50 °C under a stream of nitrogen and dissolved in 1% (v/v) aqueous TFA (1 mL). 
Prior to UPLC-MS/MS analysis, internal standards and MilliQ were added to 50 µL of these 
analyte solutions to achieve a final volume of 200 µL. The samples were analyzed using an 
Acquity UPLC system (Waters, Milford, MA, USA) equipped with a BEH C18 analytical column 
(50 × 2.1 mm, 1.7 μm particle size, Waters, Milford, MA, USA)). The mobile phases were 5 
mM NFPA in water (A) and acetonitrile (B), and the flow was set at 0.3 mL/min. The mobile 
phase gradient was as follows: a linear increase from 90% A (t = 0 min.) to 50% A (t = 4 
min.) followed by a 1 min. equilibration at the initial conditions. The column was kept at 
a constant temperature of 45°C. A Quattro Premier triple quadrupole mass spectrometer 
(Waters) was connected to the UPLC was operated in positive electrospray ionization (ESI+). 
The capillary voltage was set to 3.0 kV, and the source and desolvation temperatures were 
120°C and 450°C, respectively. The cone and desolvation gas flow were set at 100 L/h and 
600 L/h, respectively. Compound-specific cone voltages and collision energies can be found 
in Table S1. Quantification was performed using an internal standard approach and nine-
point calibration curves. MG-H1-d3 was used as internal standard for the quantification of 
pentosidine. Quantification was performed using the precursor−product ion multiple reaction 
monitoring (MRM) transitions reported in Table S1. Instrumental detection and quantitation 
limits (IDL and IQL, respectively) were determined as the concentration from a peak with a 
signal-to-noise ratio of 3 and 10, respectively, in a standard chromatogram. Method detection 
and quantitation limits (MDL and MQL, respectively) were determined for AGEs detected in 
sample extracts as the concentration from a peak with a signal-to-noise ratio of 3 and 10, 
respectively, in a sample chromatogram. For pentosidine (not detected in the samples) the 
MDL and MQL were determined using a value of 3 and 10 times the noise at the retention 
time of pentosidine as peak area. Compound-specific detection and quantification limits are 
listed in Table S2. The arithmetic mean recovery (± SE) was 113 ± 2% for CML-d2, 104 ± 2% 
for CEL-d4, and 33 ± 1% for MG-H1-d3. The relative differences observed between duplicate 
analyses were 12%, 7%, and 15% for CML, CEL, and MG-H1, respectively.
2.6 Cell Culture and Exposure  
THP-1 monocytes (ATCC, TIB- 202), cultured in RPMI 1640 with L-glutamine, Hepes and 
phenol red (Gibco, Thermo Scientific, Waltham, MA, USA) supplemented with 10% (v/v) FBS, 
D-glucose (4.5 g/L), Na-pyruvate (1mM) and 2-mercaptoethanol (50μM), were seeded in 
a 96-wells plate at a cell density of 70,000 cells/well and differentiated into macrophages 
by adding 200 nM of PMA to the cell culture medium and culturing them for 72 h. After 
differentiation, the cells were exposed to 1, 2.5, 5 and 10% (v/v) of glycated casein in serum 
and phenol-red free medium and always in a 50% DPBS solution. Only samples that were 
proven to be free of endotoxins were used. Control conditions included phenol-red free 
medium and 50% DPBS. Incubations were done both with and without the anti-carboxymethyl 
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lysine (CML) antibody (Abcam, Cambridge, MA, USA) in a 1/500 dilution. Samples with 
anti-CML antibody were incubated overnight at 4°C before using. For the RAGE antagonist 
experiments, cells were incubated with 10% glycated casein and with and without 1 µM FPS-
ZM1 (Merck, Darmstadt, Germany).
2.7 Assessment of Cell Viability 
Cell viability was assessed using the MTT assay. Supernatant was removed and stored for 
ELISA analyses. 100 μl of MTT solution (0.5 mg/mL in DPBS) was added to each well, after 
which the plate was incubated in the dark at 37°C for 1 h. After 1 h, the MTT solution was 
removed from the wells and 100 μl of DMSO was added to each well. After 10 min incubation 
at room temperature, absorbance was measured at λ = 540 nm in a microplate reader (Bio-
Rad, Hercules, California, USA).
2.8 Quantification of Tumor Necrosis Factor (TNF)-α Release by ELISA 
Tumor necrosis factor (TNF)-α release in cell culture supernatant was assessed by a 
commercially available ELISA kit (Sanquin, Amsterdam, the Netherlands). The analyses were 
carried out in accordance with the manufacturer’s protocol using the Pelikine Toolset for 
all reagents (Sanquin). For the individual AGEs and RAGE experiments, TNF-α release was 
assessed by a commercially available ELISA kit (R&D systems, Minneapolis, MN, USA). The 
analyses were carried out in accordance with the manufacturer’s protocol.
2.9 Statistics 
The experiments were run in duplicate and triplicate on different days using the average of 
the duplicates as one value. The data were analyzed using the GraphPad Prism software (v 
5.00, GraphPad Software, San Diego, CA, USA), tested for normality using the D’Agostino & 
Pearson omnibus normality test, and examined with the non-parametric one-way ANOVA 
Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test or Mann-Whitney U test to 
compare the two sets of treatment. For comparing with controls set to 100%, the Wilcoxon 
signed-rank test was used. Significance level was set to p < 0.05. Significance is indicated as: 
* = p < 0.05; ** = p < 0.01; *** = p < 0.0013.
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3. Results 
3.1 Analytical Characterization of Glycated Casein 
To assess the effects of AGEs on human macrophage-like cells, AGEs were made in the 
form of glycated casein, combining casein, lactose, and glucose. In order to monitor the 
formation of AGEs in the glycated casein, AGE-specific fluorescence was recorded during 
the heating process. The fluorescence signal increased until 90 min of heating. AGE-specific 
fluorescence did not further increase between 90 min to 120 min of heating (figure 1).
CML, CEL, MG-H1 and pentosidine were quantified in glycated casein using 
UPLC-MS/MS. Pentosidine was undetectable in the samples. The formation of CML, CEL and 
MG-H1 in glycated casein during the 120-min heating period is shown in figure 2. The 
concentrations of all three compounds increased with time of heating. At 15 min of 
heating, MG-H1 was present in concentrations of 1.6 ± 0.9 μg/mL (mean ± standard d
eviation (SD)), being slightly higher than 0.6 ± 0.5 μg/ml CML although not significantly. 
Between 60 and 120 minutes of heating, CML concentrations increased from 
4.3 ± 0.8 μg/mL to 11.3 ± 1.7 μg/mL, making CML the most abundant AGE present in glycated 
casein after 2 h heating. CEL concentrations increased as well, but were an order of magnitude 
lower than CML and reached concentrations of 0.3 ± 0.2 μg/mL after 120 min of cooking. 
Figure 1. AGE-specific fluorescence of glycated casein measured at λex = 370 nm/λem = 440 nm in relation to the 
heating time of the three components casein from bovine milk (10 g/L), lactose (0.2 M) and glucose (11 mM). Values 
were corrected for baseline fluorescence and data are shown as mean ± SD, n = 3.
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Figure 2. Quantification of dAGEs, i.e. concentrations of (A) Nε-carboxymethyllysine (CML), (B) carboxyethyllysine 
(CEL), and (C) methylglyoxal-derived hydroimidazolone (MG-H1), during 120 min heating of a mixture of 10g/L 
casein, 0.2 M lactose and 11 mM glucose measured by UPLC-MS/MS. Data are presented as mean ± SD, n=3.
3.2 Effects of Glycated Casein on TNF-α Release of Human Macrophage-Like Cells 
In order to assess the inflammatory effects of glycated casein on human macrophage-like 
cells, THP-1 cells were exposed to glycated casein heated for 15 min. Six-hours exposure 
of THP-1 cells to various concentrations of glycated casein elevated the release of TNF-α in 
a concentration-dependent manner (figure 3). Increasing the glycated casein concentration 
from 1 to 2.5% (v/v) led to an increase of 277 ± 170 % TNF-α secretion (mean ± SD), whereas 
the increase from 5 to 10% (v/v) resulted in an increase of 141 ± 87%. Due to large standard 
deviations, only the increase of concentration from 1 to 10% glycated casein led to a significant 
increase of TNF-α secretion, 1584 ± 604 % (p < 0.01). In figure 1 and figure 2, an increase in 
AGE formation during prolonged heating at 100°C is shown. To explore the effects of glycated 
casein on the viability of macrophage-like cells at different time points during the heating 
process, the cells were exposed to a 10% (v/v) solution for 6 h. Cell viability did not alter 
with increasing cooking time until 120 min of heating, at which the cell viability significantly 
decreased from 118 ± 11 % to 86 ± 21 % (figure 4). 
To investigate the influence of prolonged heating on the pro-inflammatory effects of glycated 
casein, we measured the TNF-α release of macrophages exposed for 6 h to glycated casein 
(1% (v/v)), which was heated for 15–120 min. As figure 5 shows, TNF-α secretion did not 
change significantly between the different heating time intervals. There seems to be an 
increasing trend, but standard deviations are too large to draw that conclusion. Before 
adding the glycated casein to the cells, all samples were tested for endotoxin presence; the 
kit sensitivity was 0.06 EU/mL. No endotoxin was detected above these levels.
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Figure 4. Cell viability of human macrophage-like cells after 6 h exposure to glycated casein from different heating 
time points (10% v/v), measured by the MTT assay. Results were normalized to control (50% v/v DPBS), which was 
set to 100% (dotted line). Data are presented as mean ± SD, n = 4, * = p < 0.05.
Figure 5. TNF-α secretion of human macrophage-like cells after 6 h exposure to 1% (v/v) glycated casein from 
different heating time points measured by ELISA. Data are presented as mean ± SD, n = 4.
Figure 3. TNF-α secretion of human macrophage-like cells after 6 h exposure to different concentrations of glycated 
casein heated for 15 min measured by ELISA. Data are presented as mean ± SD, n = 3, ** = p < 0.01.
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3.3 Effects of the AGEs in Glycated Casein on TNF-α Release of Human Macrophage-Like 
Cells
To confirm that the inflammatory reaction was caused by AGEs, an anti-CML antibody was 
added to mitigate the TNF-α secretion. Adding the anti-CML antibody to cells exposed to 
2.5% (v/v), glycated casein reduced TNF-α secretion by 36 ± 24% (p = 0.1, figure 6). Next to 
this, the cells were incubated with 10% (v/v) glycated casein with and without 1 µM of the 
RAGE antagonist FPS-ZM1. Addition of 1 µM of FPS-ZM1 led to a significant 30% decrease of 
TNF-α secretion. 
3.4 Effects of Individual AGEs on TNF-α Release of Human Macrophage-Like Cells 
The cells were incubated with CML, CEL, MG-H1, and acrylamide in different conditions for 
6 h to assess the effect of individual AGEs on TNF-α release. All compounds were tested in 
concentrations ranging from 0.1 mM to 3 mM. None of the individual compounds led to any 
TNF-α secretion by the macrophage-like cells (data not shown).
Figure 6. (A) TNF-α secretion of human macrophage-like cells after 6 h exposure to 2.5% (v/v) glycated casein 
with or without anti-CML antibody measured by ELISA. After addition of an anti-CML antibody, TNF-α secretion 
decreased by 36% ± 24%. Data are presented as mean ± SD, n = 3. (B) TNF- α secretion of human macrophage-like 
cells after 6 h exposure to 10% (v/v) glycated casein with or without 1 µM RAGE antagonist (FPS-ZM1) measured by 
ELISA. After addition of the RAGE blocker, TNF-α secretion decreased by 30 ± 18%. Data are presented as mean ± 
SD, n = 4, * = p < 0.05.
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4. Discussion
In this study, we showed that dietary AGEs directly led to a concentration-dependent increase 
in TNF-α secretion from human macrophage-like cells, which is induced through the binding to 
RAGE. Our AGEs were made in a home cooking environment at 100°C and are therefore much 
more representative for dietary AGEs formed during food processing and cooking than AGEs 
formed at 37°C. The presence of AGEs in the glycated casein was confirmed by UPLC-MS/MS, 
and testing the glycated casein for endotoxin presence eliminated the possibility of the TNF-α 
secretion to be induced by endotoxins. Exposing macrophage-like cells to the glycated casein 
induced a clear TNF-α secretion. This opposes the findings of Buetler et al., where eliminating 
endotoxins by TX-114 extraction diminished the capability of their solutions to induce TNF-α 
secretion in human cell lines [13]. Further differences between our study and that of Buetler 
et al., and others, is firstly their use of endogenous AGEs developed at 38°C to our dietary 
AGEs, which are developed at 100°C and secondly their use of human lung epithelial cells and 
human retinal pigment epithelial cell line opposed to our human immune cells. Immune cells 
are naturally much more prone to excrete cytokines. Interestingly, Cai et al. fractioned AGEs 
from food products and showed their involvement in intracellular oxidative stress and some 
inflammatory potential in human umbilical vein endothelial cells. This underlines our results 
that dietary AGEs induce cellular stress [16].
The glycated casein induced TNF-α secretion could be attenuated by anti-CML antibodies, 
showing that the AGEs directly induce TNF-α secretion. Addition of the anti-CML antibody 
did, however, not completely diminish the TNF-α secretion. Since CML is not the only AGE 
present in the glycated casein, this finding indicates that other AGEs can also exert an 
inflammatory effect. Our observation that only adding CML antibodies can mitigate the 
inflammatory effect induced by glycated casein is quite remarkable. Blocking RAGE with the 
antagonist FPS-ZM1 showed that the effect was caused by AGEs binding to RAGE. These 
combined results corroborate our conclusion that the TNF-α secretion is induced by AGEs 
specifically. The most well-known pathway for TNF-α production through RAGE stimulation is 
NF-κB activation via activation of mitogen-activated protein (MAP) kinases, leading to TNF-α 
secretion [17]. Indeed, this has been shown by Lander et al. in rat pulmonary smooth muscle 
cells. It would be of interest to investigate this in human macrophages in future experiments.
Opposed to our results from glycated casein, the individual AGEs CML, CEL, MG-H1 and 
acrylamide did not show any induction of TNF-α release in human macrophage-like cells. 
This result indicates that AGEs need to be bound to proteins to exert an inflammatory 
reaction. This hypothesis has been mentioned in multiple studies [18,19]. Remarkably, a lot of 
conflicting research exists on whether individual AGEs can bind to RAGE and thereby induce 
an inflammatory response and whether they need to be bound to proteins to have this effect. 
Our results underline the hypothesis that AGEs can exert an inflammatory reaction through 
binding to RAGE, but only when bound to proteins. The reason why individual AGEs do not 
bind to RAGE has to be investigated further.
What would the results of this study imply for the human situation? Endogenously generated 
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AGEs are known to induce significant adverse health effects when formed in the human 
body at 37°C. AGEs can bind to RAGE, thereby activating an intracellular signaling cascade 
ending in the excretion of pro-inflammatory cytokines, leading to metabolic diseases such as 
atherosclerosis [10,20,21]. Another important mechanism by which AGEs can cause damage 
to the human body is by crosslinking with endogenous proteins such as collagen and elastin 
and thereby increasing stiffness in, for instance, muscle tissue [22]. In this study, we showed 
that dietary AGEs can also induce pro-inflammatory cytokine secretion. If AGEs in food are 
able to enter the human body, they might be able to contribute to the body’s endogenous 
AGE pool and worsen specific metabolic diseases. Food products that contain AGEs are 
those high in proteins and sugars and are processed at high temperatures, such as baked 
meats, cereals, peanut butter, and chocolate [6,7]. It is currently discussed whether dietary 
AGEs are absorbed in the gastrointestinal tract and contribute to the endogenous AGE pool 
[23–26]. Upon absorption, these dietary AGE products may aggravate metabolic diseases 
by the production of pro-inflammatory cytokines, as our study shows. Independently from 
this question of absorption, it should be emphasized that the pro-inflammatory effects of 
AGE may also be of local relevance in the gastrointestinal tract and might contribute to the 
symptoms of diseases such as inflammatory bowel diseases, Crohn’s disease, and ulcerative 
colitis. 
5. Conclusions 
In conclusion, our study revealed that dietary AGEs themselves stimulate TNF-α secretion 
in human macrophage-like cells. To what extent dietary AGEs pose a risk for developing 
inflammatory diseases in the human GI tract remains to be investigated.
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Supplements
Table S1. Target compounds and selected instrumental parameters for quantification of each compound by UPLC-
(ESI+)MS/MS.
Table S2. Instrumental detection and quantitation limits (pg on column) and method detection and quantitation 
limits (pg on column)
Note: the underlined precursor > product ion transition was used for quantification, the italic precursor > product 
ion transition was used for confirmation.
Compound Precursor > 
product ion (m/z)
Cone voltage (V) Collision energy 
(eV)
Internal 
Standard used
CML
205.2 > 84.2 20 20
CML-d2
205.2 > 130.2 20 12
CEL
219.2 > 84.2 20 20
CEL-d4
219.2 > 130.2 20 10
MG-H1
229.2 > 114.1 20 13
MG-H1-d3
229.2 > 166.2 20 13
Pentosi-
dine
379.4 > 135.1 20 40
MG-H1-d3
379.4 > 187.1 20 35
Compound IDL
(pg on column)
IQL
(pg on column)
MDL
(µg/ml)
MQL
(µg/ml)
CML 0.5 1.5 0.001 0.003
CEL 1 3.5 0.01 0.03
MG-H1 1.7 5.7 0.03 0.1
Pentosidine 6.4 21 1.2 4
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Abstract
Protein- and sugar-rich food products processed at high temperatures contain large amounts 
of dietary advanced glycation endproducts (dAGEs). Our earlier studies have shown that 
specifically protein-bound dAGEs induce a pro-inflammatory reaction in human macrophage-
like cells. To what extent these protein-bound dAGEs survive the human gastrointestinal (GI) 
tract is still unclear. In this study we analysed gastric and small intestinal digestion of dAGEs 
using the validated, standardised TNO in vitro gastroIntestinal digestion Model (TIM-1), a 
dynamic in vitro model which mimics the upper human GI tract. This model takes multiple 
parameters into account, such as: dynamic pH curves, peristaltic mixing, addition of bile and 
pancreatic digestive enzymes, and passive absorption. Samples of different digested food 
products were collected at different time points after (i) only gastric digestion and (ii) after 
both gastric plus small intestinal digestion. Samples were analysed for dAGEs using UPLC-MS/
MS for the lysine derived Nε-carboxymethyllysine (CML) and Nε-carboxyethyllysine (CEL), 
and the arginine derived methylglyoxal-derived hydroimidazolone-1 (MG-H1), and glyoxal-
derived hydroimidazolone-1 (G-H1). All AGEs were quantified in their protein-bound and free 
form. The results of this in vitro study show that protein-bound dAGEs survive gastrointestinal 
digestion and are additionally formed during small intestinal digestion. In ginger biscuits, the 
presence MG-H1 in the GI tract increased with more than 400%. This also indicates that 
dAGEs enter the human GI tract with potential pro-inflammatory characteristics. 
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1. Introduction
A typical characteristic of the Western diet is the abundance of fried and otherwise 
processed and heat-treated foods. During thermal processing of food, large amounts of 
dietary advanced glycation endproducts (dAGEs) are formed [1]. Especially in food products 
containing ample amounts of carbohydrates and proteins, dAGEs are highly present. This 
formation of dAGEs occurs via the Maillard reaction (figure 1) in which the carbonyl group 
of a reducing sugar reacts with an amino moiety of an amino acid under the influence of 
heat [2]. dAGEs are formed at the final stage of this reaction and are largely responsible for 
the brown colour and palatability of heat-processed food. Although in some studies dAGES 
are considered to play an important role in the negative health effects attributed to the 
Western diet, the health consequences of these compounds are not yet well understood. In 
a recent study, we demonstrated pro-inflammatory effects of dAGEs on human macrophage-
like cells through binding to the receptor for advanced glycation endproducts (RAGE) [3]. 
Only protein-bound dAGEs were found to have this pro-inflammatory effect, which was 
measured as TNF-α secretion, whereas free dAGEs, such as Nε-carboxymethyllysine (CML) 
and methylglyoxalderived-hydroimidazolone-1 (MG-H1), did not induce any TNF-α secretion. 
Since the dAGE-protein binding may be vulnerable to acid hydrolysis and proteolysis that 
occur during gastrointestinal (Gl) digestion, it is to be expected that GI digestion may 
influence the pro-inflammatory effects. After the ingestion of protein-rich food products, 
several mechanical and enzymatic processes break down the ingested proteins during GI 
digestion. In the stomach, acid hydrolysis occurs and the proteolytic enzyme pepsin cleaves 
proteins into smaller polypeptides. In the small intestine the pH is increased to a neutral level 
and different proteolytic enzymes from the pancreatic juice cleave the polypeptides further 
to dipeptides and peptides, which become then available for absorption. The possible release 
of the AGEs from proteins into their free form may result in a reduced pro-inflammatory 
effect of dAGEs. Thus far, the influence of GI digestion on the pro-inflammatory potency of 
dAGEs has not been investigated.
The existing evidence on the effects of digestion in dAGEs is conflicting. While some studies 
found breakdown of protein binding during digestion [4, 5], most studies found a survival of 
protein bound AGEs in the GI tract [6-8]. Moreover, it has previously been suggested that 
especially high molecular weight dAGES, which include the protein-bound dAGEs, were able 
to inhibit intestinal protease activity. Already in 1993, Pitotti et al. found an inhibiting effect 
of Maillard reaction products on protease activity to glycated proteins [9]. However, one of 
the issues that arise when assessing these studies for human relevance, is the use of static GI 
digestion in vitro models. Often, the stomach phase of these models consists of a mixture of 
digestion enzymes with a constant pH of 2 – 2.5 where the food products are exposed to for 
two hours. After the stomach phase the digests are transferred to a new static environment 
consisting of different buffers and digestion enzymes with a constant pH of 6.5 – 7.5 for 4 – 
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6 hours [6-8]. In contrast to these static GI digestion in vitro models, the human GI tract is 
a dynamic system that includes mixing via peristaltic movement and alternating pH levels. 
Additionally, digestive fluids and meal components are removed from the GI tract by both 
passive and active absorption [10]. The TNO gastroIntestinal Model (TIM-1) is a dynamic in 
vitro model that is able to mimic much of the human GI tract. This model takes multiple 
parameters into account, such as: dynamic pH curves, peristaltic mixing, addition of bile and 
pancreatic enzymes, and passive absorption [11]. The TIM-1 model accurately mimics the in 
vivo food and drug behaviour with a high prediction capability compared to other models 
[12]. The studies that have been performed on the effect of GI digestion on dAGEs thus 
far, not only poorly reflect the in vivo situation, they also did not use accurate methods to 
measure dAGEs. These methods include fluorescence and/or competitive ELISA of CML and 
‘methylglyoxal - derived AGEs’ [13]. Additionally, most studies only assessed meal-resembling 
systems, and most of these studies focussed on the effect of glycation on protein digestion 
instead of the digestion of the dAGEs themselves.
Therefore, in this study we aimed to investigate to what extent the dAGE-protein binding 
is affected by human GI digestion. This is done by digesting a food-based matrix and actual 
food products (ginger biscuits and apple juice) using the TIM-1 GI model and analysing 
the digests for different free-dAGEs and protein-bound dAGEs by ultrahigh pressure liquid 
chromatography coupled to triple quadrupole mass spectrometry (UPLC-MS/MS).
Figure 1. Simplified overview on AGE formation via the Maillard reaction. As an example, the molecular structure 
of four different dAGEs: Nε-carboxymethyllysine (CML), Nε-carboxyethyllysine (CEL), glyoxalderived-hydroimida-
zolone-1 (G-H1), and methylglyoxalderived-hydroimidazolone-1 (MG-H1), as well as protein-bound CML are shown.
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2. Materials and methods
2.1 Chemicals and reagents
Casein from bovine milk, α-lactose monohydrate, NaOH, sodium-phosphate, and 
2-mercaptoethanol were obtained from Sigma-Aldrich (Saint Louis, MO USA). Pancreatin 
(Pancrex V) was obtained from Paines and Birne (Greenford, UK). Porcine bile extract was 
obtained from Merck (Darmstadt, Germany). Analytical standards of CML (>99%), CEL 
(>98%), GH-1 (98.2%) and MG-H1 (>98.2%), as well as the deuterium labelled internal 
standards CML-D4, CEL-D4, and MG-H1-D3 and G-H1-13C2, were obtained from Iris Biotech 
(Marktredwitz, Germany). Boric acid (99.5%), chloroform (99.5%), nonafluoropentanoic acid 
(NFPA; 99%), sodium hydroxide (98%), sodium borohydride (96%), and trifluoroacetic acid 
(TFA; 99%), were obtained from Sigma (Zwijndrecht, Netherlands). HPLC-grade acetonitrile 
and methanol were obtained from Actu-all Chemicals (Oss, Netherlands).
2.2 Preparation of samples
Glycated casein (GC) for use as food-based matrix was prepared by combining casein, glucose, 
and lactose, in the double proportions of milk powder (22 mM glucose, 0.4 M lactose, 20 g/L 
casein from bovine milk), and diluted in 50 mM phosphate buffer, pH 7.4. One part of the 
mixture was aliquoted and stored at -80°C for use as control sample (unglycated casein (UC)). 
The remaining mixture was heated in an Erlenmeyer on a heating plate at 100°C for 1. After 1 
samples were taken and immediately cooled in ice water. Samples were aliquoted and stored 
at -80°C. The food products ginger biscuits and apple juice from the same respective batches 
were bought at a local Dutch supermarket.
2.3 TNO in vitro model of the stomach and small intestine (TIM-1) 
Figure S1 shows a schematic of the in vitro model, which has been described extensively 
before [14]. Briefly, the model comprises four connected glass compartments, representing 
the stomach, duodenum, jejunum and ileum, respectively. Inside each glass compartment is 
a flexible silicone inner wall. The space between the inner and outer walls is filled with water 
of 37°C. By periodically applying pressure on the water, the flexible inner walls are squeezed, 
simulating peristalsis. In each individual compartment the pH is measured continuously and 
regulated by ‘secretion’ of hydrochloric acid (gastric compartment) or sodium bicarbonate 
(intestinal compartments). The set-points of pH, gastric emptying and intestinal transit 
time are controlled by a computer. The current experiments were performed in duplicate 
under the average physiological conditions as found in the human gastrointestinal tract for 
adults (figure S2). The gastric emptying, intestinal residence time and gastric and intestinal 
pH-curves mimicked the situation as found in humans for intake after a meal (figure S2). 
Additional to figure S2, intestinal pH were set at 6.8 in the duodenum, 6.8 in the jejunum, 
and 7.2 in the ileum. The concentrations of secretion fluids (electrolytes, enzymes, bile, and 
pancreatic juice) were adjusted to the average concentrations as described for adults after 
ingestion of a meal. Pancreatic output was simulated by secreting 10% pancreatin (protease, 
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lipase, and amylase) in small intestinal electrolyte solution. Biliary output was simulated by 
secreting a 2% bile (porcine bile extract) solution at 0.5 ml/min. Prior to the experiment the 
compartments were filled with start residues as described before [15], except for the gastric 
residue, which was mixed with the ‘meal’. Hollow fibre membrane systems continuously 
dialyzed the digested and dissolved low-molecular weight compounds from the jejunum 
(figure S1-MN left) and ileum compartments (figure S1-MN right), which simulated absorption 
of nutrients by the body, and which maintained physiological concentrations of bile and 
electrolytes.  The enzyme activity of pepsin was 2500 units/mg. These units are defined as 
a change in the absorbance at λ = 280nm of 0.001 per minute at pH 2.0 at 37°C, measured 
as trichloroacetic acid (TCA)-soluble products using haemoglobin as substrate. The enzyme 
activities of the pancreatin was expressed in international units and were: amylase 12000 
IU/g, protease 1000 IU/g, and lipase 15000 IU/g. Experiments were done both in the gastric 
compartment only, as well as in the complete model. In the experiments in which only the 
gastric compartment was used, the duodenal compartment was only used for neutralization 
of the gastric efflux, without secretion of bile and pancreatin. This neutralization occurred 
before sampling. In the gastric experiments, during 3 hours approximately 95% of the gastric 
contents were gradually delivered into the small intestine for neutralization (figure S2) through 
the ‘pyloric sphincter’ (figure S1-B). Experiments in the complete model lasted 6 hours, after 
which approximately 90% of the small-intestinal contents were gradually delivered (figure S2) 
into the ‘large intestine’ (sampling bottle) through the ‘ileo-caecal sphincter’ (figure S1-H). 
Samples were taken every hour from the jejunal and ileal diaysates (Figure S1-MN, left and 
right respectively), and the ileal efflux (figure S1-H). After termination of the experiments, 
the residues remaining in the system were collected as well, to allow a mass-balance to be 
made. In case of the liquid food products GC and applejuice, the starting product contained 
300 grams of food and for the solid ginger biscuits 30 grams of biscuits were run through 
the model. All results that were later obtained with the UPLC MS/MS were corrected for the 
amount of AGEs present in the gastro-intestinal fluids and enzymes of the TIM-1 model by 
running a control experiment with only 50 mM phosphate buffer.
2.4 Quantification of dAGEs in digests by ultra-performance liquid chromatography-
tandem mass spectrometry (UPLC-MS/MS)
In this study, every sample was analysed in both the hydrolysed (total dAGEs, i.e. free + 
protein-bound dAGEs) and unhydrolysed form (free dAGEs). The sample preparation is based 
on earlier studies [1, 16] and similar to our previous study [3]. The technical procedure is 
described in van der Lugt et al. (2018) [3].  The details on the sample preparation and UPLC-
MS/MS settings are mentioned in the supplements. The free dAGE content in the samples 
was analysed by omitting the hydrolysis step in the sample preparation procedure, thereby 
circumventing the release of protein-bound dAGEs. Quantification was performed using the 
precursor-product ion multiple reaction monitoring (MRM) transitions reported in table S1. 
The accuracy of the analysis was monitored by spiking each sample with a specific dAGE 
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standard for each analysed dAGE. The average accuracies ranged from 75-133% (see table 
S2), demonstrating that no severe losses occurred during sample preparation, and no signal 
enhancements or suppression occurred during UPLC-MS/MS analysis. Ion ratios between the 
quantifier ion and qualifier ion were monitored. In case ion ratios deviated more than 20% 
from the ratio observed in the standard, the identity of the peak could not be confirmed. 
In the case of MG-H1 and G-H1, ion-ratio deviations were observed in GC, ginger cookies 
and apple juice. A brief investigation into this issue revealed that isomers of MG-H1 (i.e. 
MG-H2 and MG-H3) and G-H1 (i.e. G-H2 and G-H3) may co-exist in the samples. Additional 
explorative experiments showed that these may co-elute and alter the ion-ratios (data not 
shown). Future work is needed to explore this work further, but with the isomers issue in 
consideration, deviating ion ratios were accepted for MG-H1 and G-H1. It is expected that 
this also played a role in the slightly elevated (or lower) accuracies for MG-H1 and G-H1 (table 
S2). The LOQ for the protein-bound dAGEs was 125 µg/L and 10 µg/L for the free dAGEs 
(table S3). This 12.5 fold difference can be explained by omitting the acid hydrolysis step, 
which introduces a dilution of the sample. By omitting this step, the sample is not diluted, 
resulting in lower LOQs.   
2.5 Analysis of protein size by SDS-page and Coomassie Blue Staining
A sample of 10 µg of digested and undigested GC and UG with reducing laemmli buffer was 
loaded onto an Any kD™ Mini-PROTEAN® TGX™ Precast Protein gel (Bio-rad, Hercules, CA, USA) 
and run in a Bio-rad cell. Due to volume constraints, the protein amount for small intestinal 
digested UG was adjusted to 7 µg. For assessment of protein size, the gels were stained 
by Coomassie brilliant blue R250 (Bio-Rad) and imaged with Amersham Imager 600 (GE 
Healthcare, Chicago, IL, USA). For casein assessment, the samples were treated as previously 
mentioned. After running, the protein was transferred to a Nitrocellulose membrane (Bio-
Rad). Primary antibodies used: Anti-Casein (ab166596, Abcam, Cambridge, UK) Secondary 
antibody used: Anti-rabbit IgG, HRP-linked Antibody (Cell Signaling Technology, Danvers, MA, 
USA). The membrane was then incubated with Clarity Western ECL Substrate (Bio-rad) for 
colour development. Staining of the membranes was analysed using Amersham Imager 600.
2.6 Data assessment
Every sample was analysed in both the hydrolysed (total dAGEs) and unhydrolysed form 
(free dAGEs), as discussed above. To obtain the concentration of protein-bound dAGEs in 
the samples, the results from the free dAGE measurement were subtracted from the total 
dAGE measurement of each sample and each dAGE. To correct for any dAGEs present in 
the TIM-1 solutions and enzymes, a control run of TIM-1 with 50 mM phosphate buffer was 
conducted and analysed using the UPLC-MS/MS. The small quantities found in the digests 
from phosphate buffer were subtracted from all dAGE results in the samples. The UPLC-
MS/MS results (in μg/ml) were then multiplied by the volume of the effluents to obtain the 
absolute amount of dAGEs. 
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3. Results
3.1 Digestion of dietary AGEs - protein binding
3.1.1 Glycated casein (GC)
The digestion of protein-bound dAGE was assessed with the TIM-1 using a food-based 
matrix containing a mixture of heated glucose, lactose and casein. After running the samples 
through the model, the digests were analysed for the presence of protein-bound and free 
dAGEs using UPLC-MS/MS.
The starting product (undigested GC, t = 0 h) did not contain any free dAGEs. After gastric 
digestion, none of dAGEs measured were present in free form (figure 2A). Figure 2B shows 
the results of consecutive gastric and small intestinal digestion. Free CEL was only found 
in the residue, which is everything left in the TIM-1 system after 6 h that did not reach the 
effluent but would naturally enter the colon. Free CML was recovered in the effluent after 2 
h of digestion (9.2 ± 3.4 % of total CML) (mean ± SD). Similar percentages of free-form CML 
were also found after 3 and 4 h of digestion. Only marginal amounts of free G-H1 was found 
in the samples in general (6.7 ± 0.9 % of total G-H1 after 3 h of digestion). The amount of 
free MG-H1 ranged from 10.9 ± 3.6 % of total MG-H1 after 2 h of digestion to 25.8 ± 10.5 % 
of total MG-H1 after 5 h. After 6 h of digestion all MG-H1 found was present in the free form 
(1.4 ± 0.3 μg). 
In general, concentrations of protein-bound CML, G-H1, and MG-H1 were highest after 2-3 
h of gastric digestion (figure 2A) and combined gastric and small intestinal digestion (figure 
2B), while gradually decreasing afterwards. The residue contained relatively high amounts of 
protein-bound CML, G-H1, and MG-H1. Passive absorption of nutrients from the jejunum and 
ileum was assessed by continuously dialyzing the digested and dissolved low-molecular weight 
compounds from the jejunum and ileum compartments through hollow fiber membrane 
systems. No free or protein-bound dAGEs were found in the dialysate of either jejunum or 
ileum (data not shown). As a control, unglycated casein (UC) was used which consisted of the 
same components as GC but it did not undergo thermal treatment. No dAGEs were found in 
the UC (data not shown). 
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Figure 2. Free- and protein-bound CEL, CML, G-H1, and MG-H1 in the ileal efflux of GC after gastric digestion (A) and 
complete gastric-small intestinal digestion (B) measured by UPLC-MS/MS. Time point 0 h digestion is the undigested 
starting product. Data are presented as mean ± SD, n = 2. R = residue. Missing bars indicate that UPLC-MS/MS results 
were below the LOQ.
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3.1.2 Ginger biscuit
To confirm the findings in the food-based matrix (GC) in actual food products, a popular 
ginger biscuit was digested using the same regime as glycated casein. The results for gastric 
digestion are presented in figure 3A. The starting product contained small quantities of free 
CML (4.4 ± 0.5 % of total CML) (mean ± SD) and MG-H1 (1.6 ± 0.4 % of total MG-H1). No free 
CEL was found in the starting product and gastric digestion did not lead to the formation of 
any free CEL. However, CML, G-H1, and MG-H1 were found in free form at all different time 
points of the gastric digestion period. The fractions of free vs total dAGE were highest after 1 
h of gastric digestion with 12.4 ± 2.9 % of total CML, 10.7 ± 10.8 % of total G-H1, and MG-H1 
13.3 ± 4.3 % of total MG-H1.
Figure 3B shows the results for the combination of gastric and small intestinal digestion. 
Overall, MG-H1 concentrations (both the free and protein-bound form) in the ginger biscuit 
are higher than the other three dAGEs. After 2 h of digestion, the amounts of all free dAGEs 
peaked, containing 22.1 ± 1.2 % of total CEL, 12.0 ± 0.1 % of total CML, 15.7 ± 2.1 % of total 
G-H1 and 24.1 ± 2.3 % of total MG-H1. After 2 h the amounts of both protein-bound and free 
dAGEs gradually decreased. 
Passive absorption of protein-bound and free MG-H1 occurred in both the jejunum and ileum 
(figure 4), largely in protein-bound form. In absolute amounts, a total of 8.1 ± 1.6 mg MG-
H1 (free and protein-bound) left the small intestine in the effluent, while 12.8 ± 0.4 mg of 
MG-H1 (which is 61% of the total detected protein-bound MG-H1) was absorbed via passive 
diffusion. In contrast, passively absorbed G-H1 was only found in the ileum after 4 h and in 
only one sample.
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Figure 3. Free- and protein-bound CEL, CML, G-H1, and MG-H1 in the ileal efflux of ginger biscuits after gastric 
digestion (A) and complete gastric-small intestinal digestion (B) measured by UPLC-MS/MS. Data are presented as 
mean ± SD, n = 2. R = residue. Missing bars indicate that UPLC-MS/MS results were below the LOQ.
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Figure 4. Passive absorption of MG-H1 and G-H1 from ginger biscuits measured by UPLC-MS/MS. (A) Jejunum di-
alysate. (B) Ileum dialysate. Data are presented as mean ± SD, n = 2. Missing bars indicate that UPLC-MS/MS results 
were below the LOQ.
3.1.3 Apple juice
As an additional food product, digestion of dAGEs in apple juice was assessed (figure 5). 
Only free AGEs were found in the apple juice digests in varying amounts throughout gastric 
digestion (figure 5A). Free AGEs were also only found in the apple juice digests of the small 
intestine (figure 5B), albeit only for CEL and MG-H1.
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Figure 5. Free- and protein-bound CEL, CML, G-H1, and MG-H1 in the ileal efflux of apple juice after gastric digestion 
(A) and complete gastric-small intestinal digestion (B) measured by UPLC-MS/MS. Data are presented as mean ± SD, 
n = 2. R = residue. Missing bars indicate that UPLC-MS/MS results were below the LOQ.
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3.2 Digestion of glycated casein – protein digestion
To assess the possible effects of glycation on protein digestion, the digests of GC were first 
separated with SDS-page and stained with the Coomassie stain. Results can be seen in figure 
6. In figure 6A, the large band just above the 25 kDa before digestion (0 h) reduces during 
digestion, indicating a decrease in protein size. During the combination of gastric and small 
intestinal digestion (figure 6B) the larger proteins disappear and more smaller size proteins 
are present in the samples. The persistent band seen at 50 kDa is very likely to be pancreatic 
lipase [17]. The difference between digestion of GC and UC was assessed by immunostaining 
the SDS-page membranes for bovine casein. Figure 7 shows the results for digested GC versus 
UC in the gastric experiments. During the gastric digestion of UC, casein is only detectable 
in very low levels in the digests of the stomach after 2 h of digestion, whereas casein is still 
present in the digests of GC after 3 h of digestion. Immunostaining the small intestinal digests 
for casein did not show any differences (data not shown).
Figure 6. Protein size in digests of GC. Numbers above the gels indicate the duration (h) of digestion and M represents 
two different molecular markers. (A) gastric digestion. (B) gastric and small intestinal digestion.
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Figure 7. Protein levels of casein in GC and UC digests after 0, 1, 2, and 3 h of gastric digestion.
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3.3 Digestion of AGEs – recovery
In order to calculate the absolute amounts of the different dAGEs (free and protein-bound) 
leaving the stomach and small intestine compartments, every effluent of the TIM-1 model 
was weighed to allow for a mass-balance to be made. These absolute amounts were then 
expressed as percentages of the total amounts of the starting products that were ingested 
in order to assess the recovery of dAGEs in the TIM-1 model. The results can be seen in 
table 1 for both total (free and protein-bound) dAGEs and only protein-bound dAGEs. For 
GC, the recoveries after gastric digestion for all dAGEs was < 100%, and further decreased 
during small intestinal digestion. Recoveries for the ginger biscuit were much higher. After 
gastric digestion the recoveries for protein-bound dAGEs ranged from 152 ± 13 % for CEL to 
231 ± 156 % for G-H1. After additional small intestinal digestion, the recoveries for protein-
bound dAGEs increased even further and ranged from 276 ± 96 % for CEL to 454 ± 73 % for 
MG-H1. Recoveries for the free-form dAGEs in apple juice were all lower than 100% after 
gastric digestion. Remarkably, no CML and G-H1 and 37 ± 25 % for CEL were recovered after 
small intestinal digestion, whereas free MG-H1 was recovered for 296 ± 63 % after the small 
intestinal digestion.
 
 
Gastric Small Intestinal
Total (%) Protein-bound (%) Total (%) Protein-bound (%)
GC CEL 0 ± 0 0 ± 0.0 5 ± 7 5 ± 7
CML 77 ± 4 77 ± 4 27 ± 5 26 ± 5
G-H1 91 ± 13 91 ± 13 33 ± 13 32 ± 13
MG-H1 73.5 ± 0.4 73.5 ± 0.4 42 ± 15 38 ± 15
Ginger 
biscuit
CEL 152 ± 13 152 ± 13 332 ± 104 276 ± 96
CML 182 ± 27 180 ± 30 372 ± 54 350 ± 53
G-H1 247± 159 231 ± 156 406 ± 221 371 ± 218
MG-H1 175 ± 3 163 ± 2 494 ± 76 454 ± 73
Apple 
juice
CEL 96.8 ± 0.5 - 37 ± 25 -
CML 62 ± 15 - 0.0 ± 0.0 -
G-H1 27 ± 38 - 0.0 ± 0.0 -
MG-H1 23 ± 33 - 296 ± 63 -
Table 1. Recovery of CEL, CML, G-H1, and MG-H1, after gastric and the combination of gastric and small intestinal 
digestion (noted as “small intestinal” in the table). ‘Total (%)’ reflects the recoveries of both free and protein-bound 
dAGEs as a percentage of the total dAGEs in the undigested meal. ‘Protein-bound’ is the recovery of only protein-
bound dAGEs as a percentage of the protein-bound dAGEs in the undigested meal. In case similar recoveries are 
shown for total (%) and protein-bound (%), this indicates that no free dAGEs were detected. Data are presented as 
mean ± SD, n = 2.
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4. Discussion
In this study, the digestion of the dAGE-protein-binding was assessed in a sophisticated 
human gastrointestinal in vitro model using a food-based matrix and actual food products. 
dAGEs are largely present in thermally treated food products. Earlier findings have shown that 
specifically protein-bound dAGEs induce a pro-inflammatory reaction in human macrophage-
like cells. To what extent these protein-bound dAGEs survive the GI tract was unclear until 
now.
Our results show that the protein binding of dAGEs is able to survive gastric and small 
intestinal digestion and consequently stays intact throughout the whole GI tract (figures 2, 
3, and 4). These findings underline findings from earlier studies that used static digestion 
models, where the protein binding survived digestion. These studies were mostly focused 
on assessing the effect of glycation on protein digestibility. Among others, Zhao et al. (2017) 
saw a decrease in digestibility of β-casein after glycation with glyoxal [6]. In addition, Pinto et 
al. (2014) found larger aggregates of casein when casein was heated combined with glucose 
than when casein was heated alone. Moreover, the heated glucose-casein combination 
was less digestible than heated native casein [18], indicating that glycation interferes and 
complicates protein digestion. These results correspond to the results that were observed 
in the current study when comparing the digestion of GC with UC (figure 7), but only in the 
gastric compartment. The digestion of the casein protein was assessed with immunostaining 
and hampered gastric digestion of casein was seen as protein levels of casein in UC were 
almost completely diminished after 2 h, whereas casein was still detectable in the digests of 
GC after 3 h of digestion. In the small intestines, no more differences were present between 
protein levels of casein in GC and UC. This was also seen by Joubran et al. (2017), who found 
that most peptides were liberated in the duodenum in an in vitro infant gastrointestinal tract 
[7]. In addition Corzo-Martinez et al. (2012) saw differences in proteolytic breakdown between 
different glycated proteins, so the type of protein may play a role in digestion efficiency [5]. 
Despite the fact that the casein protein was broken down in the small intestines, our results 
show that the dAGE-protein binding stays intact. As Coomassie staining and immunoblotting 
for casein (figure 6) showed a decrease in protein size during small intestinal digestion and 
break down of casein, it is possible that the dAGEs are bound to these smaller proteins or 
peptides after digestion. 
There are several ways through which glycation can interfere with protein digestion in the 
small intestines. Inhibition occurs via steric hindrance of the proteolytic cleavage site by an 
AGE and via the direct binding of an AGE to the proteolytic cleavage site [7, 19]. Lysine and 
arginine contain tryptic binding sites because the ε-amino groups of lysine and the guanido 
groups of arginine are charged positively and will therefore be attracted to the negatively 
charged active centre of trypsin [20]. However, the same ε-amino group of lysine and the 
guanido group of arginine are major reactive sites in the Maillard reaction, which possibly 
explains why glycation of proteins may disrupt protein digestion. Within the group of amino 
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acids, lysine is the most reactive in the Maillard reaction [21-23]. CML and CEL are lysine-
derived dAGEs and MG-H and G-H are arginine-derived dAGEs. By blocking the residues 
on these amino acids, dAGEs inhibit proteolytic digestion [20]. Interestingly, in this study a 
distinct effect of glycation on gastric digestion of casein rather than small intestinal digestion 
was observed (figure 7). The mechanism through which glycation may interfere with gastric 
digestion is less well known. Hydrolysis and pepsin proteolysis are the primarily responsible 
mechanisms for protein digestion in the stomach. The gastric pH plays an essential role in 
the activity of gastric enzymes and thus gastric digestion. A major advantage of the TIM-1 
model is the dynamic pH range of the stomach compartment (figure S2). In the previously 
used static in vitro models, the pH is set to 2 – 2.5 for two h, which poorly reflects the 
physiological situation as in the human stomach the pH is more dynamic. The fasted gastric 
pH varies between 1 - 1.5, but after ingestion, the pH increases to 5 – 7, depending on the 
buffer capacity of the meal. After approximately 3 h of digestion, the pH has returned to 
basal levels [24]. Human gastric emptying time is of large influence on the gastric pH, but this 
is also highly variable and dependent on the type of meal eaten. Sams et al. (2016) found 
that with liquid meals, the gastric pH ranges between 4 to 7 after 50% of gastric emptying, 
while the gastric pH is still 4.6 after ingestion of a solid meal and 50% gastric emptying. 
Pepsin exerts maximal activity at a pH of 2, is still 70% active at a pH of 4, but then rapidly 
declines in activity with increasing pH [25]. Denaturation of the proteins by gastric acid leads 
to increased accessibility of pepsin to the protein [26, 27]. The high pH of the stomach in 
the first h of digestion might explain the exit of undigested casein from the stomach into the 
duodenum in the UC samples; the pH of the stomach was not low enough for pepsin to exert 
its activity. The largest difference in casein digestion between GC and UC was seen in the 
stomach (figure 7). Opposite to lysine and arginine as tryptic cleavage sites, peptic cleavage 
sites include tyrosine, tryptophan, phenylalanine, and leucine. Even though these amino acids 
do not contain the primarily reactive residues for the Maillard reaction, all N-terminal groups 
of amino acids can react with 1,2-dicarbonyls. For instance, tryptophan has an indole side 
chain that can be glycated [28]. But since the Maillard reaction prefers lysine, the reduced 
digestibility that is seen in the GC vs UC gastric digestion is probably to be largely attributed to 
other mechanisms happening during the Maillard reaction, such as the previously discussed 
steric hindrance [6].
In the current study a large portion of protein bound MG-H1 in ginger biscuits was absorbed 
by the TIM-1 model by passive absorption through the dialysis filters (figure 4). This effect 
was not seen in the results of the other food products or for the other dAGEs, except 
one G-H1 outlier. An explanation for this can be the large concentrations of MG-H1 in the 
starting ginger biscuit compared to the other dAGEs. GC and apple juice also contain smaller 
concentrations of MG-H1. The large dilution occurring in the dialysate may have led the other 
dAGEs to be present in concentrations below the level of quantification of the UPLC-MS/
MS. It is however remarkable that protein-bound MG-H1 is passively absorbed to such a 
large extent. The physiological relevance of this finding is unclear, firstly because the method 
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by which the passive absorption occurs is not very close to the real-life situation. Secondly, 
because previous in vitro absorption studies by Hellwig et al. (2011) showed uptake of MG-
H1 in Caco-2 cells, but strong retainment of MG-H1 in the intestinal cell [29]. It will therefore 
most probably not enter the systemic circulation via passive absorption.
A very interesting result of the present study was that all food products showed endogenous 
formation of AGEs in the small intestinal tract, with ginger biscuits showing the highest 
amount of endogenously formed MG-H1 represented by the recovery of more than 400% 
(table 1). This endogenous formation was seen in earlier studies using the static in vitro 
models by Martinez-Saez et al. (2019) and Bains et al. (2017) [13, 30]. Additionally, Helou et 
al. (2015) used the TIM-1 model to assess the digestion of fluorescent AGEs from bread crust, 
or soluble melanoidins as they called them, and found an increase in fluorescent properties 
of the soluble melanoidins [31]. The authors concluded that, since the TIM-1 model only has 
a temperature of 37°C, the increase was related to “the enzymatic and chemical release of 
fluorescent and soluble melanoidins from larger insoluble melanoidin-skeletons”. This would 
mean that proteins conceal glycated parts that are released during glycation. However, our 
method of assessing dAGE concentrations includes hydrolysing the dAGEs from their protein-
binding, circumventing this problem. We show that new AGEs are being formed and not 
released from their structures. Moreover, UC did not lead to any endogenous formation of 
AGEs, indicating that the thermal treatment that food products undergo are vital for the 
formation of endogenous AGEs. In this study AGEs are only formed endogenously after 
digestion of products that also contained AGEs, which might indicate an underlying need 
for the presence of AGE precursors in food, such as glyoxal and methylglyoxal. As previously 
stated, ginger biscuits displayed a much larger formation of food-derived endogenous AGEs 
than GC and apple juice. A second mechanism for the formation of endogenous AGEs in the 
GI tract could therefore be the presence of fructose in the ginger biscuit, which is highly 
reactive in the Maillard reaction due to its reduced stability of the ring structure compared to 
glucose [32]. Although conflicting evidence exists on whether there is a correlation between 
dAGE uptake and AGE serum and urine levels, a perspective by DeChristopher published 
in 2017 proposed that a source for increased serum AGE levels may be the formation of 
AGEs in the GI tract [33]. Fructose is actively absorbed in the human GI tract together with 
glucose in a 1:1 ratio. Many processed food products contain high fructose corn syrup (HFCS), 
making the ratio fructose:glucose > 1, resulting in fructose malabsorption. This would leave 
the fructose in the GI tract to react with proteins present. In this study a small proportion of 
free AGEs were seen after digestion. However, due to this additional new formation of AGEs, 
it is not possible to conclude whether these AGEs are liberated from their protein-binding 
during digestion or were newly formed. This formation of dAGEs in the intestinal tract was 
not seen with the food-based matrix GC, from which dAGEs were digested during gastric and 
small intestinal digestion. This was contrary to the study conducted by Martinez-Saez using 
different meal resembling systems that did show an increase in dAGEs during digestion [13]. 
These contradicting results can be explained by the difference in constituents of the meal 
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resembling systems between this study and the one from Martinez-Saez. The nutrients used 
in the different studies are important for the progress of the Maillard reaction, something that 
is underlined in the aforementioned study. This indicates that meal resembling systems are 
actually poor models for food products. However, many digestion studies on dAGEs and the 
Maillard reaction make use of meal resembling systems. Our results show that the outcomes 
of these studies only using meal resembling systems should be interpreted with caution.
Gastric digestion led in both GC and apple juice to a loss of dAGEs (table 1), this implies 
a breakdown of dAGEs during digestion. In the case of protein-bound dAGEs in GC, the 
hydrolysing of the sample before UPLC-MS/MS measurement may have led to a loss of dAGEs 
bound to peptides, since some small peptides may not have precipitated. This is not the 
case for the loss seen in free dAGEs in apple juice, since these samples are not hydrolysed. 
Another problem that arose during the UPLC-MS/MS measurement is the presence of 
different isomers of G-H (G-H1, G-H2, and G-H3), the isomerization may have interfered with 
the measurement, causing the large standard deviations seen in the absolute results of G-H1. 
Another aspect that has to be taken into account is that in the current UPLC-MS/MS method 
a higher LOQ is obtained for the hydrolysed samples versus unhydrolysed samples. This is due 
to omitting the hydrolysis step in the latter approach (thereby omitting a dilution step) (Table 
S3). This may have resulted in a possible underestimation of the amount of protein-bound 
dAGEs versus free dAGEs.
The results of this study show that protein-bound dAGEs in food products stay bound to 
proteins during mimicked human GI digestion in both the meal resembling system and the 
food product. This implies for human health that dAGEs enter the human GI tract in a pro-
inflammatory state where they might cause or aggravate inflammation. Earlier studies have 
shown that RAGE is upregulated in inflamed areas of the colon in Crohn’s disease patients, 
indicating a possible role for dAGEs in inflammatory bowel diseases [34]. Glycation can also 
interfere with the digestion of proteins, leading to a loss of amino acids, both essential and 
non-essential [6, 13]. A human study compared the protein digestibility in adolescents of 
a low dAGE diet and a high dAGE diet and found only a small, but significant difference. 
The proteins in the high dAGE diet were 6% less digested than the low dAGE diets [35]. A 
more recent study assessed the effects of different glycation levels on post-prandial lysine 
availability in humans and saw a decrease in lysine bioavailability with increasing glycation 
levels [36]. This result was only seen for lysine and not for other amino acids.
In addition to having negative effects on amino acid bioavailability, some indications also exist 
of newly formed bioactive peptides during the Maillard reaction in foods [7]. A consequence 
of reduced protein and amino acid digestibility is the presence of proteins in the colon. 
Protein fermentation in the colon leads to the formation of detrimental compounds such as 
ammonia, amines, phenols and sulfides [37]. Excessive protein fermentation in the colon has 
been linked to colon cancer and ulcerative colitis [38]. There is no consensus on the effect of 
dAGEs in the colon and on the colonic microbiota as the effects depend on both the type of 
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food product and the thermal treatment [39, 40]. 
As stated before, the pH of the stomach is crucial for protein digestion, as acid hydrolysis of the 
protein liberates proteolytic binding sites. The higher the pH, the less access for proteolytic 
enzymes. People taking anti-acid medication pharmacologically elevate their stomach pH, 
making acid hydrolysis less effective and thereby interfering with the digestion of protein-
bound dAGEs. Additionally, age-related differences exist in stomach pH, where the infant 
stomach is less acidic than the adult stomach and the GI tract has different transit times [41, 
42]. Infant formulas are extensively processed and contain protein-bound dAGEs that might 
have a detrimental effect on the developing infant GI tract [43].
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5. Conclusion
In this study we have shown in a validated, sophisticated in vitro GI model that dAGEs enter 
the small intestinal and large intestinal tract in predominantly protein-bound and thereby 
pro-inflammatory state. Furthermore, it can be concluded that glycation hampered casein 
digestion. Additionally, we have shown that endogenous AGEs are formed in the GI tract with 
the quantities depending on the type of food product and thermal treatment. Our results 
show that the effect of digestion on food-based matrices, or meal-resembling systems, do 
not correspond to the effects on actual food products. This is important for future research 
into dAGEs.
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Supplements A
TIM-1 model
Figure S1. Schematic diagram of the dynamic, multi-compartmental TNO in vitro model of the stomach and small 
intestine (TIM-1). A. stomach compartment; B. pyloric sphincter; C. duodenum compartment; D. peristaltic valve; 
E. jejunum compartment; F. peristaltic valve; G. ileum compartment; H. ileocecal sphincter; I. stomach secretion; J. 
duodenum secretion; K. jejunum/ileum secretion; L. pre-filter; M. semi-permeable membrane; N. water absorption; 
P. pH electrodes; Q. level sensors; R. temperature sensor; S. pressure sensor. Reprinted from Keller et al. (2017) with 
permission [44].
Figure S2. Gastric delivery (diamond), ileal delivery (triangle) [both expressed as percentage of the ingested meal], 
and the gastric pH (square) curves as mimicked in TIM-1 over time, representing adults.
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Supplement B
Details on method of analysis for protein-bound and free dAGEs
In this study, every sample was analysed in both the hydrolysed (total dAGEs, i.e. free + protein-
bound dAGEs) and unhydrolysed form (free dAGEs). The sample preparation is based on an 
earlier studies 1, 16 and similar to our previous study3. Briefly, sodium borate (0.33 M; pH 9) 
and sodium borohydride (2 M) were added to an aliquot of the samples (equivalent to ~1 mg 
protein) to obtain a sodium borohydride concentration of 0.2 M in the samples. These sample 
solutions were incubated for 4 h at room temperature. Subsequently, 1 mL of a chloroform/
methanol (2/1 (v/v)) mix was added, and the samples were centrifuged for 10 min at 12,000 
rpm. The chloroform phase was discarded and the remaining solution containing proteins 
was hydrolysed in 6 M HCl at 110˚C for 18 h. The solutions were evaporated until dryness at 
50˚C under a stream of nitrogen and dissolved in 1 v/v% aqueous TFA (1 mL). Prior to UPLC-
MS/MS analysis, internal standards and MilliQ were added to 50 µL of these analyte solutions 
to achieve a final volume of 200 µL. The free dAGE content in the samples was analysed by 
omitting the hydrolysis step in the sample preparation procedure, thereby circumventing the 
release of protein-bound dAGEs.  The sample extracts were analysed using an Acquity UPLC 
system (Waters, Milford, MA, USA) equipped with a BEH C18 analytical column (100 x 2.1 
mm, 1.7 µm particle size, Waters, Milford, MA, USA)). The mobile phases were 5 mM NFPA in 
water (A) and acetonitrile (B), and the flow was set at 0.4 mL/min. The mobile phase gradient 
was as follows: a linear increase from 100% A (t = 0.5 min) to 70% A (t = 5 min.) followed by 
a linear increase to 100% B (0% A) at 8.5 min, keeping 100% B to t=10.3 min and returning 
back to initial conditions again (100% A), allowing a 2 min equilibration at these conditions. 
The column was kept at a constant temperature of 35˚C. A Qtrap 6500 triple quadrupole 
mass spectrometer (Sciex) was connected to the UPLC was operated in positive electrospray 
ionization (ESI+). The capillary voltage was set to 4.5 kV, and the source temperature was 
500˚C, respectively. The curtain gas was set at 35 and the (instrument specific) gas 1&2 
were set at 60. The injection volume was 5 µL. Quantification was performed using an 
internal standard approach and nine-point calibration curves (matrix matched standards). 
Quantification was performed using the precursor-product ion multiple reaction monitoring 
(MRM) transitions reported in below Table S1. The accuracy of the analysis was monitored 
by spiking each sample with a dAGEs standard. The average accuracies ranged from 75-133% 
(see Table S2), demonstrating that no severe losses occurred during sample preparation, and 
no signal enhancements or suppression occurred during UPLC-MS/MS analysis. Ion ratios 
between the quantifier ion and qualifier ion were monitored. In case ion ratios deviated more 
than 20% from the ratio observed in the standard, then the identity of the peak could not 
be confirmed. In the case of MG-H1 and G-H1, ion-ratio deviations were observed in GC, 
ginger biscuits and apple juice. A brief investigation into this issue revealed that isomers of 
MG-H1 (i.e. MG-H2 and MG-H3) and G-H1 (i.e. G-H2 and G-H3) may co-exist in the samples. 
Additional explorative experiments showed that these may co-elute and alter the ion-ratios 
(data not shown). Future work is needed to explore this work further, but with the isomers 
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issue in consideration, deviating ion ratios were accepted for MG-H1 and G-H1. It is expected 
that this also played a role in the slightly elevated (or lower) accuracies for MG-H1 and 
G-H1 (Table S2). The limit of quantification (LOQ) is provided in Table S3. The LOQ for the 
protein-bound dAGEs was 125 µg/L and 10 µg/L for the free dAGEs (Table S3). This 12.5 fold 
difference can be explained by omitting the acid hydrolysis step, which introduces a dilution 
of the sample. By omitting this step, the sample is not diluted, resulting in lower LOQs.   
Table S1. MS/MS settings for the UPLC analysis of dAGEs in glycated casein, ginger biscuit and apple juice.
dAGE Precursor > 
product ion (m/z)
Collision cell exit 
potential (CXP) 
Collision energy 
(CE) (eV)
Declustering 
potential (V)
CML
205 > 130 6 17 51
205 > 84 14 25 51
CEL
219 > 130 14 19 60
219 > 84 10 27 60
MG-H1
229 > 114 8 21 50
229 > 70 10 37 50
G-H1
215 > 152 14 20 50
215 > 116 8 19 50
Sample CML (%) CEL (%) MG-H1 (%) G-H1 (%)
Glycated 
casein
Total dAGEs 106 (13) 114 (7) 107 (21) 103 (23)
Free dAGEs 100 (4) 105 (4) 75 (32) 92 (12)
Ginger 
biscuits
Total dAGEs 100 (5) 96 (5) 133 (50) 96 (8)
Free dAGEs 98 (4) 103 (4) 91 (37) 91 (12)
Apple juice
Total dAGEs 99 (11) 104 (10) 106 (13) 106 (13)
Free dAGEs 102 (6) 101 (6) 116 (14) 101 (11)
Sample CML (µg/L) CEL (µg/L) MG-H1 (µg/L) G-H1 (µg/L)
Glycated 
casein
Total dAGEs 125 125 125 125
Free dAGEs 10 10 10 10
Ginger 
biscuits
Total dAGEs 125 125 125 125
Free dAGEs 10 10 10 10
Apple juice
Total dAGEs 125 125 125 125
Free dAGEs 10 10 10 10
Table S2. Average (+/- SD) accuracies of spiked dAGEs standards in glycated casein, ginger biscuit and apple juice.
Table S3. Limit of quantification of the dAGEs in this study.
78
79
Chapter 4
The pro-inflammatory potential of dietary 
advanced glycation endproducts after 
gastrointestinal digestion
Timme van der Lugt, Misha F. Vrolijk, Antje R. Weseler, Maaike Suuring, 
Toine F. H. Bovee, Stefan van Leeuwen, Stanislava Vonsovic, Astrid Hamers, 
Antoon Opperhuizen, Aalt Bast
In preparation
Chapter 4
80
4
Abstract
Thermal treatment of food products leads to the formation of dietary advanced glycation 
endproducts (dAGEs). We have previously shown that dAGEs induce TNF-α secretion, 
cell death, and oxidative stress in human macrophage-like cells. To what extent digestion 
influences the pro-inflammatory effects of dAGEs is and what the implications of these pro-
inflammatory characteristics in the human GI tract are currently unknown. In our previous 
study, dAGEs were digested using the TNO gastroIntestinal Model. In the current study human 
macrophage-like cells were exposed to both digested and undigested dAGEs and analysed for 
TNF- α secretion. Furthermore, the digests were fractionated and human macrophage-like 
cells were exposed to the different fractions to determine the effect on TNF-α secretion. In 
addition, Caco-2 cells (gastrointestinal epithelial cells) were exposed to undigested dAGEs and 
assessed for cell viability and oxidative stress. The results show that digested dAGEs remain 
pro-inflammatory in human macrophage-like cells and that the fractions containing the larger 
molecules substantially contribute to this effect. The effects of dAGEs on Caco-2 cells was 
dependent on thermal treatment as longer treatment led to decreased cell viability. Any heat 
treatment of a carbohydrate-protein mixture decreased intracellular reactive oxygen species 
production compared to the unheated samples in these cells. In conclusion, this study shows 
that dAGEs remain pro-inflammatory after digestion and fragmentation. These inflammatory 
effects seem to be both thermal treatment and cell-type dependent.
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1. Introduction
During thermal food processing, sugars and amino acids react with each other via the 
Maillard reaction, which is a series of non-enzymatic reactions, to different sub-sets of 
molecules. Among these molecules are Amadori products, early glycation products, advanced 
glycation endproducts (AGEs), and melanoidins. In diabetic patients, AGEs are also formed 
endogenously at 37°C from the reaction of carbohydrates and proteins. Endogenously 
formed AGEs are associated with microvascular complications in diabetes type II patients 
such as diabetic cardiomyopathy and peripheral neuropathies [1-3]. In previous studies we 
have shown that also dietary advanced glycation endproducts (dAGEs) bound to proteins, 
have distinct pro-inflammatory effects on human macrophage-like cells [4]. In addition, the 
formation of intracellular reactive oxygen species (iROS) was also induced by dAGEs in these 
cells [5]. Since the protein binding is essential for exerting the pro-inflammatory effect, we 
previously investigated the effect of human intestinal digestion on the dAGE-protein binding 
using the TNO GastroIntestinal Model (TIM-1) [6]. The results of this study revealed an intact 
protein/peptide binding of the dAGEs and even the formation of new protein-bound dAGEs 
during digestion. The question that remains is if these digested dAGEs could still have pro-
inflammatory characteristics. dAGEs exert their effects largely via activating the receptor for 
advanced glycation endproducts (RAGE) [4, 7, 8]. RAGE is a 35 kDa transmembrane receptor 
and has a multitude of ligands. Evidence suggests that activation of RAGE is dependent on 
the molecular size of the ligand, hence mainly protein-bound AGEs activate RAGE. This size-
dependency is likely due to oligomerization of RAGE in the cell membrane [9]. However, the 
specific recognition sites of RAGE, or the required ligand size for binding is currently unknown. 
In the current study we will therefore assess whether digestion alters the pro-inflammatory 
potential of glycated casein (GC), a heated food-based matrix containing a diverse set of 
dAGEs, in human macrophage-like cells (THP-1). Additionally, digested and undigested GC will 
be fractionated by size-exclusion chromatography according to molecule size, to assess the 
size of the pro-inflammatory molecules and their pro-inflammatory characteristics. To have a 
first indication of the effect of dAGEs on the gastrointestinal epithelial cells, the effect of GC 
on Caco-2 cells is also assessed.
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2. Materials and methods
2.1 Chemicals and reagents
Casein from bovine milk, lactose monohydrate, NaOH, sodium-phosphate, 2-mercaptoethanol, 
and thiazolyl blue tetrazolium bromide (MTT) were obtained from Sigma-Aldrich (Saint Louis, 
MO, USA). D-glucose, glutamate, fetal bovine serum (FBS), Dulbeccco’s Phospate-Buffered 
Saline (DPBS) were obtained from Gibco (Thermo Scientific, Waltham, MA, USA). Phorbol 
12-myristate 13-acetate (PMA) were obtained from Sigma (Zwijndrecht, Netherlands). 
2.2 Preparation of glycated casein (GC) and unglycated casein (UC)
Casein, glucose, and lactose, in the proportion of milk powder (11 mM glucose, 0.2 M lactose, 
10 g/L casein from bovine milk: 1xGC), or two times concentrated milk powder (22 mM 
glucose, 0.4 M lactose, 20 g/L casein from bovine milk: 2xGC), were suspended in 50 mM 
phosphate buffer, pH 7.4 and heated in an Erlenmeyer flask on a heating plate at 100°C up to 
120 min. At time points 0, 15, 60, and 120 min. samples were taken and immediately cooled 
in ice water. Samples were aliquoted and stored at  - 80°C. Control samples of glucose, lactose 
and casein in the proportion of milk powder (1xUC) and in the two times concentrated form 
(2xUC) were prepared without heating and were also immediately stored at  - 80°C. The levels 
of different dAGEs are given in table S1. 1xGC and the respective control (1xUC) samples 
were used in the Caco-2 experiments; 2xGC and 2xUC samples were used in all experiments 
involving THP-1 cells.
2.3 Digestion of glycated casein
The two times concentrated GC and UC samples were digested using the TNO gastrointestinal 
model (TIM-1) as described in chapter 3 [6]. In short, 300 grams of 2xGC and 2xUC were 
run through the model which comprises four connected glass compartments, representing 
the stomach, duodenum, jejunum, and ileum. In the model, the inner walls are squeezed, 
simulating peristalsis, and in each individual compartment the pH is measured continuously 
and regulated by the ‘secretion’ of hydrochloric acid (gastric compartment) or sodium 
bicarbonate (intestinal compartments). Secretion fluids (electrolytes, enzymes, bile, and 
pancreatic juice) were adjusted to the average concentrations as described for adults after 
ingestion of a meal. Pancreatic output was simulated by secreting 10% pancreatin in the small 
intestinal electrolyte solution. Biliary output was simulated by secreting a 2% bile (porcine 
bile extract) solution at 0.5 ml/min. Experiments were done both in the gastric compartment 
only, as well as in the complete model. In the experiments in which only the gastric 
compartment was used, the duodenal compartment was only used for neutralization of the 
gastric efflux, without secretion of bile and pancreatin. This neutralization occurred before 
sampling. Concentrations of Nε- carboxymethyl-lysine (CML), Nε-carboxyethyl-lysine (CEL), 
glyoxal-derived hydroimidazolone-1 (G-H1), and methylglyoxal-derived hydroimidazolone-1 
(MG-H1), were assessed by UPLC-MS/MS and are shown in chapter 4. The concentrations of 
the samples used in this study can be found in table S1.
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2.4 Determination of endotoxin in GC and UC samples
The presence of endotoxin in the glycated casein samples from all time points was assessed 
by the commercially available PYROGENT Gel Clot LAL Assay 0.06 EU/mL sensitivity (Lonza, 
Basel, Switzerland). The assay was performed in accordance with the manufacturer’s protocol 
using endotoxin-free dilutions and reagent tubes (Lonza, Basel, Switzerland).
2.5 Size exclusion chromatography
Undigested and digested 2xGC samples were fractionated using a size exclusion 
chromatography (SEC) system consisting of an Agilent 1200 series LC-UV system (Santa 
Clara, CA, USA), equipped with a TSKgel SuperSW2000, 4.6x300 mm, 4µm particles (TOSOH 
Bioscience, Griesheim (Darmstadt), Germany). The system was operated at a flow of 0.35 mL/
min and the column was kept at a room temperature. The system was run isocratically with 
a 200 mM phosphate buffer at pH 6.7 (10.6 gram KH2PO and 27.2 gram Na2HPO4 x 2H2O 
in 1 litre demineralized water). For each run, 100 µL of undiluted sample was injected. The 
fractionation run lasted 20 minutes and fractions of 30 seconds (equalling 0.175 mL) were 
collected between 5 and 14 minutes. The protein size calibration was done using a standard 
solution of 15-600 kDa mix consisting of thyroglobulin (640 kDa), γ-globulin (155 kDa), 
albumin (47 kDa), ribonuclease A (13.7 kDa) and ρ-aminobenzoic acid (0.14 kDa) (Sigma-
Aldrich, St. Louis, Missouri, USA). 
2.6 Cell culture and exposure of macrophage-like cells (THP-1)
THP-1 monocytes (ATCC, TIB-202), cultured in RPMI 1640 with L-glutamine, Hepes and 
phenol red (Gibco, Thermo Scientific, Waltham, MA, USA) supplemented with 10% (v/v) 
fetal bovine serum (FBS), D-glucose (4.5 g/L), Na-pyruvate (1mM) and 2-mercaptoethanol 
(50μM), were seeded in a 96-wells plate at a cell density of 70,000 cells/well. Differentiation 
into macrophages was induced by adding 200 nM of PMA to the cell culture medium and 
culturing them for 72 h. Macrophage-like cells were exposed to 1 and 10% (v/v) of 2xGC and 
2xUC in serum and phenol-red free medium for 6 h. Only samples that were proven to be free 
of endotoxins were used. Control conditions included phenol-red free medium and 1 or 10% 
DPBS. To investigate the effects of the SEC fractions, macrophage-like cells were exposed to 
10% (v/v) of unfractionated and fractionated sample, respectively. Ten percent SEC diluent, 
as described in section 2.5, served as a control condition.
2.7 Cell culture and exposure of gastrointestinal epithelial cells (Caco-2)
Caco-2 cells were cultured in DMEM containing 1% (v/v) non-essential amino acids, 1% (v/v) 
Na-pyruvate, 10% (v/v)  FBS and 4.5 g/ml Glucose. After reaching 80% confluence, cells were 
transferred to a 96-wells plate at a cell density of 20,000 cells/well. After the Caco-2 cells 
reached 80% confluence, the cells were exposed to final concentrations of 1%, 3%, 10%, 30% 
(v/v) 1xGC that was heated for 15 and 120 min at 100°C. To reach these final concentrations, 
the different 1xGC samples were suspended in DPBS and further suspended 1:1 in FBS and 
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phenol-red free DMEM to which the cells were exposed for 24 h. Control conditions included 
30% (v/v) 1xGC unheated, and 30% (v/v) D-glucose (0.6 mg/ml), lactose (22.2 mg/ml), casein 
(1.5 mg/ml) individually and in the combination D-glucose (0.6 mg/ml) + lactose (22.2 mg/
ml).
2.8 Cell culture and exposure of Caco-2 cells to conditioned medium (CM) from 
macrophage-like cells
THP-1 monocytes were cultured as described before and seeded into a 6-wells plate in a 
cell density of 1,050,000 cells/well. Consequently, the cells were differentiated with 200 nM 
PMA for 72 h into macrophage-like cells. After 48 h, Caco-2 cells were seeded into a 24 wells 
plate at a cell density of 150,000 cells/well. After the 72 h differentiation, macrophage-like 
cells were exposed to 1% (v/v) 2xGC for 6 h in serum and phenol-red free RPMI 1640. Control 
conditions included 1% (v/v) casein and 1% (v/v) DPBS. After 6 h exposure, the medium of 
the macrophage-like cells was transferred to the Caco-2 cells and 1% of FBS was added to 
prevent the Caco-2 cells from dying. Control conditions included the same conditions not 
exposed to macrophage-like cells and regular Caco-2 medium. The Caco-2 cells were then 
cultured for further 24 h, after which the cell supernatant was removed and stored at  -80°C 
for ELISA analyses.
2.9 Assessment of cell viability
Cell viability of macrophage-like cells was assessed using the MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) assay. After removal of the cell supernatant 100 μL of 
MTT solution (0.5 mg/mL in DPBS) was added to each well. Then the plate was incubated in 
the dark at 37°C for 1 h. Subsequently, the MTT solution was removed from the wells and 
100 μL of DMSO was added to each well. After 10 min incubation at room temperature, 
absorbance was measured in a microplate reader (Bio-Rad, Hercules, CA, USA) at λ = 540 nm.
Cell viability of Caco-2 cells exposed to CM from macrophage-like cells was assessed by a 
commercially available Pierce LDH Cytotoxicity Assay Kit (Thermo Scientific, Waltham, MA, 
USA) in accordance to the manufacturer’s protocol.
 
2.10 Quantification of tumor necrosis factor (TNF)-α in cell culture supernatants
Tumor necrosis factor (TNF)-α release in cell culture supernatants of macrophage-like cells 
was assessed by a commercially available ELISA kit (R&D systems, MN, USA). The assay was 
performed in accordance to the manufacturer’s protocol. 
2.11 Quantification of intracellular ROS (iROS) levels 
iROS levels were quantified using the DCFH-DA assay. This assay measures iROS by their 
capacity to oxidise 2′,7′- dichlorofluorescin diacetate (H2DCF-DA) to the fluorescent DCF 
[10]. In this study, Caco-2 cells were cultured and seeded into a 96 wells black plate/clear 
bottom according to the aforementioned methods in 2.7 and 2.8. Before exposing the cells 
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to dAGEs, cells were exposed to 50 µM of H2DCF-DA for 1 h. Supernatant was removed and 
cells were exposed to the test conditions and controls specified in 2.7 and 2.8 for 24 h. After 
24 h, fluorescence of DCF was measured at  an excitation wavelength of λ = 485 nm and an 
emission wavelength of λ = 525 nm and corrected for baseline fluorescence. To calculate the 
relative values, fluorescence of cells exposed to only regular Caco-2 culture medium was set 
to 100%.
2.12 Determination of protein content of digested 2xGC and Caco-2 cells
Protein content of TIM-1 digests of 2xGC, and of Caco-2 cells exposed to CM from macrophage-
like cells in the DCFH-DA assay were assessed using the Pierce BCA Protein Assay Kit (Thermo 
Scientific, Waltham, MA, USA). The assay was performed in accordance to the manufacturer’s 
protocol.
2.13 Determination of protein content of fractionated 2xGC
Protein content of fractionated TIM-1 digests of 2xGC was assessed using the NanoDrop 
(Isogen Life Science, Maarsen, The Netherlands)
2.14 Statistics
Experiments were performed in duplicate on different days with three repetitions using the 
average of the duplicates as one value. Data were analysed using GraphPad Prism software 
(v. 5.00, GraphPad Software, San Diego, CA, USA). Data obtained were tested for normality by 
using the D’Agostino and Pearson omnibus normality test. Due to a lack of normal distribution, 
data were analysed with the nonparametric Kruskal–Wallis test followed by Dunn’s Multiple 
Comparisons test or the Mann–Whitney U test to compare two sets of treatment. The 
significance level was set to p < 0.05. The significance is indicated as * p < 0.05, ** p < 0.01, 
and *** p < 0.001.
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3. Results
3.1 Effects of digested dietary AGEs
3.1.1 Pro-inflammatory effect of digested dietary AGEs on human macrophage-like cells
To assess the pro-inflammatory effects of dAGEs after GI digestion human macrophage-like 
cells were exposed to a 1% solution of either TIM-1 digested dAGEs or TIM-1 digested UC as 
a control. Digested UC, i.e. the control condition, did not lead to any TNF-α secretion (data 
not shown). Since large dilutions of the food products occur during GI digestion, the TNF-α 
secretion was corrected for the protein concentration of the different samples. The TNF- 
α secretion of the cells exposed to the digested dAGEs was then expressed relative to the 
TNF-α secretion of the undigested dAGEs sample. The absolute TNF-α secretion is shown 
in figure S1. Gastric digestion of dAGEs led to an approximately 400% increase in TNF-α 
secretion, although not significant (figure 1). Prolonged GI digestion significantly increased 
TNF-α secretion more than 400%. Results are displayed as relative to the undigested dAGEs 
(dashed line) due to large deviations between experiments. The undigested dAGEs led to 530 
± 252 pg/ml TNF-α (mean ± SD) (figure S1).
Figure 1. TNF-α secretion of human macrophage-like cells after 6 h exposure to different time points of digested 
dAGEs samples relative to the undigested dAGEs sample (0 h digestion) measured by ELISA and corrected for cell 
death (MTT) and protein content of the dAGEs samples. Dotted line represents the TNF-α secretion of the dAGEs 
prior to digestion (100%). Data are presented as mean ± SD, n = 3. * = p < 0.05, ** = p < 0.01 compared to the starting 
product.
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3.1.2 SEC separation of undigested and digested dAGEs
Since digested dAGEs induced a higher TNF-α secretion than undigested dAGEs, the 
undigested and digested samples were analysed for molecular size using size-exclusion 
chromatography. Figure 2 shows the different chromatograms for undigested dAGEs (figure 
2A), 2 h gastric digested dAGEs (figure 2B), and 2 h of gastrointestinal digestion (figure 2C). 
Figure 2D shows the size-exclusion chromatogram of different peptides and figure 2E shows 2 
h gastrointestinal digestion of the TIM-1 enzyme and buffer control. Separation of undigested 
dAGEs (figure 2A) shows a large peak at approximately 6 min. which corresponds with protein 
sizes of approximately 640 kDa (figure 2D), a second peak of sizes around 47 kDa and then 
several peaks smaller than 14kDa. Figure 2E, the chromatogram for the enzymes and buffers 
used in the TIM-1 model contents, shows a peak again at 640 kDa, some molecules smaller 
than 47 kDa and a peak in molecule sizes just under 14 kDa. The last peak consists of molecules 
smaller than 0.14 kDa. Gastric digestion (figure 2C) leads to a dramatic shift towards smaller 
molecule-sizes. The 640 kDa peak has reduced by a tenth (note the difference in y-axis scale) 
but is probably due to the TIM-1 contents. Additional peaks arise after longer elution times 
that are not present in either the undigested dAGEs nor in the TIM-1 model. This indicates 
breakdown products of dAGEs. After 2 h of gastrointestinal digestion the peaks have shifted 
to sizes below 14 kDa. 
 
Figure 2. Size-exclusion chromatograms showing the different fractions of (A) undigested dAGEs, (B) 2h gastric 
digested dAGEs, (C) 2h gastrointestinal digested dAGEs, (D) protein standards consisting of thyroglobulin (640 kDa), 
γ-globulin (155 kDa), albumin (47 kDa), ribonuclease A (13.7 kDa) and ρ-aminobenzoic acid (0.14 kDa) with indicat-
ed molecular weights, (E) 2h gastrointestinal digestion TIM-1 control.
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3.1.3 Pro-inflammatory effect of fractionated undigested dAGEs on human macrophage-
like cells
In order to investigate whether the pro-inflammatory effect of undigested dAGEs can be 
related to a particular fraction after size exclusion chromatography, human macrophage-
like cells were exposed to 10% (v/v) dilutions of these fractions. Figure 3A displays the 
TNF-α concentrations in the cell supernatant per experimental condition. Absolute TNF-α 
concentrations were corrected for the TNF-α secretion induced by only the SEC diluent per 
fraction. The unfractionated sample induced the highest TNF-α secretion. Exposing the cells 
to the first fraction did not lead to any TNF-α secretion, fraction 2 induced some TNF-α 
secretion (3.4 ± 1.9 ng/ml (mean ± SD)) and fraction 3 induced 9.6 ± 1.3 ng/ml release of 
TNF-α from the macrophage-like cells. From fraction 4 on TNF-α secretion decreased until 
fraction 13, after which no TNF-α secretion occurred anymore. 
Since we have shown that only the protein-bound dAGEs are responsible for the pro-
inflammatory response of macrophages, the protein concentration of each fraction was 
determined and the TNF-α release per mg protein was calculated (figure 3B). Since the 
unfractionated dAGEs have a high protein content compared to the fractions, it shows a 
relatively low TNF-α secretion per mg of protein compared to fractions 2 until 13. Fraction 
2 greatly induced TNF-α secretion compared to both the unfractionated 1190 ± 670 % and 
the other fractions. Compared to the unfractionated sample this increase was 1190 ± 670 %. 
Unfortunately due to a large standard deviation this increase is not statistically significant. 
Fractions 3 up until 13 induced approximately the same amount of TNF-α secretion, up 
to ± 500% of the unfractionated sample. The digested dAGEs were assessed in the same 
experiment, but the TIM-1 control (without dAGEs), already induced similar levels of TNF-α 
secretion as the digested dAGEs (data not shown).
 
Figure 3. TNF-α secretion of human macrophage-like cells measured by ELISA after 6 h exposure to the different 
fractions of undigested dAGEs separated according to molecular size (1>18). “U” is the unfractionated sample. 
(A) Absolute concentration of TNF-α in pg/ml cell supernatant, (B) TNF-α secretion expressed in pg/mg protein 
content of the undigested dAGE fractions. Data are presented as mean ± SD, n = 3.
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3.2 Effects of dAGEs on gastrointestinal epithelial cells.
To investigate the effects of dAGEs on human gastrointestinal epithelial cells, the same 
1xGC samples were used as previously published [4], with two different heating times to 
explore whether the duration of heating changes the biological effects of the dAGEs. The 
concentrations of CML, CEL, and MG-H1 in the samples are shown in table S1. The TIM-1 
digested samples could not be used since Caco-2 cells did not react well to the GI enzymes 
of the TIM-1 model. 
3.2.1 Effects of dAGEs on cell viability of human gastrointestinal epithelial cells 
Exposing Caco-2 cells to different concentrations of dAGEs heated for 15 min. did not 
affect cell viability, neither did the individual components (casein, glucose, lactose and the 
combination UC) used to produce dAGEs (figure 4). In contrast, the dAGEs heated for 120 
min. significantly reduced the cell viability by 77 ± 15 % (mean ± SD) (p < 0.01) in the 30% (v/v) 
dilution compared to the same dilution of UC and 86 ± 25 % (p < 0.01) compared to the same 
dilution of dAGEs heated for 15 min. Further dilution of the 120 min. heated dAGEs samples 
removed the cell viability compromising effects. 
 
Figure 4. Cell viability of Caco-2 cells assessed by the MTT assay after 24h exposure to dAGEs heated during the 
manufacturing process for either 15 (GC 15 min) or 120 minutes (GC 120 min), UC, and the different individual 
components of the carbohydrate-protein mixture used to prepare dAGEs. Results were normalized to control (50 % 
(v/v) DPBS), which was set to 100 % (dotted line). Data are presented as mean ± SD, n = 3, ** = p < 0.01
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3.2.3 Effects of dAGEs on iROS production of human gastrointestinal epithelial cells
The effects of different dilutions of dAGEs heated for 15 and 120 min, and the individual 
components used to prepare dAGEs on iROS production of Caco-2 cells are shown in figure 5. 
Twenty four hours exposure to 30% (v/v) casein and UC increased iROS production, although 
not significant compared to the vehicle control (50% (v/v) DPBS). iROS production of cells 
exposed to UC 30% was significantly increased compared to 30% GC heated for 120 minutes 
(p < 0.001).
 
Figure 5. iROS levels of Caco-2 cells after 24 h exposure to dAGEs heated for either 15 (GC 15 min) or 120 minutes 
(GC 120 min) and unglycated casein (UC, which consists of casein, lactose, and glucose unheated), and the different, 
unheated individual components of the mixture. The vehicle control (50% (v/v) DPBS) was set to 100% (dotted line). 
Data are presented as mean ± SD, n = 3, *** = p < 0.001.
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3.3 Interplay between macrophage-like cells exposed to dietary AGEs and human 
gastrointestinal epithelial cells.
To investigate a possible interplay between activated macrophages and Caco-2 cells by 
dAGEs. Human macrophage-like cells were exposed to a 1% (v/v) dilution of undigested 
dAGEs (2xGC), 1% (v/v) casein as control, and the vehicle control which consisted of 1% 
DPBS. After 6 h exposure, the macrophage conditioned medium (CM) was removed and 
transferred to Caco-2 cells after which they were incubated for 24 h. As control the Caco-2 
cells were additionally exposed to the same incubations but without the macrophage-CM of 
the macrophage-like cells.
3.3.1 Effects of macrophage-CM exposed to dietary AGEs on cell viability of human 
gastrointestinal epithelial cells
Twenty four hour exposure of Caco-2 cells to the media of macrophage-like cells exposed to 
either 1% (v/v) dAGEs, 1% (v/v) casein or 1% (v/v) of the vehicle control revealed an increased 
LDH leakage compared to cells who were exposed to the various cell culture medium controls 
containing the different test compounds (figure 6). No differences were seen between the 
different macrophage-CM with vehicle control, casein and dAGEs
 
Figure 6. LDH secretion of Caco-2 cells after 24 h exposure to macrophage-CM exposed to either 1% (v/v) dAGEs, 1% 
(v/v) casein or 1% (v/v) of the vehicle control or control medium including the same concentrations of dAGEs, casein 
or vehicle. Data are presented as mean ± SD, n = 4.
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3.3.2 Effects of macrophage-CM exposed to dietary AGEs on iROS formation of human 
gastrointestinal epithelial cells 
In the presence of macrophage-CM exposed to either 1 % (v/v) dAGEs, 1 % (v/v) casein or 1 
% (v/v) of the vehicle control (Ctrl + Veh), Caco-2 cells showed lower iROS levels compared 
to control cells (Ctrl) (figure 7). These cells were exposed to regular medium containing the 
different test compounds. Again, no differences were seen between the macrophage-CM 
with vehicle control, casein and dAGEs.
 
Figure 7. iROS levels of Caco-2 cells after 24 h exposure to macrophage-CM exposed to either 1% (v/v) dAGEs, 1% 
(v/v) casein or 1% (v/v) of the vehicle control or control medium including the same concentrations of dAGEs, casein 
or vehicle. Baseline fluorescence of unexposed Caco-2 cells was set at 100%. Data are presented as mean ± SD, n = 4
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4. Discussion
The pro-inflammatory effects of endogenous AGEs have been well documented [1-3]. In 
contrast, the evidence on the pro-inflammatory potential of dAGEs is however more scarce 
and needs more attention. Our earlier published study revealed that also dAGEs possess pro-
inflammatory properties, and specifically protein-bound dAGEs [4]. However, before dAGEs 
could exert these effects in the intestines or systemically, they undergo digestion by the GI 
tract. In our previous paper, we have shown that the protein-dAGE binding stays intact during 
GI digestion [6]. To what extent the digestive processes influence the inflammatory effects 
of dAGES is however unknown. In this paper, we therefore assessed the effects of dAGEs 
on their pro-inflammatory potential in human macrophage-like cells after GI digestion and 
compared this to the effects of undigested dAGEs. Our results show that digested dAGEs still 
have a high pro-inflammatory potential as illustrated by the increasing trend on the TNF-α 
secretion compared to undigested dAGEs (figure 1). After correction for the protein content, 
digested dAGEs are approximately 4x more pro-inflammatory than undigested dAGEs.
Our research group has previously analysed how GI digestion influences the availability 
and composition (protein-bound vs free form) of dAGEs [6]. Not only were protein-bound 
dAGEs able to survive the GI tract, also new endogenous AGEs were formed in the intestines. 
During digestion, proteins are usually broken down into smaller peptides. As a consequence, 
smaller protein- or peptide-bound dAGE fractions could be formed in the GI tract. These 
changes could potentially change the pro-inflammatory characteristics of the dAGEs. Indeed, 
our results show that after digestion smaller sized proteins are being formed, as shown by 
multiple new peaks that were detected after gastric digestion of GC (figure 2).  After complete 
GI digestion, again a change in chromatogram was seen, indicating further breakdown of GC.
The present study also shows that even after digestion, dAGEs remain pro-inflammatory.  In 
order to determine how fragmentation of protein-bound AGEs affects the pro-inflammatory 
effects of dAGEs, the effect of specific sizes of dAGE-protein complexes was assessed. 
Therefore, the dAGEs were fractionated by size-exclusion chromatography and the different 
fractions were tested on the induction of TNF-α secretion in human macrophage-like cells. 
After correction for protein content of the fractions, especially fractions containing molecules 
larger than 640 kDa induced high levels of TNF-α secretion (figure 3). Fractions smaller than 
1 kDa did not induce any TNF-α secretion. This indicates that especially the large molecules 
or aggregates are responsible for the pro-inflammatory effects of dAGEs. One of the possible 
mechanisms by which dAGEs could induce inflammation is via the Receptor for Advanced 
Glycation Endproducts (RAGE). RAGE is proposed to be a pattern recognition receptor and 
has many different ligands next to AGEs, among which are proteins with high inflammatory 
potentials such as high mobility group box 1 (HMGB1), lipopolysaccharides (LPS), the signalling 
molecule lysophosphatic acid (LPA), damage-associated molecular patterns, and advanced 
oxidation protein products (AOPPs) [8, 9]. We have previously shown that blocking RAGE 
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lowers the pro-inflammatory effects of AGEs [4]. Potentially, different sizes of protein-bound 
dAGES might interact differently with RAGE. Oligomerization of RAGE on the cell surface 
is important for signal transduction, and might explain why specifically larger molecule 
structures bind and activate RAGE [9, 11]. To what extent digestion of dAGEs change the 
binding to RAGE is unknown and therefore more research is needed to investigate whether 
our results here can be explained by RAGE activation. This could be achieved by blocking 
RAGE on the cell surface or by assessing the different fractions in a RAGE-binding assay. 
Remarkably, fractionated samples showed in general higher pro-inflammatory characteristics 
than the unfractionated sample. A possible explanation might be the different characteristics 
of the molecules that are formed during the Maillard reaction. One sub-set formed, named 
early glycation products, have been shown in one study to exert anti-inflammatory effects 
by polarizing macrophages to the more anti-inflammatory M2 type in C57BL/6 male mice to 
early glycation products [12]. In a study of Oh et al. (2017), lysine-galactose Maillard reaction 
products (MRPs) of 3 to 10 kDa reduced LPS-induced inflammation in RAW264.7 cells [13]. 
In a different study assessing the effect of MRPs on Caco-2 cells, a similar reduction of the 
inflammatory response was seen with small lysine-based MRPs [14]. In our experiment we 
found no pro-inflammatory effects of fractions smaller than 10kDa in size. This evidence of 
both, pro-inflammatory and anti-inflammatory properties of MRPs might explain why in this 
study the pro-inflammatory effects of the complete undigested dAGEs is less than the largest 
fraction, because the smaller fraction may possess anti-inflammatory properties that level 
out the pro-inflammatory effects. This is also exemplified by the finding that glucose-lysine 
MRPs downregulated NFKBIA (IκB-α gene) in IFN-γ + PMA stimulated Caco-2 cells, which 
suggested that inactivation of the translocation of the NF-κB subunits could be a possible 
mechanism for the anti-inflammatory properties [15]. However, our results show that the 
pro-inflammatory properties predominate the anti-inflammatory properties of MRPs in our 
food-based matric 2xGC. It is important to note that the concentrations of proteins and 
carbohydrates used in this study are approximately 50x lower than would be encountered 
when drinking a large glass of reconstituted milk powder (300 ml). 
Under physiological circumstances, macrophages are not omnipresent in the GI tract. It would 
therefore be important to determine the local effects of dAGEs in the intestines. Currently, the 
effects of dAGEs on GI cells have barely been investigated. We therefore included preliminary 
experiments into the effects of dAGEs in this study on human GI cells.  Initially, we exposed 
Caco-2 cells to dAGEs that underwent gastric and gastrointestinal digestion in the TIM-1 
model.  Unfortunately, the enzymes and secretion fluids from the TIM-1 model led to a high 
cell death in Caco-2 cells and therefore it was decided to proceed with undigested dAGEs. The 
effect of dAGEs on the cell viability of Caco-2 cells was dependent on the preparation time, 
as different heating times of the carbohydrate-casein mixture led to different outcomes. Cell 
viability decreased significantly when cells were exposed to the highest test concentration 
of dAGEs heated for 120 minutes, whereas the 15 minutes heated preparation in the same 
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test concentration barely influenced cell viability. Longer preparation times lead to higher 
levels of dAGEs and as a consequence more RAGE activation that lead to apoptosis, which 
might explain the decreased cell viability [8]. A similar outcome was seen in our previous 
study with human macrophage-like cells concerning both cell viability and TNF-α secretion 
[4]. These results indicate that in studies assessing the effects of dAGEs and MRPs in general, 
the type of food processing treatment defines the outcome. Similar results were found by 
other studies, although different compounds and effects were studies. When Pérez-Burillo et 
al. (2018) assessed the effects of different food products and different cooking techniques on 
the microbial composition and short-chain fatty acid production of human colonic bacteria, 
the results greatly depended on the type of food product and the cooking technique [16]. 
These results were underlined by the conclusions of the recent review of Snelson et al. (2019) 
on the effect of dAGEs on gut microbiota, in which only conflicting studies were found [17]. 
Since oxidative stress induces inflammation, we also investigated in this study the effects of 
dAGEs on the iROS production in the human gastrointestinal epithelial cell line Caco-2 [18, 
19]. Both the unheated casein-lactose-glucose mixture and the casein control sample caused 
an increase in iROS production in Caco-2 cells. These findings suggest that the increased iROS 
production caused by the unheated carbohydrate-protein mix emerges from the unheated 
casein, as the sugar control samples did not affect the iROS levels. Although casein, and 
especially certain peptides, are considered to have anti-oxidative properties [20, 21], one 
study exposing peripheral blood mononuclear cells to different milk protein fractions showed 
an increase in iROS levels [22]. Remarkably, in our present study heating diminished this pro-
oxidant effect in Caco-2 cells. This is in contrast to our earlier findings with macrophage-like 
cells, where we saw an increase in iROS levels after exposure to GC [5]. Hence, not only 
the biological effects of dAGEs are not only heat-treatment dependent, but also cell-type 
dependent. 
One of the difficulties that arises when assessing the biological effects of the MRPs, is that 
many different sub-sets of molecules are formed during the reaction. The Maillard reaction 
starts with the reaction between reducing sugars and amino acids, after which many different 
sequential and parallel reactions lead to many different molecules, among others dAGEs [23]. 
Even though the name ‘advanced glycation endproduct’ implies that these molecules are 
formed at a later stage of the Maillard reaction, the actual molecules formed in the final 
stage are called melanoidins [24]. Melanoidins are chemically not well-defined but literature 
suggests that melanoidins have anti-oxidative properties, which might be one explanation 
for the reduction seen in iROS production after heating of the carbohydrate-protein mixture. 
Yáñez et al. (2017) saw an increase in anti-oxidative capacity in sugar-milk protein combinations 
with increasing heating time [25]. This was measured through the radical scavenging activity 
of the sugar-protein combinations themselves. Opposite to the large melanoidin polymers, 
small MRPs have been shown to possess both anti-oxidative and pro-oxidative properties, 
depending on the amino acid and sugar starting the reaction [13]. Oh et al. (2017) stimulated 
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RAW264.7 macrophages with lipopolysaccharide (LPS) together with different sugar-amino 
acid MRPs. Lysine derived MRPs reduced LPS induced nitric oxide (NO) production, while 
arginine derived MRPs increased NO production. Especially fractions containing molecule 
sizes between 1 and 10 kDa of lysine derived MRPs reduced LPS-induced NO production [13]. 
In our experiment, the SEC data from the undigested dAGEs (figure 2A) shows the presence 
of molecules smaller than 10kDa.
 
To mimic an inflamed gastrointestinal tract, Caco-2 cells were exposed to macrophage-CM 
from macrophage-like cells which were exposed to dAGEs for 6 h. This condition has been 
shown to induce TNF-α secretion and TNF-α can have detrimental effects on the GI epithelial 
layer, such as oxidative stress, influencing cell growth and an increase in intestinal permeability 
[26]. Intriguingly, we could not detect any effects on intracellular ROS production caused by 
the exposure of the Caco-2 cells to any of the macrophage-CM. An explanation might be 
that the concentration of dAGE and subsequent TNF-α secretion was too low to induce the 
production of ROS in the Caco-2 cells. After exposure to a 1% (v/v) dilution of dAGEs (2xGC), 
macrophage-like cells excreted approximately 530 ± 252 pg/ml TNF-α (mean ± SD) (figure S1). 
In a previous in vitro study, to assess the effects of TNF-α on monolayer permeability, Caco-2 
cells were exposed to 10 ng/ml TNF-α to induce changes in Caco-2 intestinal permeability 
[26]. A different study used a concentration of 200 ng/ml TNF-α to induce IL-8 and IL-1β 
cytokine secretion of Caco-2 cells [27]. These concentrations are much higher than the 
concentrations secreted by the dAGE-exposed macrophages in our study. 
In conclusion, our study showed that after GI digestion, the pro-inflammatory potential of 
dAGEs on cells of the innate immune response persists and even increases. Larger molecular 
sized protein-bound dAGEs induce more TNF-α release than dAGEs of lower molecular 
size. In addition, based on our data, it can be concluded that biological effects of dAGES on 
gastrointestinal epithelial cells depends on the thermal processing conditions of the dAGEs. 
This may be an important finding for the future assessment of dAGEs on human health.
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Abstract 
Glucocorticoids are very effective anti-inflammatory drugs and widely used for inflammatory 
bowel disease (IBD) patients. However, approximately 20% of IBD patients do not respond 
to glucocorticoids and the reason for this is largely unknown. Dietary advanced glycation 
endproducts (AGEs) are formed via the Maillard reaction during thermal processing of food 
products and can induce a pro-inflammatory reaction in human cells. To investigate whether 
this pro-inflammatory response could be mitigated by glucocorticoids, human macrophage-
like cells were exposed to both LPS and AGEs to induce IL-8 secretion. This pro-inflammatory 
response was then modulated by adding pharmacological compounds interfering in different 
steps of the anti-inflammatory mechanism of glucocorticoids: rapamycin, quercetin, and 
theophylline. Additionally, intracellular reactive oxygen species (ROS) were measured and 
glucocorticoid receptor phosphorylation state was assessed. The results show that AGEs 
induced glucocorticoid resistance which could be mitigated by quercetin and rapamycin. No 
change in phosphorylation state of the glucocorticoid receptor was observed. Additionally, 
intracellular ROS formation was induced by AGEs, which was mitigated by quercetin. This 
suggests that AGE-induced ROS is an underlying mechanism to AGE-induced glucocorticoid 
resistance. This study shows for the first time the phenomenon of dietary AGE-induced 
glucocorticoid resistance due to the formation of ROS. Our findings indicate that food products 
with a high inflammatory potential can induce glucocorticoid resistance, these results may be 
of large importance to IBD patients suffering from glucocorticoid resistance.
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1. Introduction
The use of glucocorticoids is increasing due to the increased prevalence of chronic 
inflammatory diseases such as asthma, rheumatoid arthritis and inflammatory bowel 
diseases (IBD). Despite the good effectiveness of glucocorticoids as anti-inflammatory drugs, 
some patients do not experience the anticipated therapeutic response and appear to be 
resistant to these drugs [1,2,3]. The underlying molecular mechanisms of such glucocorticoid 
resistance is still poorly understood.
Under physiological circumstances, glucocorticoids diffuse across the cell membrane and bind 
to the alpha form of the glucocorticoid receptor (GR) [4]. After binding, the GR-glucocorticoid 
complex translocates to the nucleus and exerts its anti-inflammatory effect in several ways. 
Within the nucleus, GR homodimerises and binds to glucocorticoid responsive elements 
(GRE) in the promotor region of glucocorticoid responsive genes, thereby switching on anti-
inflammatory genes [5]. These genes include genes encoding for β2 adrenergic receptors 
and mitogen-activated protein kinase phosphatase-1 (MKP-1), which inhibits MAP kinases 
and thereby switches off pro-inflammatory gene expression [6,7]. Next to this, activated GR 
can increase histone deacetylation by recruiting histone deacetylase 2 (HDAC2) leading to a 
reduced expression of pro-inflammatory genes activated by the nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-κB). Lastly, glucocorticoids can also directly enhance 
the degradation of mRNA of pro-inflammatory genes such as that of tumor necrosis factor 
(TNF)-α [8,9].
Although the anti-inflammatory mechanisms of action of glucocorticoids are well understood, 
it is still unknown why glucocorticoid resistance occurs in some patients. The molecular 
mechanisms by which glucocorticoid resistance could arise have been reviewed by Barnes 
[3]. Phosphorylation of the GR seems to play an important role in causing glucocorticoid 
resistance. After phosphorylation of the receptor, its stability and its interaction with other 
proteins is altered, and nuclear translocation is decreased, thereby inhibiting its ability to 
bind to GRE [10-12]. Two specific proposed phosphorylation sites of the GR are serine (Ser) 
226 and 211 [13-14]. These sites can be phosphorylated in several ways. For instance, the 
mammalian target of rapamycin (mTOR) activates C-Jun N-terminal kinase (JNK) which directly 
phosphorylates Ser 226 of GR. Additionally, GR can be phosphorylated through activation of 
p38 mitogen-activated protein kinases (p38MAPK) [14]. Compounds inducing cell stress such 
as reactive oxygen species (ROS) can lead to an increase in phosphoinositide 3-kinase delta 
(pI3Kδ) and mTOR complex 1 activity, which eventually lead to less GR nuclear translocation 
through phosphorylation. Next, ROS can damage and thereby inactivate HDAC2 which 
contributes to a reduced sensitivity to glucocorticoids [15,16]. Hence anti-oxidants, such as 
the polyphenol quercetin could counteract the effects of ROS, ameliorating the sensitivity to 
the anti-inflammatory effects of glucocorticoids [17]. 
Recently, we were one of the first to show that dietary advanced glycation endproducts (AGEs) 
cause inflammation in human macrophages in vitro by binding to the receptor for advanced 
glycation endproducts (RAGE) [18]. After activation, RAGE signaling leads to the activation of 
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NF-κB via PI3K and additionally to the activation of p38MAPK. Furthermore, AGEs increase 
the formation of intracellular ROS [19,20]. Therefore, we hypothesized that dietary AGEs may 
induce glucocorticoid resistance in human cells of the innate immune response. 
Therefore, the present study aimed at investigating the effects of dietary AGEs on the anti-
inflammatory effects of cortisol in human macrophages and to unravel underlying molecular 
mechanisms by which dietary AGEs induce glucocorticoid resistance in these cells. 
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2. Materials and Methods 
2.1 Chemicals and reagents
Casein from bovine milk, α-lactose monohydrate, NaOH, sodium-phosphate, cortisol, 
theophylline, rapamycin, quercetin dihydrate, 2′,7′- Dichlorofluorescin diacetate (H2DCF-
DA), 2-mercaptoethanol, and thiazolyl blue tetrazolium bromide (MTT) were obtained from 
Sigma-Aldrich (Saint Louis, USA). D-glucose, glutamate, fetal bovine serum (FBS), Dulbeccco’s 
Phospate-Buffered Saline (DPBS) were obtained from Gibco (Thermo Scientific, Waltham, MA 
USA). Sodiumchloride, Triton-X, Tris-base, LPS and phorbol 12-myristate 13-acetate (PMA) 
were obtained from Sigma (Zwijndrecht, Netherlands). 
2.2 Preparation of dietary AGEs
Dietary AGEs were prepared as described previously [18]. In short, casein, glucose and lactose, 
in the proportions of milk powder (11 mM glucose, 0.2 M lactose, 10 g/L casein from bovine 
milk), were dissolved in 50 mM phosphate buffer (pH = 7.4) and heated in an Erlenmeyer 
flask on a heating plate at 100°C up to 15 min. After 15 minutes, a sample was taken out 
and put in ice water. Samples were aliquoted and stored at -80°C. The concentrations of 
several individual AGEs have been published in our previous study [18]. MG-H1 was present 
in concentrations of 1.6 ± 0.9 μg/ml (mean ± standard deviation (SD)), CML concentration 
was 0.6 ± 0.5 μg/ml.
2.3 Determination of endotoxin in dietary AGEs
Endotoxin presence in the AGE preparation was assessed by the PYROGENT Gel Clot LAL 
Assay with a 0.06 EU/ml sensitivity (Lonza, Basel, Switzerland). The assay was performed 
in accordance to the manufacturer’s protocol using endotoxin-free dilutions and reagent 
tubes (Lonza, Basel, Switzerland). Only endotoxin-free samples were used in cell culture 
experiments.
2.4 Cell culture and exposure 
THP-1 monocytes (ATCC, TIB- 202) cultured in RPMI 1640 with L-glutamine, Hepes and 
phenol red (Gibco, Thermo Scientific, Waltham, MA USA) supplemented with 10% (v/v) FBS, 
D-glucose (4.5 g/L), Na-pyruvate (1 mM) and 2-mercaptoethanol (50 μM), were seeded in 
a 96-wells plate in a cell density of 70,000 cells/well and differentiated into macrophages 
by adding 200 nM of PMA to the cell culture medium and culturing them for 72 h. After 
differentiation, the cells were exposed to 10% (v/v) AGEs, different concentrations of LPS, 
cortisol, theophylline, rapamycin, and quercetin in serum and phenol-red free culturing 
medium and always in a 50% DPBS solution. Exposure concentrations of the compounds in 
the AGEs were: 0.16 ± 0.09 μg/ml MG-H1, 0.06 ± 0.05 μg/ml CML, 1.1 mM glucose, 20 mM 
lactose and 1 g/L casein. Control conditions included phenol-red free culturing medium and 
50% DPBS. Ethanol (maximum 0.17 v/v%) was used as vehicle control for cortisol, theophylline 
and quercetin. DMSO (0.1 v/v%) was used as vehicle control for rapamycin.
Chapter 5
106
5
2.5 Quantification of Interleukin (IL)-8 release by ELISA
Interleukin (IL)-8 release in cell culture supernatant was assessed by a commercially available 
ELISA kit (R&D systems, Minneapolis, USA). The assay was performed in accordance to the 
manufacturer’s protocol. 
2.6 Quantification of glucocorticoid receptor protein levels by Western Blot
THP-1 monocytes were seeded in a 6 wells plate with a cell density of 2,100,000 cells/ml 
and differentiated into macrophages by adding 200 nM of PMA to the cell culture medium 
and culturing them for 72 h. After differentiation, cells were exposed to 50% DPBS, 10% 
(v/v) AGEs and 3 ng/ml LPS for 24 h. After incubation, cells were lysed with a Triton buffer 
consisting of 150 mM sodium chloride, 0.1% Triton-X, and 50 mM Tris pH 8, and protein 
content was assessed with the BCA Assay (Thermo Scientific, Waltham, USA) according to the 
manufacturer’s protocol.
A sample of 10 µg with reducing laemmli buffer was loaded onto a 10% mini protean TGX 
precast gel (Bio-rad) and run in a Bio-rad cel. Protein was transferred to an Immobilon-P 
PVDF Membrane (Merck, Darmstadt, Germany). Membranes were analysed using Amersham 
Imager 600 (GE Healthcare). Primary antibodies used: Glucocorticoid Receptor (D6H2L), 
Phospho-Glucocorticoid Receptor (Ser211), and β-actin (13E5) from Cell Signaling Technology 
(Danvers, USA), Anti-phospho-Glucocorticoid receptor Ser226 from Millipore (Temecula, USA). 
Secondary antibody used: Anti-rabbit IgG, HRP-linked Antibody (Cell Signaling Technology).
2.7 Quantification of ROS levels by DCFH-DA assay
Intracellular ROS levels were quantified using the DCFH-DA assay. This assay measures 
intracellular ROS by their capacity to oxidise 2′,7′- Dichlorofluorescin diacetate (H2DCF-DA) 
to the fluorescent DCF [21]. In this study THP-1 monocytes were cultured and seeded into a 
96 wells black plate/clear bottom with PMA according to the aforementioned method. After 
differentiation, cells were exposed to 50 µM of H2DCF-DA for 1 h. Supernatant was removed 
and cells were exposed to 10% AGEs, 3 nM cortisol and different concentrations of quercetin 
for 24 h. Control samples were exposed to 50% DPBS and the vehicle control of cortisol and 
quercetin was ethanol. After 24 h fluorescence of DCF was measured at λ excitation = 485 nm 
and λ emission = 525 nm, corrected for baseline fluorescence and taken as a measurement 
for intracellular ROS. To calculate the relative values, fluorescence of cells exposed to only 
regular THP-1 culture medium was taken as 100%.
2.8 Statistics
Experiments were performed in duplicate on different days using the average of the duplicates 
as one value. Data were analysed using the GraphPad Prism software (v 5.00, GraphPad 
Software, San Diego, USA). Western Blot results were analysed using ImageJ (v1.52e, Wayne 
Rasband, International Institutes of Health, USA). Data obtained were tested for normality 
by using D’Agostino & Pearson omnibus normality test. Data were analysed with the non-
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parametric one-way ANOVA Kruskal-Wallis test followed by Dunn’s Multiple Comparison Test 
or Mann-Whitney U test to compare two sets of treatment. Significance level was set to p  < 
0.05. Significance is indicated as: *= p < 0.05; **= p < 0.01; ***= p < 0.001. 
 
Chapter 5
108
5
3. Results
3.1. AGE-induced glucocorticoid resistance 
Differentiated THP-1 cells were exposed to different concentrations of LPS and AGEs for 24 
h, after which IL-8 secretion was assessed by ELISA and cell viability assessed by MTT. No 
cell death occurred after exposure to LPS and AGEs (data not shown). Cells were exposed to 
different concentrations of LPS and AGEs (data not shown) to test which concentrations of 
the different compounds lead to a similar IL-8 secretion. Figure 1 shows that exposing the 
macrophage-like cells to either 3 ng/ml LPS, or 10% AGEs as eventual chosen conditions led 
to the same IL-8 increase. To determine the anti-inflammatory effect of corticosteroids on 
both AGE- and LPS-induced inflammation, cells were exposed in an additional experiment to 
different concentrations of cortisol in combination with 10% AGEs or 3 ng/ml LPS. As shown in 
figure 2, 3 nM cortisol was significantly less able to decrease the AGE-induced IL-8 secretion 
compared to the LPS-induced IL-8 secretion which is highlighted in the insert of figure 2. To 
distinguish the mechanism by which AGEs induce glucocorticoid resistance, the effect was 
modulated with compounds that interfered in different pathways involved in glucocorticoid 
resistance, as depicted in figure 6. This further inquest into the underlying mechanism was 
only performed with cells exposed to AGEs. The cells were exposed to all three compounds in 
different concentrations with and without AGEs and cortisol. Adding different concentrations 
of rapamycin to human macrophage-like cells led to a significant improved cortisol response 
with approximately 10% (figure 3A). However, this improvement by rapamycin did not follow 
a dose-dependent pattern. Theophylline alone did not have any anti-inflammatory effect and 
did not improve glucocorticoid responsiveness (figure 3B). Figure 3C shows that the anti-
oxidant quercetin itself at 5 μM did not reduce IL-8 secretion, but when adding quercetin 
together with cortisol, IL-8 secretion was reduced dose-dependently and significantly. Adding 
5 µM quercetin by itself led a decrease of only 5% (not significant) whereas the combination 
of 5 µM quercetin with cortisol led to a 27% reduction.
Figure 1. Absolute IL-8 secretion of human macrophage-like cells after 2 4h exposure to 3 ng/ml LPS, AGEs (10% v/v) 
or control (Ctrl) condition. Data presented as mean ± SD, n=3, p=0.05 (Ctrl vs LPS and Ctrl vs AGE).
Dietary advanced glycation endproducts decrease glucocorticoid sensitivity in vitro
109
5
Figure 3. Relative IL-8 secretion of human macrophage-like cells after 24 h exposure to AGEs (10% v/v), 3 nM of 
cortisol and; (A) different concentrations of rapamycin; (B) different concentrations of theophylline; (C) different 
concentrations of quercetin. Data presented as mean ± SD, n=3, * p < 0.05.
Figure 2. IL-8 secretion of human macrophage-like cells normalized to no cortisol after 24 h exposure to 3 ng/ml LPS 
or AGEs (10% v/v) and 3 – 300 nM of cortisol (n=4). Absolute IL-8 values of cells exposed to only LPS were 110 ± 20 
ng/ml and to only AGEs 154 ± 20 ng/ml,.Insert: IL-8 secretion of human macrophage-like cells relative to no cortisol 
after 24h exposure to 3 ng/ml LPS or AGEs (10% v/v) in the presence of 3 nM cortisol (n=4). Data presented as mean 
± SD, n=4, *p < 0.05 for LPS (3 ng/ml) vs AGE (10%) in the presence of 3nM cortisol. 
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3.2. Phosphorylation of the glucocorticoid receptor
Activation of mTOR can lead to GR phosphorylation and since the mTOR inhibitor rapamycin 
was able to reduce IL-8 secretion compared to cortisol, the next step is to explore a possible 
role for GR phosphorylation in AGE-induced glucocorticoid resistance. The cells were 
exposed to either the control condition, 10% AGEs, or 3 ng/ml LPS for 24 h. Protein levels of 
GR and phosphorylated GR were assessed by Western Blot and calculated relatively to β-actin 
(figure 4). No significant difference was found in phosphorylation state between the different 
conditions.  
Figure 4. Protein levels of GR, phosphorylated GR at serine (s) 211, and phosphorylated GR at serine 226. β-actin is 
shown as loading control.
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3.3. Intracellular ROS levels
As shown in figure 3, quercetin dose-dependently improved glucocorticoid responsiveness. 
To determine whether this could be related to mitigation of intracellular ROS levels by 
quercetin, cells were exposed to 10% AGEs, 3 nM cortisol, and different concentrations of 
quercetin for 24 h after which intracellular ROS levels were measured. As shown in figure 5A, 
10% AGEs increased intracellular ROS levels by approximately 50% compared to the control 
condition. Cortisol (3 nM) did not reduce intracellular ROS levels, while, quercetin alone did 
diminish intracellular ROS levels. Figure 5B shows that combining cortisol with quercetin led 
to a dose-dependent reduction of intracellular ROS levels. Quercetin (5 µM) significantly 
reduced intracellular ROS levels compared to 10% AGEs and 10% AGEs with cortisol.
Figure 5. Intracellular ROS levels of human macrophage-like cells exposed to 10% AGEs, 3nM cortisol (C), and 
different concentrations of quercetin. Baseline fluorescence of THP-1 cells was set at 100%. Data presented as mean 
± SD, n=4. 
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4. Discussion
In the present study, it is shown for the first time that dietary AGEs induced glucocorticoid 
resistance of macrophage-like (THP-1) cells. Exposure of THP-1 cells to dietary AGEs increased 
the production of IL-8, indicating an inflammatory response, which was comparable to the 
pro-inflammatory effect of 3 ng/ml LPS. The glucocorticoid cortisol was able to decrease LPS-
induced inflammation significantly better than AGE-induced inflammation. This indicates 
that exposure to dietary AGEs may lead to glucocorticoid resistance. Modulation of the 
pro-inflammatory response by different pharmacological compounds interfering in different 
steps of the anti-inflammatory mechanism of glucocorticoids showed that AGE-induced 
glucocorticoid resistance can be restored. The use of glucocorticoids is increasing due to 
the increased prevalence of chronic inflammatory diseases as asthma, rheumatoid arthritis 
and IBD. Despite the good effectiveness of glucocorticoids, some patients are resistant to 
these drugs. Glucocorticoid resistance is a disorder that is characterized by insensitivity 
to glucocorticoids [3]. Although much research already focused on the mechanism of 
glucocorticoid resistance, still it is not completely understood why some patients are 
insensitive to glucocorticoids, while others are not. Several mechanisms have been suggested 
to be involved in the development of resistance towards glucocorticoids. The present research 
aimed to identify the mechanism of AGE-induced glucocorticoid resistance by exposing THP-
1 cells to different compounds that interfere at different stages of the anti-inflammatory 
mechanism of glucocorticoids.
Barnes published an excellent review about the mechanisms of glucocorticoid resistance 
(figure 6) [3]. Phosphorylation of the GR was suggested as one important cause of such 
resistance. Phosphorylation of the GR at Ser226 and 211 inhibits the binding of the activated 
GR to GRE, resulting in a decreased expression of anti-inflammatory genes and consequently 
an increased expression of pro-inflammatory genes. One of the factors responsible for the 
phosphorylation of the GC is mTOR. Our results show that inhibition of mTOR by rapamycin 
increased the sensitivity of THP-1 cells to cortisol.  However, no differences were found in 
the protein levels of phosphorylated GC (at Ser226 and 211) between control conditions 
and AGE-treated cells. Even though rapamycin increased the sensitivity, these results suggest 
that phosphorylation of the GC at the two serine residues is not the main mechanism for 
AGE-induced glucocorticoid resistance. Another suggested mechanism can be mediated 
through oxidative stress. Oxidative stressors such as ROS are able to inactivate HDAC2 
through the formation of peroxynitrite and subsequent nitration of tyrosine residues of 
HDAC2 [16,22], thereby inducing glucocorticoid resistance [23,24]. HDAC2 normally ensures 
chromatin remodelling of pro-inflammatory genes, hence inactivation results in increased 
expression of pro-inflammatory genes, among which IL-8 [8]. It is therefore expected that 
antioxidants could ameliorate the sensitivity to glucocorticoids by increasing HDAC2 activity. 
In the present study, AGEs were found to increase the formation of ROS in THP-1 cells, which 
was significantly reduced by the antioxidant quercetin. Our results furthermore show that 
quercetin in combination with cortisol decreased IL-8 production, while quercetin alone did 
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not have this effect. The inhibition of IL-8 secretion by the combination quercetin and cortisol 
indicate that the anti-inflammatory effect of quercetin is dependent on cortisol. This can be 
explained by the improvement of the cortisol response by quercetin, which is in line with 
previous reported data from Mitani et al. (2017) [25] that proved that quercetin was able 
to restore glucocorticoid resistance in U937 monocytes. Our results show that AGE-induced 
glucocorticoid resistance is likely to be caused by formation of ROS. A plausible explanation 
for this effect is the damage of HDAC2 by ROS, rendering it inactive [15,26-28]. The strong 
antioxidant quercetin is able to improve glucocorticoid sensitivity by neutralizing ROS. The 
HDAC activator theophylline did not have any effect on AGE-induced inflammation and 
glucocorticoid resistance. This could be due to the fact that only very low concentrations 
of theophylline restores HDAC activity [29]. Secondly, theophylline might in fact not act 
on HDAC2, as was found by Ito et al. (2002) [30]. Theophylline seems to work at HDAC1 
and HDAC3 specifically, which could explain why no effect was seen in our study. However, 
since HDAC2 activation was not investigated in this study, future research may focus on the 
involvement of HDAC2 in AGE-induced glucocorticoid resistance.
Based on the results of this study and existing literature, the proposed mechanism by 
which AGEs induce glucocorticoid resistance is shown in figure 7. AGEs can induce ROS via 
two pathways. Firstly, AGEs bind to RAGE, which activates NADPH-oxidases, leading to the 
formation of ROS. Activation of RAGE also eventually leads to an increased iNOS expression 
[22,31]. AGEs themselves are formed under oxidative conditions and are pro-oxidant 
molecules which are also able to form ROS [32,33]. This AGE-induced ROS formation then 
inactivates HDAC2, leading to glucocorticoid resistance. What is the implication of these 
findings for humans? It is under debate whether dietary AGEs are absorbed within the human 
body, but they are present within the gastro-intestinal tract. Additionally, glucocorticoid 
resistance occurs in approximately 20% of people with IBD [1,2]. The results of the current 
study show that the type of food IBD patients eat may be of large importance to IBD patients 
suffering from glucocorticoid resistance. Studies are currently underway in our lab to analyze 
the digestion of dietary AGEs to investigate the effects of dietary AGEs on inflammation. In 
this way we hope to get a better picture of the role of this studies’ phenomena on the in vivo 
situation. Next to the potential negative effect of a high-AGE diet on glucocorticoid sensitivity, 
our study shows that at least one specific polyphenol, quercetin can increase glucocorticoid 
responsiveness. Additionally, another polyphenol, curcumin, has been shown to have a 
similar effect in a COPD model [34]. People eating high-AGE diets, containing many fried, and 
baked foods, might also eat less fruits and vegetables that contain many of the polyphenols in 
our diet. The question whether an inverse relation exists between AGE and polyphenol intake 
can be studied in the future.
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Figure 6. Mechanism of glucocorticoid resistance and the addition of the receptor for advanced glycation 
endproducts (RAGE) [3,19]. Glucocorticoids diffuse through the cellmembrane into the cell where they bind to 
the glucocorticoid receptor (GR). This complex then translocates into the nucleus where it exerts its effect. Under 
glucocorticoid resistance-conditions, a stressor activates phosphoinositide 3-kinase delta (pI3Kδ), thereby activating 
the PI3K/AKT/mTOR pathway leading to an increase in cJun protein which phosphorylates the GR and induces 
binding of the AP-1 protein to the GR, inhibiting the glucocorticoid-GR complex from translocating to the nucleus. We 
suggest that AGEs bind to RAGE thus activating both, PI3K- and p38 mitogen-activated protein kinase (p38MAPK)-
mediated phosphorylation of the GR. On the left side, the proposed effects of different compounds (in yellow) on the 
glucocorticoid resistance are shown. Quercetin inhibits PI3K and protects histone deacetylase 2 (HDAC2). Rapamycin 
is an mTOR and cJun inhibitor. Theophylline inhibits PI3K and activates HDAC.
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5. Conclusions
In conclusion: The present study showed for the first time indications that inflammation 
induced by AGEs is less well mitigated by cortisol than LPS-induced inflammation. Indicating 
that AGEs may cause glucocorticoid resistance by increasing intracellular ROS. Quercetin is 
able to improve the glucocorticoid response by reducing intracellular ROS levels. 
Figure 7. Proposed mechanism of glucocorticoid resistance caused by AGEs. The pro-oxidative AGEs lead to ROS 
formation. AGEs bind to RAGE, RAGE activates NADPH oxidases and upregulates iNOS which in turn induces ROS. 
HDAC2 is inhibited by ROS.
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Main findings
dAGEs induce pro-inflammatory effects in macrophages and have implications for human 
digestion, the cellular effects in gastrointestinal cells are thermal treatment dependent. 
During food processing, food products usually undergo thermal treatment. Under the 
influence of high temperatures, dietary advanced glycation endproducts (dAGEs) are formed 
via the Maillard reaction. Endogenous advanced glycation endproducts (AGEs) are known for 
their pro-inflammatory effects. However, the effects of dAGEs are less well-known, especially 
the effects in the gastrointestinal (GI) tract. The aim of this thesis was to investigate the 
potential local effects of dAGEs. To this end, 1) the pro-inflammatory potential of dAGEs 
was measured through TNF-α secretion, 2) the digestion of dAGEs was assessed using the 
sophisticated TNO gastroIntestinal Model (TIM-1), 3) the pro-inflammatory potential of 
digested dAGEs was assessed and the effects of dAGEs on gastrointestinal cells, and 4) the 
glucocorticoid sensitivity of cells exposed to dAGEs was assessed to see in what way dAGE-
induced inflammation may be mitigated.
In chapter 2 we examined the TNF-α secretion and cell viability of human macrophage-like 
cells exposed to glycated casein (GC) and the individual (free) dAGEs Nε-carboxymethyllysine 
(CML), Nε-carboxyethyllysine (CEL), and methylglyoxal-derived hydroimidazolone 1 (MG-H1). 
GC, which includes protein-bound dAGEs, induced TNF-α secretion in a dose dependent 
fashion, whereas the free dAGEs did not. Long heating times of GC reduced cell viability. 
Blocking the receptor for advanced glycation endproducts (RAGE) significantly reduced 
TNF-α secretion. The dAGE-protein binding stays intact during in vitro digestion of GC, 
ginger biscuits and apple juice (chapter 3). Glycation of casein slows down casein digestion 
compared to unglycated casein (UC). During GI digestion, endogenous formation of AGEs 
occurs largely depending on the type of food product. Exposing the human macrophage-like 
cells to the digested dAGEs induced a higher TNF-α secretion than undigested dAGEs (chapter 
4). The largest molecules in the GC show the highest pro-inflammatory potential, while the 
smallest fractions show no pro-inflammatory effect. In GI epithelial cells long heating times 
decreased cell viability while any heat treatment led to a decrease in intracellular reactive 
oxygen species (ROS) compared to the unheated samples. This indicates the importance of 
thermal treatment on the cellular effects. Inflammatory bowel disease (IBD) patients suffer 
from inflammation in the GI tract and one of the most commonly used anti-inflammatory 
drugs are glucocorticoids. dAGE-induced inflammation decreased glucocorticoid sensitivity 
of human macrophage-like cells (chapter 5). This dAGE-induced glucocorticoid resistance was 
mitigated by supplementation of the polyphenol quercetin, which can possibly be explained 
through scavenging of intracellular ROS.
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Discussion
dAGEs and pro-inflammatory effects: size matters
One of the reasons why the pro-inflammatory effect of dAGEs has been disputed in recent 
years is because the evidence on pro-inflammatory effects of dAGEs has not been consistent. 
Some studies found pro-inflammatory effects, others did not. Buetler et al. (2011) attributed 
the conflicting results to endotoxin presence, since they found no TNF-α secretion after 
eliminating their endogenous AGEs by TF-114 extraction. Because of this, in chapter 2 we 
first tested our dAGEs on endotoxin presence and only used endotoxin-free samples to treat 
the cells. Our dAGEs did induce TNF-α secretion, which could be attenuated by blocking 
RAGE with an antagonist. Opposed to the effect of GC, individual dAGEs CML, CEL, MG-H1, 
and acrylamide did not induce any TNF-α secretion. This indicates the importance of protein 
binding in order to exert a pro-inflammatory effect. This hypothesis has been mentioned in 
multiple studies [1, 2]. The importance of dAGE-protein binding might be related to their 
ability to bind RAGE. Which specific AGEs bind to RAGE is under much debate. Free AGEs 
such as CEL and CML do not seem to bind to RAGE, whereas AGE-modified proteins and AGEs 
containing a peptide backbone do [1-5]. This suggests a possible size-dependent interaction 
between RAGE and its ligands, which might be due to oligomerization of RAGE in the cell 
membrane. Therefore, protein-bound AGEs are able to bind more strongly to oligomerized 
RAGE compared to individual RAGE [3]. Xue et al. (2014) found indications that in the case 
of MG-H1-modified peptides, the imidazolone ring of MG-H1 seems to be important in its 
binding to RAGE [5]. 
The large structural differences between the RAGE ligands are striking and make it complicated 
to find the exact elements necessary for ligand binding to RAGE. To explore the size-dependent 
effects of dAGEs, in chapter 4 GC was fractionated according to size and the different fractions 
exposed to human macrophage-like cells. Our results showed that especially large fractions 
induced high levels of TNF-α secretion. Strikingly, individual fractionated samples led to a 
higher TNF-α secretion than the unfractionated samples. This indicates that different sizes 
of dAGEs can have different biological effects. Different sub-sets of molecules are formed 
during the Maillard reaction, called Maillard reaction products (MRPs). A sub-set named 
early glycation products have been shown in one study to exert anti-inflammatory effects 
by polarizing macrophages to the more anti-inflammatory M2 type in C57BL/6 male mice 
[6]. In a study of Oh et al. (2017), lysine-galactose MRPs of 3 to 10 kDa reduced LPS-induced 
inflammation in RAW264.7 cells [7]. This evidence of both pro-inflammatory and anti-
inflammatory properties of MRPs might explain why the unfractionated GC induces less TNF-α 
secretion than the individual fractions; the smaller fraction may possess anti-inflammatory 
properties, through potential inhibition of the translocation of NF-κB subunits, that level 
out the pro-inflammatory effects [8]. Despite the potential anti-inflammatory effects of 
smaller MRPs, the results in chapter 4 show that, at least in our food-based matrix, the pro-
inflammatory effects predominate the anti-inflammatory properties of smaller MRPs.
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Digestion of dAGEs
Before dAGEs may potentially exert these pro-inflammatory effects locally in the intestines or 
even systemically, they will first need to undergo digestion. Studies into the effect of gastric 
digestion on dAGEs are scarce and most studies are conducted using static in vitro models. 
In these models food products are most commonly exposed to synthetic gastric juice and 
pepsin set at a pH value of 2 – 2.5 for two hours. Human gastric digestion however is not a 
static environment; it is dynamic and includes peristaltic mixing and alternating pH levels [9]. 
The physiological pH levels in the stomach differ between 1  - 1.5 for basal levels and 5  - 7 
immediately after ingestion. After approximately three hours of ingestion, the pH returns to 
basal levels [10]. Additionally, digestive fluids and meal components are removed from the GI 
tract by both passive and active absorption [16]. Unfortunately, the static in vitro models do 
not take such physiological parameters into account.
Since almost all available studies on the digestion of dAGEs used these physiologically less 
relevant static in vitro models, in chapter 3 we assessed the digestion of dAGEs and their 
protein binding in the sophisticated TNO gastroIntestinal Model (TIM-1).  TIM-1 is a dynamic 
in vitro model which mimics the upper human GI tract. This model takes multiple parameters 
into account, such as: dynamic pH curves, peristaltic mixing, addition of bile and pancreatic 
digestive enzymes, and passive absorption of fluids and food compounds. We analysed both 
our food-based matrix (GC) and two actual food products: ginger biscuits and apple juice. 
Our results showed that the protein binding of dAGEs is able to survive gastric and small 
intestinal digestion and consequently stays intact throughout the whole GI tract. We also 
found a hampered digestion of GC compared to UC.
The results of our study are underlined by different studies using static in vitro models. In order 
to determine the effect of gastric digestion on dAGEs, Hellwig et al. (2013) exposed casein 
modified with Nε-fructoselysine, CML, and lysinoalanine to synthetic gastric juice and pepsin 
with a pH value of 2 at 37°C for two hours. In this study, modifying casein lead to a reduction 
of digestibility of casein in the intestines [11]. Although most of the physical parameters 
were taken into account, all dAGEs were exposed to the gastric juices for the complete two 
hours. This is not the case in the human body where constantly a small portion of the meal is 
transported to the duodenum and gastric emptying time is depending on the type of food [12, 
13]. In addition, several other studies have been published on the digestibility of dAGEs in the 
small and large intestine. Joubran et al. (2015) assessed the digestive proteolysis of glycated 
α-lactalbumin in adults and infant gastro-duodenal conditions [14]. The type of carbohydrate 
used in the experiments determined the extent to which proteolysis could occur. Digestion of 
glycated α-lactalbumin led to higher anti-oxidative properties, while other oligosaccharides 
protected against proteolysis. However, the details on what gastric conditions were used, 
were not disclosed in the paper and their method of thermal processing corresponded to 
neither endogenous nor exogenous conditions. Underlining these results, Zhao et al. (2017) 
saw a decrease in digestibility of β-casein and β-lactoglobulin after glycation with glyoxal [15]. 
In a different study, Pinto et al. (2013) subjected β-lactoglobulin and β-casein to a heating 
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regime of 90°C for 24 hours and found larger aggregates of casein combined with glucose 
than native casein, while glycation retarded the aggregation of β-lactoglobulin. Also, when 
heated both glucose-protein combinations were less sensitive to enzymatic digestion than 
their heated native counterparts [16]. Moscovici et al. (2014) found a decreased sensitivity of 
bovine lactoferrin glycated with fructo-oligosaccharides to proteolysis after heating at 60°C 
in a water restricted environment for 12 hours, and an enhanced proteolysis after 24 hours 
of heating [17]. Both studies indicate the importance of the starting product and thermal 
treatment on the effect on tertiary structure of the protein and thereby its digestibility. 
In addition to the above mentioned experimental studies, an excellent systematic review 
by van Lieshout et al. (2019) analysed the effects of glycation on protein digestibility and 
concluded that glycation decreases protein digestibility [18]. One explanation for the 
reduction of protein digestibility by the MR lies in the nature of the reaction itself. The major 
reactive site for the MR is the ε-amino group of lysine, and to a lesser extent the guanido 
group of arginine [19]. These same residues are also tryptic binding sites [20]. Consequently, 
this leads to a direct hindrance of the proteolytic cleavage sites [20, 21]. Additionally, indirect 
steric hindrance of the proteolytic cleavage sites can occur through binding to residues close 
to proteolytic cleavage sites, or it can cause cross-linking that inhibits access for proteases 
[18]. Alternatively, glycation may also promote proteolysis by opening up the tertiary 
structure of proteins (conjugation may interfere with refolding the protein after heating [21]), 
which was observed in the study by Moscovici et al. [17]. A recent human trial administering 
milk protein to healthy young men, which was glycated to different extents, found a reduced 
lysine availability that was dependent on the level of glycation. This reduced availability was 
only seen for lysine, not for the other amino acids [22]. Additionally, Joubran et al. (2017) 
found that the MR changes the functionality of the whey protein α-lactalbumin. They also 
found that the specific carbohydrate involved in the reaction determined the change of the 
protein [21].
Based on these studies it can be concluded that dAGEs themselves, and their protein binding, 
are not broken down in GI tract. The extent of digestion of dAGEs is depending on the raw 
materials and thermal treatment. Additionally, the binding of dAGEs to proteins leads to a 
decreased digestibility and bioavailability of amino acids, with lysine in particular, leading to 
a loss of essential and nonessential amino acids in food products.
Formation of AGEs in the GI tract
In addition to not being hydrolysed in the GI tract, the results of our TIM-1 study in chapter 
3 show a large increase in AGEs formed in the GI tract during digestion in the small intestinal 
tract. This effect was especially large in the digests of ginger biscuits, for which an increase 
of up to 400% of protein-bound MG-H1 was detected. These results correspond to previous 
studies using different static in vitro studies, which have also showed endogenous formation 
of AGEs within the GI tract. One of these studies showed that simulated digestion of 
ovalbumine with fructose alone produced compounds with a fluorescence spectrum that 
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is characteristic for AGEs [23]. In line with this, DeChristopher suggested that the formation 
of fructose-derived AGEs in the small intestine can be explained by fructose malabsorption. 
This may consequently lead to increased serum AGE levels [24, 25]. Fructose malabsorption 
can occur when the ratio of fructose to glucose is higher than 1:1, or when an individual has 
a fructose transporter deficiency.  Ratios higher than one can be found in for instance high 
fructose corn syrup (HFCS) and apple juice. Normally, fructose is passively transported in 
the intestinal cell by glucose transporter 5 (GLUT5) and transported into the bloodstream 
by glucose transporter 2 (GLUT2) [26]. However, evidence suggests that glucose enhances 
fructose absorption in humans possibly through co-absorption with glucose via GLUT2 [27, 
28]. As a consequence of fructose malabsorption, its levels will increase inside the intestines, 
which might eventually lead to the increased formation of AGEs due to the more reactive 
nature of fructose in the MR than glucose. Although fructose-specific AGEs are not well 
defined, fructose seems to be 7 - 10 times more sensitive to glycation than glucose [23, 29].
However, many of these studies focussed on fructose based dAGEs. The effect of glucose 
on the intestinal AGE formation was also shown by Martinez-Saez in an unheated meal 
resembling system [30]. Helou et al. (2017) proposed a different hypothesis for the formation 
of AGEs in the GI tract. In their study they used the TIM-1 model to assess the digestion of 
fluorescent soluble melanoidins/dAGEs from bread crust, and found an increase in fluorescent 
molecules in the digests [31]. The authors concluded that, since the TIM-1 model only has 
a temperature of 37°C, the increase was related to the release of soluble melanoidins from 
larger insoluble melanoidin-skeletons. This would mean that proteins conceal glycated parts 
that are released during glycation. However, our study included a hydrolysation step in which 
the dAGEs were detached from their proteins, circumventing this problem. We show that 
new AGEs are being formed and not released from their structures. UC did not lead to any 
endogenous formation of AGEs, indicating that the thermal treatment that food products 
undergo is vital for the formation of endogenous AGEs. In addition, in our study AGEs were 
only formed endogenously after digestion of products that also contained AGEs, which might 
indicate an underlying need for the presence of dAGE precursors in food, such as glyoxal and 
methylglyoxal. To our knowledge, no studies have focused on the role of dAGE precursors on 
intestinal AGE formation and this might be an interesting topic for future research.
Effects of dAGEs in the GI tract
After the ingestion of thermally processed food products, dAGEs enter the human GI tract. 
Evidence on the local effects of dAGEs in the GI tract remain scarce. An important question 
that arises is what the influence of the GI passage is on the pro-inflammatory potential dAGEs. 
To investigate this, the GC digests from chapter 3 were assessed on endotoxin presence and 
endotoxin-free samples were used to expose human macrophage-like cells in chapter 4. 
Our results showed that digested dAGEs maintain their high pro-inflammatory potential as 
illustrated by the increasing trend on the TNF-α secretion compared to undigested dAGEs. 
After correction for protein content, digested dAGEs are approximately four times more 
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pro-inflammatory than undigested dAGEs. It is important to note that the concentrations of 
digested GC used in this study are 100X smaller than the concentrations that are encountered 
in vivo in the human GI tract. In order to determine the effects of digested dAGEs on GI 
epithelial cells (Caco-2), similar experiments were conducted with these cells. Unfortunately, 
the Caco-2 cells did not respond well to the enzymes and buffers from the TIM-1 model, so 
undigested GC was used for further assessment of the effect of dAGEs on Caco-2 cells. The 
effect of dAGEs on the cell viability of Caco-2 cells was dependent on the preparation time. 
Cell viability decreased significantly when cells were exposed to GC heated for 120 minutes, 
whereas the 15 minutes heated GC barely influenced cell viability. Unfortunately, we were 
not able to assess cytokine secretion of Caco-2 cells. Intracellular reactive oxygen species 
(ROS) production of Caco-2 cells decreased after exposure to heated GC, indicating an anti-
oxidative effect. Remarkably, UC did increase intracellular ROS. This is opposite to the effects 
seen in chapter 5, where GC caused an increase in intracellular ROS in human macrophage-
like cells. Hence, the biological effects of dAGEs seem to be both thermal treatment and 
cell-type dependent. 
The thermal treatment dependency might be attributed to the different MRPs formed 
during food processing. The molecules formed at the last stage of the MR are melanoidins 
[32]. Melanoidins are chemically not well-defined, but literature suggests that melanoidins 
have anti-oxidative properties, which might be one explanation for the reduction seen in 
intracellular ROS production after heating of GC in our study. Yáñez et al. (2018) analysed the 
effect of the rate of MR on the formation of antioxidants during the reaction, through the 
measurement of DPPH radical scavenging capacity of MRPs. Their results showed formation 
of antioxidants especially in the intermediate and final stage [33]. Additionally, a faster 
MR rate (in the presence of glucose) led to a lower anti-oxidative capacity than when the 
MR progressed at a slow rate (in the presence of lactose). An explanation for the higher 
antioxidant formation can be the difference in chemical structure between lactose and 
glucose, leading to the formation of different compounds through the MR. In a different 
study aimed to analyse the anti-oxidative capacity of MRPs, biscuits were heated for different 
amounts of time, after which they were digested using a static in vitro digestive model [80]. 
Subsequently the digests were incubated with human faeces, after which DPPH, FRAP, and 
ICRED were measured. The results show increased anti-oxidative capacity after digestion 
and fermentation with faeces at higher preperation temperatures and longer durations. The 
following in vivo study in which WT male Wistar rats were given diets differing in MRP content 
showed possible probiotic activity in the colon for the diets high in MRPs [34].
One of the major whey proteins in milk and infant formula is α-lactalbumin. This protein 
possesses several biological properties among which serving as an antioxidant. Joubran et al. 
(2017) assessed the effect of glycation of α-lactalbumin with several carbohydrates (glucose, 
galactose and galacto-oligosaccharides) on its anti-oxidative properties and saw an increase 
in anti-oxidative capacity of glycated α-lactalbumin after in vitro digestion [21]. Chuyen et al. 
(1998) attempted to measure the anti-oxidative capacity of specifically Amadori products and 
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melanoidins and observed anti-oxidative properties by both compound groups. With higher 
capacity when the molecular structures of the melanoidins were larger [35]. Opposite to the 
large melanoidin polymers, small MRPs have been shown to possess both anti-oxidative and 
pro-oxidative properties, depending on the amino acid and sugar starting the reaction. Oh et 
al. (2017) stimulated RAW264.7 macrophages with LPS together with different sugar-amino 
acid MRPs [7]. Lysine derived MRPs reduced LPS induced nitric oxide (NO) production, while 
arginine derived MRPs increased NO production. Especially fractions containing molecule 
sizes between 1 and 10 kDa of lysine derived MRPs reduced LPS-induced NO production.
In addition to the inherent anti-oxidative properties of MRPs, bifidobacteria have been 
shown to be capable of using bread melanoidins as a carbon source, indicating a prebiotic 
potential of bread melanoidins. However, the melanoidins were not digested in a digestion 
model prior to microbial exposure [36]. Next to fermentation of dAGEs by the microbiota, 
due to the decreased digestibility of glycated proteins, unabsorbed amino acids and proteins 
are also transported into the colon. Protein fermentation in the colon is often detrimental 
due to the formation of several products that negatively affect the colon such as ammonia, 
amines, phenols and sulfides [37, 38]. As a consequence of dAGE fermentation by the 
microbiota and the accompanying produced compounds, the composition of the microbiota 
and its production of short-chain fatty acids (SCFA), which are generally considered anti-
inflammatory, can change [39, 40].
Our results have shown positive health effects of MRPs on GI cells and negative health effects 
on macrophages. This gives the indication that dAGEs may not cause inflammation in the GI 
tract of healthy people. However, people who already have a large presence of macrophages 
in their GI tract, such as IBD patients, may experience negative effects from dAGEs. Protein-
bound dAGEs may aggravate the already existing inflammation. The most commonly used anti-
inflammatory drugs used in IBD patients are glucocorticoids. Despite the good effectiveness 
of glucocorticoids, some patients are resistant to these drugs. Glucocorticoid resistance is a 
disorder that is characterized by insensitivity to glucocorticoids [41]. Approximately 20% of IBD 
patients suffer from glucocorticoid resistance [42, 43]. In chapter 5, we investigated whether 
the dAGE-induced IL-8 secretion from macrophages can be mitigated by glucocorticoids. 
The efficiency of the endogenous form of glucocorticoids, cortisol, was tested on both LPS-
induced inflammation and dAGE-induced inflammation. Our results showed that cortisol was 
less able to reduce dAGE-induced inflammation, indicating that exposure to dAGEs may lead 
to glucocorticoid resistance. The polyphenol quercetin was able to at least partly reverse the 
dAGE-induced glucocorticoid resistance by reducing intracellular ROS in human macrophage-
like cells. This indicates that next to the potential to aggravate intestinal inflammation, dAGEs 
from food products may interfere with the effectiveness of glucocorticoids, for instance in IBD 
patients, which are aimed to reduce inflammation.
Based on the results of this thesis, we conclude that the compounds formed during the 
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MR have diverse effects on human GI health, from pro-inflammatory to anti-inflammatory 
and from anti-oxidative to pro-oxidative. Consequently, interference with anti-inflammatory 
drugs may occur. We propose that the ratio of different subsets that are formed through the 
MR might the in heated food products might determine the biological effects.
Importance of starting product and thermal treatment
The results of all our in vitro studies show that the cellular effects are largely dependent on 
both the starting product (specific carbohydrates and amino acids) and the thermal treatment 
of the product. The endogenous formation of AGEs in the GI tract in chapter 3 was dependent 
on the food product. In both the THP-1 and Caco-2 studies (chapter 2 and 4), the outcomes 
were dependent on thermal treatment: GC heated for 120 minutes significantly decreased 
cell viability of THP-1 and Caco-2 cells. In contrast, heating GC attenuated intracellular ROS 
production of unheated casein (UC) in Caco-2 cells. Evidence on the importance of starting 
product and thermal treatment on biological effects can be found in literature as well [7, 44]. 
Recently, this has been nicely demonstrated by some studies assessing the effect of processed 
food products on the human microbiota. Diet is known to have a large influence on the 
composition of the intestinal microbiota. One of the most well-known examples of the effect 
of diet on the microbiota is the difference in microbiome between breast-milk fed infants and 
infants fed with infant formula [45]. The microbiota of formula-fed infants has been shown to 
contain a decreased amount of bifidobacteria. Since bifidobacteria have been shown to have 
protective effects against pathogens and to fortify the intestinal immune system, a reduction 
in these bacteria may therefore compromise infant health [45, 46]. Infant formula contains a 
substantial amount of dAGEs and since protein-bound dAGEs survive the GI tract, they could 
influence microbiota composition [47]. A recent review by Snelson et al. (2019) assessed 
the effects of dAGEs on gut microbiota regarding composition changes and SCFA production 
[48]. Concerning the microbiota composition, conflicting results between the in vitro and 
animal in vivo studies were found. Their conclusions however were that in animals, high-
dAGE diets were associated with a decrease in Bacteroidetes, bifidobacteria, lactobacilli and 
α-diversity (the number of different species). It is generally considered that a decrease in all 
these three species and the α diversity leads to a less healthy GI tract. The effects of dAGEs 
on the microbiota seem to be dependent not only on the type of food or glycated material 
used, but also on biological differences between indivduals [31]. In general, human in vivo 
studies assessing the effect of dAGEs on microbiota are scarce. Most studies on the effect 
of dAGEs on the microbiota only used one type of food product or glycated material and 
one type of heating, which is not an optimal representation because treatment and starting 
product largely influence the outcome. This was additionally shown in a recent in vitro study 
by Pérez-Burillo et al. (2018), who analysed the effect of different foods products (chickpeas, 
bread, red pepper, banana, and chicken) on SCFA production [49]. All food products were 
prepared in different ways (i.e. roasted, fried, boiled, and grilled). The food products were 
digested with a static in vitro GI digestion model and consecutively fermented in vitro. After 
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in vitro fermentation, SCFA production was analysed as well as the microbial community 
composition. Their main findings confirm that the effects on the microbiota both greatly 
depended on the type of food product and the cooking technique. It must be noted that the 
analyses of the food products focused on furosine (early glycation), and 5-(hydroxymethyl) 
furfural (HMF) (intermediate glycation), so the composition of specific dAGEs in the food 
products was not measured. It can be concluded that results of studies using only one type of 
starting product of thermal treatment should therefore be interpreted with caution and may 
explain the conflicting results found in literature concerning the effects of dAGEs.
Exposure assessment 
Our results show that dAGEs formed during the MR have diverse effects on human GI health, 
depending on the way of food processing and the type of food product. The question that 
remains is to what extent humans are exposed to dAGEs. Multiple databases exist on the 
presence of different individual dAGEs in food products. Most of these databases measure 
only the presence of CML in food products. Several complications occur when assessing the 
intake of dAGEs using a database. Firstly, many food products have to be prepared, and the 
method of food preparation largely determines the levels of dAGEs. Some people eat their 
steaks ‘raw’ while others cook it for a longer time and enjoy theirs ‘well done’. The effects of 
these preparation ways are however not included in the databases. Secondly, Niquet-Leridon 
et al. (2015) showed large differences in CML content between different brands of the same 
product. This might be due to use of different starting products, thermal treatment, and 
packaging [50]. Thirdly, as discussed before, many different dAGEs exist, and assessing the 
amount of one dAGE in a food product most likely does not give a proper representation 
of the total amount of dAGEs in the food product. Zhu et al. (2018) therefore proposed a 
panel of lysine-, arginine-, cysteine-, and nucleotide-derived dAGEs to estimate the amount 
of dAGEs in food products in a more accurate way [51]. Lastly, many of these databases 
make no distinction between protein-bound and free dAGEs, while our results show that this 
distinction is important to assess the possible effects. For future studies into the exposure of 
humans to dAGEs, it is therefore pivotal that a consensus should be made on the measuring 
techniques of dAGEs and to acknowledge the problem that occurs with different food 
processing techniques.
Even though some concerns exist on the currently available dAGE databases, it is still 
interesting to have an indication on the contribution of specific food products to the daily 
dietary intake of dAGEs. Scheijen et al. (2016) analysed many commonly consumed Dutch 
food products on the presence of CML, CEL, and MG-H1 [52]. We calculated the intake of 3 
dAGEs combined (CML, CEL, and MG-H1) per day per food item for the particular food item 
users from 19-30 years old in the Netherlands, based on the database published by Scheijen 
et al. (2016) and the Dutch National Food Consumption Survey [53]. Table 1 shows some 
examples of the food products within the top 15% range of the amount of dAGEs/day. The 
amounts of CML, CEL, and MG-H1 were summed up to give an overview on the total amount 
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in the product. 
Table 1. Average intake of 3 dAGEs combined (CML, CEL, and MG-H1) per day per food item for the particular food 
item users from 19-30 years old in the Netherlands.
Food product Average intake 
per day (g) [53]
dAGEs content 
(mg/100g) [52]
Daily exposure to 
dAGEs (mg/day)
Blood sausages 75.5 32 24.2
Beef steak (canned) 18.7 78 14.6
Cereals (frosted flakes) 27.1 39 10.5
Fried rice 10.9 91 9.9
Peanut butter (Calve) 51.5 18 9.3
Brown bread 6.7 100 6.7
Peanuts 31.7 21 6.7
Meat ball 10.1 60 6.1
Chicken Wings 4.6 127 5.9
Ginger biscuit 32.8 12 3.9
Can this be clarified by the Maillard reaction?
When looking at the top 15% of food products that contribute to the daily amount of ingested 
dAGEs in table 2, all products are subjected to thermal treatment during processing. Blood 
sausages, steak, and meat balls are all meat products containing proteins and sugars, as well 
as lipids that can contribute to the MR through the Namiki pathway. The cereals depicted 
are toasted corn topped with sugar syrup, leading to a faster reaction rate than normal 
cereals. Peanuts also contain 52% fat, 26% protein, and 3.1% sugars and are roasted at high 
temperatures. Brown bread has a relatively low amount of dAGEs per 100g compared to the 
other products, but the high consumption leads to a relatively high contribution to the total 
amount of dAGEs ingested per day. In general, the relatively high levels of dAGEs in these 
food products can therefore be clarified by the MR.
Populations at risk
Using the different dAGE databases and food consumption data from different population 
groups, it might be possible to distinguish groups of people that eat a lot of dAGEs and thus to 
define which people would be at higher risk for the intestinal effects of dAGEs. However, the 
effect of dAGEs on the intestinal health of healthy people is currently unknown. Our results 
indicate that healthy people will most likely not experience adverse health effects by dAGEs, 
as no pro-inflammatory effect was seen in Caco-2 cells. In contrast, our results show that 
people who already have an inflamed GI tract, such as IBD patients, may experience negative 
effects from dAGEs. Although scientific evidence is scarce, diet is known to play a role in the 
symptoms of IBD. Commonly given diet-related advice for IBD patients includes avoidance of 
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processed meat, fried foods, sugars and nuts [54, 55]. Interestingly, exactly these products 
are also listed in our exposure assessment in table 1 and thus contain a lot of dAGEs. Based on 
the pro-inflammatory effect of dAGEs seen in this thesis, it seems logic that patients suffering 
from IBD will need to avoid these products as they may benefit from eating less dAGEs.
In addition to a possible correlation between the exposure to certain food groups and 
the presence of IBD symptoms, another important aspect in IBD is the composition and 
functionality of the gut microbiota. Studies into the effects of AGEs on the microbiota in 
relation to IBD are scarce. An in vitro study exposed faecal samples of healthy volunteers 
vs ulcerative colitis patients to native bovine serum albumin (BSA) and glycated-BSA (with 
glucose) [56]. When exposing the microbiota from healthy volunteers to glycated-BSA, the 
colonic microbiota started to reflect that of ulcerative colitis patients. Moreover, in both 
ulcerative colitis and non- ulcerative colitis microbiota, an increase in sulphate reducing 
bacteria was seen when exposed to glycated BSA versus native BSA. Within the ulcerative 
colitis samples, a significant increase was seen after exposure to glycated BSA compared to 
native BSA in the numbers of Clostridium perfringens/histolyticum group and Bacteroides 
spp. and a significant decrease in numbers of bifidobacteria and E. rectale group. These 
changes were not seen in the control model. No changes in the SCFA concentrations that 
could be attributed to any treatment were seen in the models [56]. These results indicate 
that dAGEs may influence the already impaired microbiota of IBD patents. 
Irritable bowel syndrome (IBS) is a gastrointestinal disorder with frequent abdominal pain 
and changes in stool frequency and form, but no known underlying pathology or aetiology 
[57]. However, increased intestinal permeability and presence of activated immune cells in 
the GI tract have been found in IBS patients [57, 58]. Similar to IBD, IBS patients often report 
the influence of different food products on their symptoms. Also here, these symptoms could 
be influenced by the extent to which patients are exposed to dAGEs. Based on our results, 
any person suffering from a disease or a drug side-effect that influences the GI epithelial 
layer or leads to macrophage presence in the GI tract, may suffer from consequences of a 
high-dAGE diet. In addition to IBD and IBS, these disorders include, but are not limited to: 
intestinal ischemia, chemotherapy-induced mucositis, NSAID-induced enteropathy, intestinal 
infections, celiac disease, food allergy, and heartburn [59]. As discussed before, low gastric 
pH is important to protein digestion and the dAGE-protein binding is important for the pro-
inflammatory effects. Antacids neutralize the gastric acid to prevent heartburn, which might 
lead to even more protein-bound dAGEs in the GI tract [60].
Additionally, the use of specific food products as part of a specific diets may lead to a higher 
dAGE intake. For instance, lactose-free UHT milk may contain more dAGEs due to lactose 
being hydrolysed into glucose (reacts 10 times more rapidly than lactose) and galactose 
(reacts 20 times more rapidly than lactose) [61]. 
Finally, infants are a sensible group when it comes to GI health. During infancy, the GI tract and 
the immune system are still developing and have an important function in the development 
of allergies [62, 63]. Infant formulas contain protein-bound dAGEs due to the high processing 
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temperatures [64]. A study from 2008 showed 28 to 389 times more CML in infant formulas 
than breastmilk [47]. Hydrolysed infant formulas also contained significantly more CML than 
non-hydrolysed formula. Additionally, breast-fed infants showed approximately 46% lower 
plasma CML levels compared to the formula-fed infants, showing the uptake of CML into the 
systemic circulation in infants, although the majority of this CML was excreted via urine [47]. 
Strategies to reduce dAGEs in food 
Due to the possible effects of dAGEs in certain populations, it is important to find strategies 
that might reduce dAGEs in food products or reduce their health effects. Lund et al. (2017) 
nicely reviewed dAGE reducing strategies [61]. We will therefore only give a small overview 
of the most promising strategies here. Some pharmaceutical strategies to influence the MR 
in both the human body and food have been investigated. Aminoguanidine has for instance 
been suggested as a promising pharmaceutical to trap α-dicarbonyls in the early stages of the 
MR to prevent further formation of MRPs. However, clinical trials showed large side-effects 
and therefore this drug was abandoned. Next to pharmaceutical approaches, also food-
based strategies may be used to reduce dAGE production. In this regard, amines could be 
changed in food products by polyphenols to make them less reactive in the MR. Polyphenols, 
especially the oxidized quinones, can react with amines, thereby reducing dAGE formation 
[65]. However, this can influence protein functionality and may thereby reduce amino acid 
bioavailability. In addition to reducing dAGE formation, we have shown in chapter 5 that the 
polyphenol quercetin can also mitigate the negative effects of dAGEs endogenously. When 
it comes to trapping α-dicarbonyls, both polyphenols like epicatechin and the B6 vitamer 
pyridoxamine have been shown to trap α-dicarbonyls. 
A different strategy currently approved in Canada is the use of hexose oxidases in UHT and 
sterilized milk. Hexose oxidases prevent the specific reducing sugars containing six carbon 
atoms from reacting in the MR.  Since the MR can also be influenced by different conditions 
during thermal processing such as temperature, presence of diluents (e.g. water), and H+ 
ions, this allows for many possibilities to mitigate dAGE formation during food processing 
[66]. 
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Conclusions, future perspectives, and implications
In this thesis we investigated to what extent dAGEs may cause detrimental effects in the 
human GI tract. From the conducted studies, it can be concluded that dAGEs need to be 
protein-bound to exert a pro-inflammatory effect and that decreased digestibility of glycated 
proteins leads to the increased availability of protein-bound dAGEs throughout the complete 
GI tract. Moreover, besides the presence of dAGEs, also new endogenous AGEs are formed in 
the GI tract. Here in the GI tract, these AGEs are likely to exert pro-inflammatory effects, which 
may especially be detrimental in patients suffering from GI diseases involving inflammation. 
However, more research is needed to elucidate the exact effects of dAGEs in the GI tract 
in humans. It would be important to assess a possible correlation between IBD and IBS 
symptoms and dAGE-intake. In case such a correlation is established, clinical studies could be 
set up in order to assess the influence of both high-dAGE and low-dAGE diets.
This thesis has additionally pointed out several pitfalls in existing dAGE research. Firstly, due 
to the formation of many different compounds during the MR, many effects seem food-type 
and thermal treatment dependent. This is an important aspect that is currently not taken into 
account by many dAGE-researchers and may explain, to at least some extent, the conflicting 
results of many in vitro and in vivo studies. It is therefore pivotal to characterise the dAGEs 
and food product-extracts used in studies. To go even further, food-based matrices may not 
be optimal means to study the effects of dAGEs as they are simplified food products and do 
not contain many components that in the actual food products may inhibit or stimulate the 
MR as well as the biological effects. Although research of individual dAGEs is interesting from 
a mechanistic point of view, this cannot be used to draw conclusions on the overall effects of 
MRPs and food processing. Following up on this, we have shown that important differences 
are present between the inflammatory effects of protein-bound and free dAGEs, indicating 
that distinctions should be made between such dAGEs in assessing their biological effects.
Finally, our studies into the effects of digestion on the pro-inflammatory effects and 
endogenous formation of dAGEs give an important implication for risk assessment of 
food products in general, namely that the effects of digestion on food components is very 
important for their toxicological effects. The endogenous formation of dAGEs during digestion 
implies that including digestion studies in food risk assessment is pivotal for correct exposure 
assessment and thus for the correct assessment of potential risks.
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Samenvatting
Tijdens de bereiding van voedsel, zowel in de fabriek als in de keuken, wordt voedsel 
blootgesteld aan hoge temperaturen. Deze hoge temperaturen zorgen voor het verloop 
van een chemische reactie, genaamd de Maillard reactie. De Maillard reactie begint met 
de reactie tussen suikers en eiwitten, welke Schiff-basen vormt. Deze Schiff-basen reageren 
verder via meerdere opeenvolgende reacties tot advanced glycation endproducts (AGEs), 
een diverse groep moleculen die grotendeels bruin van kleur zijn. AGEs zijn volop aanwezig in 
bereid voedsel, te zien aan de bruinkleuring. De Maillard reactie verloopt ook in het lichaam, 
bij 37°C, met endogene suikers en eiwitten. In het lichaam zorgen deze endogene AGEs voor 
verschillende effecten, waaronder het veroorzaken en verergeren van ontstekingen. Ondanks 
deze kennis is het tot op heden niet bekend in hoeverre voedings-AGEs effect hebben in het 
menselijk lichaam. Via ons voedsel komen er veel voedings-AGEs terecht in het lichaam en 
voornamelijk in het maag-darmkanaal. De effecten van deze voedings-AGEs in de darmen 
zijn nog nauwelijks onderzocht. Het doel van dit proefschrift is daarom om de mogelijke pro-
inflammatoire (ontstekingsbevorderende) effecten van voedings-AGEs in het darmstelsel te 
onderzoeken en te inventariseren welke verschillende Nederlandse populatiegroepen vooral 
last kunnen hebben van deze effecten van voedings-AGEs.
Voedings-AGEs en ontstekingsreacties
Endogene AGEs veroorzaken ontstekingsreacties door het activeren van de receptor voor 
advanced glycation endproducts (RAGE). Activatie van RAGE zorgt voor de secretie van pro-
inflammatoire cytokines, zoals tumornecrosefactor-α (TNF-α) en interleukine-8 (IL-8). In 
hoofdstuk 2 hebben we humane macrofagen blootgesteld aan verschillende voedings-AGEs, 
waarna we de secretie van TNF-α en celdood gemeten hebben. De verschillende voedings-
AGEs bestonden uit eiwitgebonden AGEs en vrije AGEs. De eiwitgebonden AGEs werden in 
de vorm van geglyceerd caseïne (GC) geproduceerd door het verhitten van caseïne, lactose, 
en glucose in een fosfaatbuffer op 100°C gedurende 15 tot 120 minuten. De verschillende 
vrije AGEs waren: Nε-carboxymethyllysine (CML), Nε-carboxyethyllysine (CEL), methylglyoxal-
derived hydroimidazolone 1 (MG-H1), en acrylamide. De humane macrofagen produceerden 
TNF-α na blootstelling aan GC, de eiwitgebonden AGEs, op een dosis-afhankelijke wijze. De 
verschillende vrije AGEs veroorzaakten geen TNF-α secretie. Dit duidt op een belangrijke rol 
voor de eiwitbinding van AGEs als het gaat om de pro-inflammatoire effecten. Naast het pro-
inflammatoire effect zorgde een langere verhittingstijd van GC tot een verhoogde celdood 
van de macrofagen. Het blokkeren van RAGE met een antagonist leidde tot een significante 
reductie van TNF-α secretie, wat duidt op een RAGE-afhankelijk effect van eiwitgebonden 
voedings-AGEs. 
Vertering van AGEs
Voordat voedings-AGEs in het lichaam terechtkomen, worden ze eerst verteerd in het 
maag-darmkanaal. In hoofdstuk 2 hebben we laten zien dat het pro-inflammatoire effect 
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van voedings-AGEs afhankelijk is van de AGE-eiwitbinding. Tijdens de maag-darmpassage 
van voedingsmiddelen worden eiwitten afgebroken tot aminozuren, dit zou kunnen leiden 
tot de afbraak van de AGE-eiwitbinding, waardoor de voedings-AGEs een verminderd 
pro-inflammatoir effect zouden kunnen hebben. In hoofdstuk 3 hebben we verschillende 
voedingsproducten die rijk zijn aan voedings-AGEs (GC, speculaas koekjes en appelsap) 
blootgesteld aan een geavanceerd in vitro maag- en dunne darm model: het TNO 
gastroIntestinal Model-1 (TIM-1). Dit model bootst het maagdarmkanaal na en houdt rekening 
met meerdere parameters, zoals: dynamische pH-curven, peristaltiek, toevoeging van gal- 
en pancreasenzymen, en passieve absorptie. Tijdens de in vitro vertering van GC, speculaas 
koekjes, en appelsap bleef de AGE-eiwitbinding intact. Dit betekent dat voedings-AGEs hun 
pro-inflammatoire eigenschappen behouden in de dunne darm.  Als we de vertering van GC 
vergelijken met de vertering van ongeglyceerde eiwitten (UC), blijkt dat de aanwezigheid van 
eiwitgebonden AGEs de eiwit vertering vertraagt. Dit kan de biologische beschikbaarheid van 
essentiële en non-essentiële aminozuren verlagen en daarmee consequenties hebben voor 
de menselijke gezondheid. Daarnaast laten we zien dat tijdens de vertering van speculaas 
koekjes en appelsap nieuwe AGEs worden gevormd in de dunne darm. Deze kunnen bijdragen 
aan de pro-inflammatoire effecten. Dit effect lijkt ook product-afhankelijk te zijn, de toenames 
waren verschillend tussen de verschillende voedingsproducten.
Effecten van voedings-AGEs in het maag-darmkanaal
Om het effect van vertering op het pro-inflammatoire potentieel van voedings-AGEs te 
onderzoeken, hebben we in hoofdstuk 4 humane macrofagen blootgesteld aan de door TIM-
1 verteerde GC. Hieruit bleek dat de verteerde GC voor meer TNF-α secretie zorgt dan de 
onverteerde GC. Om te onderzoeken in hoeverre de grootte van de moleculen effect heeft 
op het pro-inflammatoir potentieel van voedings-AGEs zijn de onverteerde GC-samples 
gefractioneerd op grootte en zijn de humane macrofagen blootgesteld aan deze individuele 
fracties. Hier zien we dat de grootste moleculen in GC voor de meeste TNF-α secretie 
veroorzaken, terwijl de kleinste moleculen geen TNF-α secretie veroorzaken. Om het effect 
van voedings-AGEs in het maag-darmkanaal verder te onderzoeken hebben we darmepitheel 
cellen blootgesteld aan GC. Hoe langer de verhittingstijd van GC, hoe meer darmepitheel 
cellen doodgingen. In tegenstelling tot deze bevinding, zagen we ook dat hoe langer GC 
verhit is, hoe lager de productie van intracellulaire reactieve zuurstofcomponenten (iROS) 
door darmepitheel cellen was in vergelijking tot onverhit GC. Met deze resultaten laten we 
zien dat de specifieke thermische behandeling van voedingsproducten een belangrijke rol 
speelt in de uiteindelijke waargenomen biologische effecten van de voedings-AGEs.
AGEs en corticosteroïdengevoeligheid
Patiënten met inflammatoire darmziekten (IBD) zoals de ziekte van Crohn en Colitis Ulcerosa 
lijden aan chronische ontstekingsreacties in hun maag-darmkanaal. Om deze ontstekingen te 
behandelen krijgen deze patiënten corticosteroïden toegediend. Corticosteroïden zijn een van 
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de meest gebruikte anti-inflammatoire medicijnen, maar een groot deel van IBD-patiënten is 
(deels) resistent tegen deze medicijnen. In hoofdstuk 5 hebben we onderzocht in hoeverre 
voedings-AGEs de corticosteroïdengevoeligheid kan beïnvloeden in humane macrofagen. 
In dit hoofdstuk laten we zien dat GC de corticosteroïden-gevoeligheid van macrofagen 
verlaagt wat zou kunnen leiden tot corticosteroïden-resistentie. Deze ongevoeligheid kan 
worden gereduceerd door de suppletie met het antioxidant quercetine. Deze verhoging 
van corticosteroïde-gevoeligheid door quercetine komt waarschijnlijk door het wegvangen 
van iROS door dit antioxidant. Hiermee laten we zien dat voedingsproducten met een hoog 
pro-inflammatoir potentieel corticosteroïden-resistentie kan veroorzaken. Deze resultaten 
kunnen van groot belang zijn voor IBD-patiënten die een verlaagde corticosteroïden-
gevoeligheid hebben.
Algemene conclusie
Het huidige Westerse dieet zorgt ervoor dat mensen veelal worden blootgesteld aan 
voedings-AGEs. Deze voedings-AGEs worden voornamelijk gevormd tijdens de bereiding van 
het voedsel, waarbij temperatuur een belangrijke rol speelt. Voedings-AGEs veroorzaken 
een ontstekingsreactie in humane macrofagen. Voedings-AGEs zijn daarom een potentieel 
risico voor patiënten met inflammatoire darmaandoeningen. Om een pro-inflammatoir 
effect te kunnen uitoefenen moeten voedings-AGEs eiwitgebonden zijn, het verteringsproces 
van het maag-darmkanaal verbreekt deze AGE-eiwitbinding niet en er worden zelfs meer 
eiwitgebonden AGEs gevormd in het darmkanaal tijdens de vertering van voedingsproducten 
met hoge concentraties voedings-AGEs. Hierdoor blijven voedings-AGEs pro-inflammatoir 
tijdens en na de vertering. De duur van het verhittingsproces en de type en hoeveelheid 
suiker en eiwitten in de voeding zijn erg belangrijk voor de uiteindelijke biologische effecten 
van voedings-AGEs. Uit ons onderzoek komt naar voren dat voornamelijk mensen met 
inflammatoire darmziektes baat zouden kunnen hebben bij het verminderen van hun 
voedings-AGE-inname. Dit met als doel om hun symptomen te verminderen.
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Valorisatie
Het verhitten van voedsel is erg belangrijk voor de mensheid. Het zorgt voor het doden van 
pathogene organismen waarmee de voedselveiligheid verbeterd en stoffen kunnen worden 
vrijgemaakt of gevormd zoals bijvoorbeeld antioxidanten [1].
Het verhitten van voedsel kan ook voor ongezonde effecten zorgen. Een bekend voorbeeld 
is het verbranden van voedsel, hierdoor worden kankerverwekkende stoffen gevormd. Maar 
niet alleen het zwarte, verbrande deel van voedsel kan een negatief effect hebben. Het 
verhitten van voedsel leidt tot het verlopen van de Maillard reactie, een chemische reactie 
tussen suikers en eiwitten die versneld wordt door hoge temperaturen. Tijdens deze Maillard 
reactie worden bruinkleurige moleculen genaamd advanced glycation endproducts (AGEs) 
gevormd. In dit proefschrift hebben we laten zien dat deze voedings-AGEs verschillende 
biologische effecten kunnen hebben.
Het is tot op heden onbekend in hoeverre voedings-AGEs worden opgenomen in het 
lichaam. In dit proefschrift hebben we laten zien dat voedings-AGEs in de dunne en dikke 
darm terechtkomen in een pro-inflammatoire vorm. Deze informatie kan van belang zijn 
voor verschillende populatiegroepen. Ten eerste patiënten die lijden aan inflammatoire 
darmziektes zoals de ziekte van Crohn (CD) en colitis ulcerosa (UC). Deze ziektebeelden vallen 
onder de paraplu ‘inflammatory bowel disease (IBD)’. IBD lijdt tot ontstoken secties van het 
maagdarmstelsel door een onbekende oorzaak. De ziekte verlaagt de kwaliteit van leven van 
patiënten en gaat gepaard met veel pijn en verteringsproblemen [2]. De afgelopen decennia 
is de incidentie van IBD in Zuid-Limburg erg gestegen, van 17.90 per 100.000 inwoners in 1991 
naar 40.36 per 100.000 inwoners in 2010 [2]. In 2010 was de geschatte prevalentie van IBD in 
Nederland 613 per 100.000 inwoners [2]. De incidentie en prevalentie blijft momenteel stijgen 
in heel Europa [3]. Deze stijgingen kunnen verklaard worden door verbeterde diagnostische 
technieken, maar ook door omgevingsfactoren zoals voeding. IBD heeft een grote impact 
op de levenskwaliteit van de patiënt, maar heeft ook socio-economische consequenties. De 
ziekte wordt behandeld door middel van anti-inflammatoire medicijnen, en in het uiterste 
geval wordt een deel van de darm chirurgisch verwijderd. Binnen Europa heeft uiteindelijk 
30-50% van de IBD patiënten een chirurgische ingreep nodig [3]. Burisch et al. (2013) schatte 
de totale, directe, ziektekosten in Europa op 4.6 – 5.6 miljoen Euro. Naast deze ziektekosten 
is er ook relatief veel ziekteverzuim door IBD-patiënten en arbeidsongeschiktheid. IBD-
patiënten ervaren verschillende periodes van remissies en oplaaiingen van symptomen. 
Vooral bij deze symptomen zou het verminderen van voedings-AGEs kunnen helpen. Een 
groep anti-inflammatoire medicijnen die veel aan IBD-patiënten wordt voorgeschreven zijn 
corticosteroïden. Opmerkelijk genoeg is een relatief groot percentage, ongeveer 20%, van 
IBD-patiënten in zekere mate ongevoelig voor corticosteroïden [4, 5]. En de onderliggende 
oorzaak hiervan is tot op heden nog niet gevonden. Dit proefschrift laat zien dat voedings-
AGEs de potentie hebben om deze ongevoeligheid te veroorzaken of in ieder geval te 
vergroten. Een dieet laag in voedings-AGEs en hoog in polyfenolen zou de corticosteroïde-
Valorisatie
145
A
gevoeligheid kunnen verhogen in deze patiënten. 
Naast het potentiele effect van voedings-AGEs op de symptomen van IBD-patiënten kunnen 
voedings-AGEs ook de vertering van eiwitten beïnvloeden en daarmee de biologische 
beschikbaarheid van aminozuren beïnvloeden. AGEs worden ook gevormd in het darmstelsel. 
Deze resultaten zijn belangrijk voor de ontwikkeling van gezondere voedingsproducten 
door de levensmiddelenindustrie. Die hun bereidingsmethodes en grondstoffen kunnen 
aanpassen. 
Dit proefschrift laat zien dat er een aantal factoren zijn die belangrijk zijn voor de vorming 
van voedings-AGEs in voeding bij het maken en bewerken van deze voedingsmiddelen in 
de fabriek. Uiteraard ten eerste de temperatuur waarop voedingsmiddelen worden bereid, 
hoe lager de temperatuur, hoe minder voedings-AGEs er gevormd worden. Ook hebben we 
laten zien dat de biologische effecten en vorming van voedings-AGEs afhankelijk kunnen 
zijn van de voedings-matrix, hoogstwaarschijnlijk de verschillen in suikers en eiwitten. 
Fructose lijkt vele malen reactiever in de Maillard reactie dan bijvoorbeeld glucose. Glucose-
fructosestroop is een veel gebruikt zoetmiddel in de voedingsmiddelenindustrie, dit gebruik 
inperken zou eventueel voor minder inname van voedings-AGEs door consumenten kunnen 
zorgen. Ook kunnen eventueel de precursors van AGEs zoals glyoxal en methylglyoxal in eten 
verminderd kunnen worden door het aanpassen van de industriële bereidingsmethodes. 
Deze aanknopingspunten kunnen bijvoorbeeld gebruikt worden door de Nederlandse 
Voedsel- en Warenautoriteit (NVWA) voor verder verdiepend onderzoek. De NVWA kan dan 
deze informatie gebruiken om indien nodig een advies te schrijven voor de overheid. 
Naast de rol van levensmiddelenproducenten in het verminderen van de voedings-AGEs 
inname kunnen consumenten ook gezondere bereidingsmethodes in de keuken toepassen.
Naast het aanpassen van bereidingsmethodes kunnen verschillende stoffen aan het eten 
toegevoegd worden om de voedings-AGE-vorming en biologische effecten te verminderen. 
Polyfenolen zoals quercetine en epicatechine kunnen hierin van pas komen.
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Dankwoord
Lieve papa,
Eigenlijk begon dit dankwoord heel anders, over hoe ik 5 jaar geleden begon aan een groot 
avontuur en dat ik graag iedereen wilde bedanken die daar bij betrokken is geweest.
24 juni 2020, een week voordat ik dit boekje naar de drukker wilde sturen, werd onze hele 
wereld op z’n kop gegooid. Het doet me verschrikkelijk veel pijn en verdriet te bedenken dat 
jij er niet zal zijn bij mijn promotie, om jouw trotse hoofd daar niet te zien zitten op de eerste 
rij.
Zonder de kwaliteiten die je mij hebt doorgegeven had ik dit traject niet volbracht en was 
ik waarschijnlijk niet eens op het idee gekomen om er aan te beginnen. Je eigenwijsheid, je 
hunkering naar kennis, je zelfstandigheid. Jij kon je ook ergens volledig in verdiepen en dan je 
eigen ideeën vormen en je eigen weg nemen.
Tijdens mijn promotietraject begon jij ook wetenschappelijke artikelen te schrijven, zonder 
enige opleiding daarvoor. Ik weet nog dat je me opbelde en volledig ontstemd was dat je 
aanpassingen moest maken aan je artikel voordat ze het wilde publiceren, en dat ik moest 
lachen en je uitlegde dat dat juist heel erg goed was. Toen werd je weer trots. Jouw eerste 
artikel werd zelfs eerder gepubliceerd dan het mijne. Ik ben verschrikkelijk trots op je dat je 
dat gelukt is, net als dat ik weet dat jij verschrikkelijk trots op mij bent dat ik ga promoveren.
Ons hoofdstuk is veel te vroeg afgesloten, maar ik zal doorgaan in jouw gedachte, out-of-the-
box blijven denken en vertrouwen op mijn eigen kunnen.
Lieve papa, 
Dankjewel.
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Verder wil ik graag nog bedanken:
Iedereen die deel uit heeft gemaakt van mijn promotieteam:
Aalt, vanaf het moment dat ik voor mijn sollicitatiegesprek binnen kwam in jouw kantoor 
voelde ik me welkom. De wetenschappelijke discussies die wij samen konden voeren hebben 
mijn zelfvertrouwen erg gesterkt. Ik vond het ook geweldig om een half uur over de titel van 
een manuscript met je te kunnen discussiëren. Dankjewel dat je altijd mijn input en ideeën 
serieus nam en voor de vrijheid die ik altijd van je gekregen heb.
Antoon, naarmate het project vorderde kwam je meer in beeld. Ik vond het fijn dat je naast 
aandacht voor het inhoudelijke project, ook veel aandacht besteedde aan mijn ontwikkeling 
als onderzoeker en als mens. Bedankt voor alle opleidingsmogelijkheden en lessen rondom 
het project. Heel erg bedankt dat je altijd achter me stond, vooral in de moeilijkste periode. 
Ik kijk er dan ook naar uit om samen te blijven werken bij BuRO.
Misha, begonnen als AIO collega, geëindigd als co-promotor. Het is bijzonder gelopen! Als 
AIO-collega heel erg bedankt voor de gezellige lunches, koffies, borrels, onze tripjes naar 
BuRO, en de PET cursus in Wageningen. Ontzettend bedankt dat je me bent gaan helpen en 
uiteindelijk hebt toegezegd mijn co-promotor te zijn. Je bent een super co-promotor en ik 
weet zeker dat je nog veel toekomstige AIO’s succesvol gaat begeleiden. Bedankt dat ik altijd 
over alles bij je terecht kon en kan.
Antje, dankjewel voor alles dat je me geleerd hebt, je Gründlichkeit, en onze gezellige 
gesprekken. Ik kon altijd bij je terecht en dat heb ik altijd ontzettend gewaardeerd. 
Daarnaast wil ik graag de leden van mijn beoordelingscommissie bedanken: Prof. dr. Casper 
Schalkwijk, Prof. dr. Daisy Jonkers, Prof. dr. Dick Sijm, Prof. dr. Renger Witkamp, en dr. Hubert 
Deluyker.
Voordat ik aan dit AIO-traject begon zijn er een aantal docenten geweest in mijn Master 
opleiding die mij veel hebben geleerd, ondersteund, en me het vertrouwen hebben gegeven 
dat ik dit kon doen. Heel erg bedankt aan Renger Witkamp en Wilma Steegenga bij 
Wageningen University, and Lise Bjørkhaug Gundersen at the University of Bergen. 
A massive thank you to all my past and present Phartox  PhD colleagues for all the gezelligheid 
in the last 5 years: Alie, past roomie Charlotte, Christy, chatting and shopping buddy Ellen, 
George, crazy :) Gesiele, deep conversation buddy Julen, MTB buddy Kim, Kristien, LeTao, 
Merel, Ming, Mireille, my roomie Philippe, Quan, Rianne, Robert, Stefan, Shan, Sven, and 
Wenbo. 
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En natuurlijk alle andere collega's van Phartox: Frederik-Jan: heel erg bedankt voor alle hulp, 
Agnes, Agnieszka, Agi,  Alex M., Alex R. voor alle gezellige drankjes, Ben, Daniëlle, Geja, Ger, 
Gertjan, Guido, Harry, Helma, Jacques, Jan, Jos, Josephina, Lily, Lou voor alle praktische 
hulp, Marie-Claire, voor alle fijne gesprekken, Marie-José, Matthijs, Paul, Peter, Rian, Roger 
B: waar moet ik beginnen met jou te bedanken?, Roger G., en Sébastien.
De mannen van de spoelkeuken: Will en Alex, en Eddy voor het rondbrengen van de pakjes.
Iedereen bij WFSR die mij geholpen heeft: Stefan, Stanislava, Wouter, Astrid, en Toine
Iedereen bij Campus Venlo voor alle hulp en gezelligheid: Koen, Sanne, Jessica, Anouk, 
Cheng, Evy, Miriam, Tim, en natuurlijk Rob
My Maastricht family for all the love and laughter: Evelyn, Inge, Carey, Mirella, Frank, Julia, 
Daniela, Terezinha, Juan, Jana, Jasia, Anthony (and Caty) and including my fellow members 
of the PhD Academy social committee: Geert, Inēs, Jan, Martien, Mike, Nicolo, and Tate. 
Martijn voor alle koffietjes, en Guy voor de gezellige stapavonden en uitstap naar Carmen in 
Heidelberg.
Mijn schaatsmaatjes van de Limburgse Schaatsvrienden, met in het bijzonder Bram en Jorrit.
Ook heel erg bedankt aan de familie Cazemier en de familie van den Berg die mij altijd hebben 
ondersteund.
Mijn vrienden buiten Maastricht die me altijd zijn blijven opzoeken en waar ik veel fijne 
vakanties en tripjes mee heb beleefd: Anna en Sybren, Annelies en Tim, Dirk, Elske, Froukje 
en Tjalle, Frida en Sveinung, Imme en Teije, Joep en Eline, Jan en Miriam, Jeroen (ook voor 
het helpen met het idee van de cover), Jinthe, Linda, Loes, Mirthe, Rutger, en iedereen die 
ik misschien onverhoopt vergeten ben.
Of course my amazing and lovely paranymphs: Carmen and Bruna. Thank you for being my 
paranymphs, thank you for helping me to get to this defence through this horrible time. I 
love you both to bits. Ik kijk uit naar nog meer schnapps wandelingen in de Duitse heuvels 
Carmen!  
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En natuurlijk mijn familie:
Lieve Roel en Olga, heel erg bedankt voor alle fijne gesprekken en goede tips van de afgelopen 
jaren. Het is erg fijn om te weten dat ik altijd bij jullie terecht kan en ik zal de komende jaren 
ook nog zeker vaak bij jullie aankloppen om lekker te eten en te kletsen.
Lieve Jard, dankjewel voor alles. En Luc ook uiteraard!
Lieve mama, natuurlijk draag ik dit boekje ook deels op aan jou. Dankjewel voor alles. 
Dankjewel dat je me altijd hebt gestimuleerd om echt een VWO-diploma te halen, en nu sta 
ik hier! :)
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Timme van der Lugt was born on February 17th, 1990 in Amsterdam, The Netherlands. 
After finishing pre-university education at secondary school ‘Berger Scholengemeenschap’ 
in Bergen (NH) in 2009, she enrolled in the bachelor program “Nutrition and Health” at 
Wageningen University, after graduating in 2012 she continued with the Master program 
“Nutrition and Health” with the specialization “Molecular Nutrition and Toxicology”. During 
her master she worked at the Hormone Laboratory of the University of Bergen (Norway). 
Upon obtaining her Master degree in 2014, she worked at the chairgroup Nutrition and 
Pharmacology of Wageningen University before starting her PhD research at the department 
of Pharmacology and Toxicology at Maastricht University. From May 2015 until May 2020 she 
investigated the pro-inflammatory potential of dietary advanced glycation endproducts, as 
described in this thesis, under the supervison of prof. dr. A. Bast, prof. dr. A. Opperhuizen, dr. 
M. F. Vrolijk and during her first years under the supervision of dr. A.R. Weseler. During this 
period, she presented her work at several national and international conferences and won a 
prize for best poster presentation at the annual NUTRIM symposium 2015. Additionally she 
has completed the post-graduate education in Toxicology.
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